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ABSTRACT 
Survival from cancer is becoming a reality for more people in the world each year. 
Survival rate from colorectal cancer disease is approximately 80% one year after 
diagnosis, but falls to 62% at 5 years from diagnosis. Quality of life research in colorectal 
cancer to date has focused on investigating patients' experience during the diagnostic or 
treatment phase while the experiences of those who have survived this cancer have been 
ignored. 
Based on the concept of Health-Related Quality of Life (HRQOL) this study was focused 
on understanding and assessing the impact of colorectal cancer disease and its treatment 
on Greek patients' HRQOL over time. Also, this study sought to identify multiple factors 
(related either to patient or disease characteristics) that contributed to patients' HRQOL 
in both specific and general domains. Age, gender, stage at diagnosis, time elapse since 
diagnosis, income, education, colostomy appliance, disease recurrence, depression and 
communication between couples were examined for their effect on HRQOL over time. 
145 Greek outpatients (male 87, female 58) completed the Functional Assessment of 
Cancer Therapy-Colorectal (FACT-C) Quality of Life Instrument and the Mental 
Component of the Short Form 36 Health Survey questionnaire measuring both generic 
and disease-specific HRQOL, as well as the Center for Epidemiologic Studies Depression 
Scale (CES-D) to detect depressive symptoms, and the Enriching & Nurturing 
Relationship Issues, Communication & Happiness (ENRICH) scale to assess 
communication between couples, at an interval of either one year or more than 5 years 
since diagnosis. Statistical significance was set at (p<0.05) and data were analysed using 
the Statistical Package for the Social Sciences (SPSS). 
The findings suggest that patients who survived colorectal cancer experienced an overall 
high quality of life independent of the stage of disease at diagnosis or time since 
diagnosis. Among those factors that had a negative effect on patients overall HRQOL 
over time depression was the most prevalent. Stoma patients experienced an overall 
lower HRQOL than non-stoma patients. Most domains of HRQOL assessment such as 
physical, emotional and role functioning of stoma patients were negatively affected, but 
these did not reach statistical significance. Notably, stoma patients in this sample showed 
significantly more dissatisfaction with body image than patients without a stoma - a 
finding that was more prevalent in women. This may suggest that stoma formation 
negatively affects sexual function and body image. Finally, patients with lower incomes 
and a recurrence or metastatic disease also experienced a poorer HRQOL. 
It is recommended that a practice-based strategy is developed in Greece to assess the 
HRQOL and psychosocial functioning of these patients as well as the recommendation 
that in the preoperative stage, after surgery and in the rehabilitation phase for stoma 
patients to be assessed and supported by a specialist Stoma Care nurse. Other suggestions 




1.1 Background and Rationale of the Study 
Colorectal cancer is a major health problem since it is the second leading 
cause of cancer mortality in many -developed countries (Stewart, 2003). 
Approximately 1 million new cases of colorectal cancer occur in the world 
each year (Ferlay et al., 2001). In Greece, 1,670 new cases were officially 
registered in 1990 (Greek Cancer Registry Central Health Council, 2000), 
while in 2002 were estimated 3,769 new cases of cancer of colon and rectum 
according to GLOBOCAN figures (GLOBOCAN, 2002). The year 2004 the 
number of deaths by colorectal cancer was estimated to 2,126 people (WHO, 
2004). 
More men are affected by colorectal cancer than females (Fraser & 
Adelstein, 1982) while it is a disease that mainly affects the older adult 
population. So, more than half of patients are over 60 years old, with a peak 
incidence in people aged 70-80 years old (Engstrom et al., 1999; Jones, 
1999). 
The prognosis is influenced by a number of factors at the time of diagnosis 
including age, the type, size and position of the tumour, the extent to which 
the tumour has spread as well as the depth of penetration of the tumour 
through the bowel wall (Skibber et al., 2001). Survival rates are significantly 
improved when a diagnosis of early stage (Dukes A and B) is made (Table 
2.2). 
The most common therapeutic choice for colorectal cancer remains surgery. 
It may be used alone or in combination with radiotherapy and chemotherapy. 
The location and the extent of the malignancy will determine the type of 
surgical resection (Skibber et al., 2001). Left hemicolectomy, right 
hemicolectomy and sigmoidectomy are types of surgery which are used in 
the treatment of colon cancer. During these surgical procedures the piece of 
bowel that contains the cancer is removed and the two open ends are 
rejoined. The abdominoperineal excision is a treatment of choice for rectal 
cancer when the tumour is situated in the lower part of the rectum, resulting 
in a permanent colostomy. The anterior resection is a therapeutic choice for 
rectal cancer when the tumour is not very close to the anal sphincter, 
resulting in the preservation of the sphincter function (Skibber et al., 2001; 
Hoebler, 1997). 
Adjuvant therapy, chemotherapy or radiotherapy, is commonly given after 
surgery to eliminate any residual cancer and to reduce the risk of the cancer 
reoccurring. Also, they can be used with patients who may have a poor 
prognosis (Giles & Venables, 1994), or with patients who have developed 
secondary cancer in other parts of the body (Cancer BACUP, 2001). The 
effectiveness of chemotherapy and radiation therapy depends on some 
factors such as disease stage, methods of treatment, but before any 
conclusion is made, further research is required. 
The early detection of the disease, as well as the modern achievements in 
medicine and technology that have contributed to the development of new 
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therapeutic interventions, prolongs patients' survival changing colorectal 
cancer from being regarded as a life threatening illness to a chronic disease, 
for many patients. Across all disease stages, approximately 80% of patients 
now survive the first year after diagnosis from colorectal cancer and 
approximately 62% survive 5 years and beyond (Brenner, 2002). 
Although much work has been undertaken investigating people's experience 
of cancer during the diagnostic or treatment phase, little work had been done 
investigating people's experience of cancer and quality of life after 
treatment. The improvements in survival have required attention to explore 
the needs of patients as they enter the post-treatment/survivorship phase of 
their cancer journey (Zebrack, 2000; Given et al., 1997). It is becoming 
increasingly recognized that the survivorship phase is often a difficult and 
complex journey for many, with no guarantee that those surviving cancer 
will return to a state of "normal" health similar to the one experienced before 
their diagnosis of cancer or similar to healthy peers (Schag et al., 1994). This 
has resulted in increasing attention on the challenges faced by patients as 
they move into their post-treatment/survivorship phase with particular focus 
on understanding and assessing the impact of cancer survival on quality of 
life. 
The term Quality of Life (QOL) correlated with a broad range of conditions 
of life that result to a "good life", "well-being", "happiness", or "life 
satisfaction". These conditions of life include social indicators (wealth, 
safety), physical conditions, health satisfaction, or personal resources 
(including mental health and life perspective) (Rapley, 2003; Cella et al., 
2002). The WHOQOL Group (1993, p. 1) defines QOL as "An individual's 
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perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations values 
and concerns". Important QOL dimensions are: physical health, 
psychological state, level of independence, social relationship, personal 
beliefs and relationship to the environment (WHOQOL, 1993). Health 
outcomes research narrows the field to those domains or components of 
QOL that are important to patients and are experienced as a result of illness 
and medical procedures. Patients give their subjective information about 
perceived health and quality of life while a number of terms have been 
adopted into the literature to describe the Health Related Quality of Life 
(HRQOL) from patients' perspective (Sullivan, 2003; Cella et al., 2002). 
There is now consensus that the HRQOL should be an end point of concern 
alongside more objective measures (e.g. 5 year survival) in new cancer trials 
and intervention studies. Although there is not now an agreed definition of 
HRQOL, a definition accepted by David Cella has guided the assessment of 
this study and understanding of basic concepts. According to this definition 
"Health-Related Quality of Life is a subjective and multidimensional 
concept that refers to the extent to which one's -usual or expected- physical, 
emotional, social well-being are affected by a medical condition or its 
treatment" (Cella, et al., 2002, p. 11). For the cancer survivor, assessment of 
HRQOL should not only consider living with cancer symptoms (e.g. pain 
and fatigue) and treatment side-effects, such as a living with a colostomy, 
lymphoedema, amputation but also the broader aspects of the individual's 
psychological and social well-being. 
Research suggests that although the physical functioning of cancer survivors 
varies from site to site over time, the impairment of psychosocial 
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functioning of their quality of life and depression are common. A study by 
Schag et al. (1994) concludes that patients who survived lung, colon and 
prostate cancer all had psychological distress in the disease-free phase of 
their illness. Other issues purported to affect cancer survivors include fears 
of recurrence, metastases, and death, dependence on caregivers, survivor 
guilt and negative effects on the family (Barsevick et al., 1997). 
Especially for colorectal cancer, both surgical procedures, either low anterior 
resection or abdominoperineal excision necessitate dissections that may 
result in changing patients* physical and sexual functioning; very often with 
long-term impact. Particularly, anterior resection may damage the pelvic 
nerves that are involved in sexual functioning. Furthermore, with this 
technique, internal anal and sphincter control may be impaired (Skibber et 
al., 2001; Sprangers et al., 1995). During abdominoperineal procedure in 
men some nerve fibers are destroyed that are vital to the genital system, 
causing sexual dysfunction and impotence (Grumann et al., 2001; Allal et 
al., 2000; Hoebler, 1997; Sprangers et al., 1995). Sexual functioning is not 
the only area that is affected by the illness and its treatment. A variety of 
physical side-effects may still impair a patient's life after the surgery phase 
including diarrhoea, faecal leakage, frequencies of bowel movement, urinary 
problems and disturbed sleep (Lewis et al., 1995; Sprangers et al., 1995; 
Williams & Johnston, 1983). The degree to which these symptoms are 
experienced in stoma and non-stoma patients varies. On the other hand, the 
colostomy appliance is a consequence of surgery that is expected to cause 
considerable problems such as physical and social limitations, as well as 
psychological distress in patients' lives over time (Camilleri-Brennan & 
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Steele, 1998; Sprangers et al., 1995; McDonald and Anderson, 1984; 
Williams and Johnston, 1983). 
It is also well regarded that treatment should not be the only factor to shape 
people's perception of their HRQOL and cancer experience during the post-
treatment/ survivorship phase. Delvin et al. (1971) many years ago showed 
that people from a lower social class, with lower income, and poorer 
education experienced poorer quality of life. Ramsey et al. (2000) concluded 
that low income status is associated with worse outcomes for some aspects 
of HRQOL. Also, tumour factors such as location of tumour and stage of 
disease may interact with treatment determining HRQOL over time. 
Furthermore Health-Related Quality of Life is seen as a dynamic concept 
which can change over time as people change perceptions about their health 
outcome, or change their expectations in terms of specific life circumstances 
(often referred to as response shift bias) (Carr, 2001; Sprangers, 1999; 
Caiman, 1984). Therefore, an important area of consideration is how 
HRQOL changes during the post-treatment /survivorship phase. Deficits in 
peoples' HRQOL are experienced in emotional, physical, social functioning, 
and fatigue after six months and 1 year survival when compared with 
healthy populations (Arndt et al., 2004; Kopp et al., 2004). Regarding long-
term survivors, findings are very limited, and little if any work has examined 
the HRQOL of cancer survivors from Greece. 
Two recent studies (Rauch et al., 2004; Mosconi et al., 2002) have compared 
the long-term HRQOL of colorectal cancer survivors with those of the 
general population. These studies show that colorectal survivors reported a 
satisfied HRQOL, very often comparable with those of the general 
population in most QOL domains. 
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Knowledge of the experience of cancer over time is useful to clinicians to 
prevent possible late effects of the disease during follow-up evaluations, or 
to policy makers to plan specific health programs. 
Having identified the need for further research in relation to the colorectal 
cancer experience and its impact on quality of life of patients, years after the 
treatment and rehabilitation stage, the literature in this area was reviewed. 
Key areas were considered relevant to explore. Firstly, to identify the current 
evidence relating to the quality of life of patients who had survived 
colorectal cancer and the factors that contribute to the current quality of life 
status; secondly, to explore the evidence relating to the comparison of 
quality of life of these people with those of the general population. 
Such a review reveals that most studies on colorectal cancer at present have 
used HRQOL as an outcome of clinical trials but not as a primary end point 
of concern while studies that have evaluated long-term effect of colorectal 
cancer disease on HRQOL are very limited. Also, very few measure global 
HRQOL using validated disease-specific instruments. There appears to be 
no study that measures quality of life with a disease-specific measure such 
as FACT-C (Appendix 9) that comes from USA developers, in European 
population. 
1.2 Greek Patients with Colorectal Cancer 
In Greece, there is a mixed system of public-private funding and provision 
of health care services. Its development is based, to a large extent, on social 
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insurance. The Greek health care system constitutes three subsystems, which 
operate almost independently: (a) the National Health System, which 
comprises public hospitals, health centres, and the National Centre of 
Emergency Assistance, (b) the Social Security Institution and other Social 
insurance Funds, and (c) the private sector, with numerous diagnostic 
centres, private clinics, and laboratories. Colorectal cancer patients are 
treated in both public and private hospitals. Socio-economic status is the 
main factor that distinguishes cancer patients who seek medical care in the 
private hospitals in which they have to pay from those who are hospitalized 
in the public free hospitals. 
Regarding the care and information disclosure for cancer patients in Greece, 
withholding the truth from a cancer patient appears common. Only 25% of 
physicians admit that they reveal the diagnosis or prognosis to the patient 
with cancer (Mystakidou, et al., 1999). A recent study (Mystakidou et al., 
2002) found that only a small percentage (23%) of relatives of cancer 
patients believe that the diagnosis and prognosis should be revealed to the 
patients, while the majority (54%) of relatives believes that only 
"sometimes" they would agree for the patient to be informed. However, they 
are also of the opinion that patients should be given information on possible 
treatment choices (71%), and the complications or side effects of treatment 
(53%). It seems that caregivers take all the responsibilities, or even decide 
on the patients' behalf, and the person remains in ignorance. Although in 
most European countries, doctors tend to reveal the truth directly to patients, 
without the family's consent, this is not yet common practice in Greece; 
possibly as a result of strong family bonds. Strong family relations in Greek 
society, which are still traditional and collectivist, help parents with health 
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problems restore their morale by getting support from their adult children, 
and feeling useful to them. Thus, in the face of adversity, family members 
maintain their subjective quality of life through supportive family 
relationships, and may experience higher levels of life satisfaction (Efklides, 
Kalaitzidou, & Chakin, 2003). 
Regarding the psychosocial factors that may contribute to the adjustment of 
Greek cancer patients to their disease, Spanea, Anagnostopoulos, Kalantzi-
Azizi, and Skarlos (2005) have found that no medical ( e.g disease stage at 
diagnosis, type of surgery), demographic (e.g., age, education), or 
psychological (e.g., coping strategies) variables were associated with 
psychosocial adjustment (mental health functioning). The exception was 
anxious preoccupation (characterized by constant preoccupation with cancer 
and feelings of devastation, anxiety, tears and apprehension) which 
negatively influenced psychological well-being and adjustment. 
1.3 Objectives 
The present study provides an insight into a specific cultural group of 
colorectal cancer survivors that have not been investigated before. 
It attempts to evaluate specific dimensions of HRQOL and overall HRQOL 
of Greek Colorectal cancer survivors after the treatment phase of their 
cancer journey to mid/long term survival. It also identifies those factors 
(clinical, demographic) contributing to the current state of the HRQOL at 
one year after diagnosis and beyond. 
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1.4 Basic Research Questions 
The present study was designed to answer the following questions: 
1. How do Greek colorectal cancer patients perceive their HRQOL during 
the post-treatment /survivorship phase? 
2. What factors (clinical, demographic) influence colorectal cancer patients' 
HRQOL? 
3. How do HRQOL measures change for patients with colorectal cancer of 
different stages at diagnosis, and at different times since diagnosis? 
1.5 Overview of the Study 
Chapter 1 includes an introduction to the study that consists of general 
information about the problem of colorectal cancer. The problem of those 
people who have survived cancer of colon and rectum, the rationale, and the 
significance of the study, the cancer experience within the Greek context, and 
the study's objectives are also provided. 
Chapter 2 describes the problem of colorectal cancer emphasizing the 
epidemiology, etiology, symptoms and curative procedures. 
In Chapter 3 the relevant literature review examines the need and demand for 
consideration of HRQOL in colorectal cancer survivors as well as the effect 
that the disease and treatment have on patients' quality of life years after 
diagnosis. It specifically describes differences that were observed over time 
in quality of life between stoma and non-stoma patients. 
In chapter 4 the literature review describes the conceptual basis of QOL and 
how it has been constructed and debated into the literature. Also, it examines 
10 
the need and demand for HRQOL assessment in the context of the cancer 
expérience as well as the current methods of HRQOL assessment in cancer 
patients. 
Chapter 5 consists of the methodology of the research and présents the 
procédures and design used in this study. It focuses on investigating Greek 
patients' cancer expérience through a subjective assessment of their HRQOL. 
It présents the main objectives, research questions and the hypothèses of the 
study. Also included are a description and sélection of the populations and the 
sample, description and validation of the criteria instruments and description 
of data collection. The techniques for data analysis are also included. 
The findings of the study are presented in chapter 6. 
The discussion of the findings, implications, and recommendations for further 
related research are presented in chapter 7. 
Chapter 8 includes the conclusions, and the final section contains the selected 





This chapter gives an introduction to colorectal cancer. Consideration of the 
epidemiology, symptomatology, diagnostic techniques, staging and therapy 
of the disease are presented. An overview is also given of current screening 
perspectives for early detection of risk factors for individuals. 
2.2 Epidemiology of Colorectal Cancer 
Colorectal cancer, also known as large bowel cancer, refers to cancer of the 
colon and rectum. 
The epidemiology of colorectal cancer has generated more interest recently, 
because this disease may provide a particularly good model for the study of 
interactions of genes and environment in the aetiology of cancer (Skibber et 
al.,2001). 
Colorectal cancer is the third most commonly diagnosed malignancy in the 
U.S for both women and men after breast and lung cancer and prostate and 
lung cancer respectively (Jemal et al., 2003). In 2003, more than 130,000 
new cases of colorectal cancer were diagnosed in the U.S. (Jemal et al., 
2003). 
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Almost one million new cases occur in the world each year (Ferlay et al., 
2001). 
In 2004 in Europe the most common form of cancer was lung cancer (13.3% 
of all incident cases), followed by colorectal cancer with 376,400 incident 
cases (13.2%) and 203,700 (11.9%) was the number of colorectal cancer 
deaths in Europe the same year (Boyle & Ferlay, 2005). 
In the United Kingdom it is reported to be the second most common cause of 
cancer disease after lung cancer with 30,000 people diagnosed each year 
from which approximately 18,000 will die (Scottish Cancer Therapy 
Network, 2000). 
In Greece colorectal cancer is the fourth most commonly diagnosed 
malignancy for men after lung, prostate, and bladder cancer and the fourth 
cause of death after lung, prostate and liver cancer (GLOBOCAN, 2002). 
For women colorectal cancer is the second most commonly diagnosed 
malignancy after breast cancer and the second cause of death after breast 
cancer (GLOBOCAN, 2002). While in 1990 1,670 new cases were 
registered in Greece (Greek Cancer Registry Central Health Council, 2000), 
according to GLOBOCAN figures for Greece in the year 2002, 3,769 new 
cases of cancer of colon and rectum were registered, and in the same year 
the number of deaths by colorectal cancer was 2,031 (GLOBOCAN, 2002). 
A Similar number of deaths -2,126 deaths-from colorectal cancer was 
reported for Greece in the year 2004 by WHO data (WHO, 2004). 
The incidence of colorectal cancer is higher in North America, Western 
Europe, Australia and New Zealand, whereas the age-standardized 
incidence rate of colorectal carcinoma is very low in India and Africa. Sharp 
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increases in incidence have been seen in Eastern Europe and Japan and the 
incidence rates vary tenfold between developed and developing countries 
(Skibber et ah, 2001). 
The dramatic rise in incidence in some countries points to environmental 
rather than genetic factors (Skibber et al., 2001; Wilmink, 1997). 
Immigration from a low-incidence to a high incidence environment will 
increase a person's risk (Skibber et al., 2001). 
Advances in treatment increase the number of colorectal survivors over time. 
Across all disease stages, approximately 80% of patients now survive 
beyond the first years after diagnosis (Brenner, 2002). A 5-year survival rate 
of 61% is reported by the U.S. (Skibber et al., 2001). In Greece 10,253 
people survived 5-years after the time of diagnosis according the 
GLOBOCAN figures for the year 2002 (GLOBOCAN, 2002). The survival 
rate is around 41% to 42% in European and Indian registries (Skibber et al., 
2001). Lower survival rate of 32% and 38% are reported in China and 
developing countries respectively (Skibber et al., 2001).The lowest 
estimated survival rate of 30% is in Eastern Europe (Skibber et al., 2001). 
Survival rates are significantly improved when a diagnosis of early stage 
(Dukes A and B) is made. 
Male incidence adjusted for age and ethnicity, appears greater than female 
rates (Skibber et al., 2001). Age- specific registration rates of colon and 
rectal cancer show a 6.7 % increase for males and a 0.7 % increase for 
females in the Birmingham Cancer Registry per five year period during the 
period 1970 to 1987 in England (Wilmink, 1997). In Greece 1,937 men and 
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1,832 women diagnosed during the year 2002 with colorectal cancer 
(GLOBOCAN, 2002). 
It is suggested that women tend to be younger than men at diagnosis with 
mean ages of 55.1 years and 58.6 years respectively (Dukes, 1940). Also, 
women have been found to have a better prognosis than men depending on 
whether they have had children; nulliparous women having the same 
prognosis as men (Koch, McPherson & Egedahl, 1982). 
Colorectal cancer is a disease of elderly people. Less than 5% of colorectal 
cancer patients are under the age of 40, while more than half are over 60; 
with a peak incidence in people aged 70-80 years old (Jones, 1999). 
2.3 Aetiology and Risk Factors of the Disease. 
Colorectal cancer has long been recognized to have a familial component. 
Two features of colorectal cancer have been fundamental in the recent 
progress in understanding its genetics basis. First, the majority of colorectal 
cancer arises from premalignant adenomatous polyps and has a monoclonal 
composition. Second, there are two well-defined inherited syndromes that 
predispose to colorectal cancer although the number of hereditary colon 
cancer syndromes has been expanding rapidly. These are the classic familial 
adenomatosis polyposis (FAP) syndrome and hereditary nonpolyposis 
colorectal cancer (HNPCC) syndrome (Won-Seok Jo & Chung, 2004). 
The FAP is characterized by the development of multiple colonic adenomas 
and is caused by mutations in the tumor suppressor gene (APC gene) on 
chromosome 5. Although it is responsible for only 1% of colorectal cancers 
it has 100% lifetime risk for developing colorectal cancer before the age of 
40 years (Won-Seok Jo & Chung, 2005). The HNPCC may account for as 
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much as 6 % of the patients with colorectal cancer whilst the individuals 
who have nonpolyposis syndrome are considered to be at 80% risk for 
developing colon cancer by age of 50 (Bell, 2005; Bromer &Weinberg, 
2005; Won-Seok Jo & Chung, 2005;). 
Epidemiological factors have provided initial evidence about the specific 
factors that initiate the process of carcinogenesis in the large bowel mucosa. 
Amstrong and Doll (1975) first described the high correlations of incidences 
and mortality rate of colorectal cancer with the consumption of meat, animal 
protein and fat. Diets high in fat increase the production and change the 
compositions of bile salts. These altered bile salts are converted into 
potential carcinogens by intestinal flora (Hoebler, 1997). Among the risk 
factors studied are also the intake of red meats cooked at high temperatures 
due to neterocyclic amines that are then present. On the other hand dietary 
fiber has been found to protect against colorectal cancer (Skibber et al., 
2001). 
Patients with chronic ulcerative colitis have an increased risk of colorectal 
cancer (Bernhard & Hunry, 1998; Wilmink, 1997). Two independent risk 
factors for cancer among these patients have been well documented: younger 
age at diagnosis and extent of disease at diagnosis. The increased risk of 
patients with Crohn's disease (CD) is considered less certain (Wilmink, 
1997). 
Identification of colorectal cancer-related syndromes, as well as 
identification of all the other colorectal cancer-related factors, is very 
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important for a new approach to cancer risk assessment and cancer screening 
for affected individuals and their families, or for the general population. 
Table 2.1 demonstrates risk categories for colorectal cancer disease and 
screening recommendations. 
Table 2.1: Current Recommendations for CRC Screening for High-Risk, 
Intermediate-Risk and Average (Low)-Risk Individuals 
Risk Categories Screening Recommendations 
High-Risk Category 
- Patients with Familial Adenomatous Syndrome (FAP) 
- Patients with Hereditary Nonpolyposis Syndrome 
(HNPCC) 
- M Y H Polyposis Syndrom 
- If genetic test is positive: annual Flexible Sigmoidoscopy 
(FS) beginning at age 10-12 years; if no polyps, annual FS 
to age 40, then 3-5 years thereafter; for patients with 
attenuated F A P (AFAP) (characterized by germline A P C 
mutation, but fewer polyps) annual colonoscopy initiated by 
the age 25 years. 
If genetic test is negative: FS in all potentially affected 
relatives like Intermediate Risk Category for family history 
of colorectal cancer or Adenomatus Polyps. 
- Colonoscopy every 1-2 years beginning at age 25, or 10 
years before the earliest case within the family, whichever 
comes first, annual screening after age 40. 
- No official guidelines; like recommendations for 
screening in attenuated FAP. 
Intermediate-Risk Category 
- Peutz-Jegher's Syndrome (PJS) 
- Juvenile Polyposis Syndrome ( JPS) 
- Hyperplastic Polyposis Syndrome (HPS) 
- Patients with personal History of Adenomatous 
Polyps 
- Colonoscopy every 3 years starting at age 18 years. 
- Colonoscopy every 1 to 2 years starting at age 15 to 18 
years. 
- Colonoscopy 1 year after diagnosis and then every 2 to 3 
years. 
- Colonoscopy every 3 to 5 years. 
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- Patients with personal History of Colorectal Cancer 
- Personal history of Inflammatory Bowel Disease 
- Uncerative Pancolitis > 8 years 
- Crohn's Pancolitis >8 years 
-Left-sided ulcerative colitis >15 years 
-Personal history of Colonic Adenomas 
- Family history of Colorectal Cancer or Adenomatous 
Polyps: first-degree relatives with sporadic CRC or 
adenomas prior to age 60 or multiple first-degree 
relatives with CRC or adenomas); 
-Second or third-degree relatives with sporadic CRC or 
Adenomatous Polyps. 
- Colonoscopy 12 months follow resection; subsequently 
every 3 years. 
-Colonoscopy with 4 quadrant biopsies every 10 cm to rule 
out dysplasis every 1 to 2 years. 
- Colonoscopy beginning at age 40, or 10 years younger 
than the age at diagnosis of the youngest affected relative. 
The interval between normal colonoscopies should be 5 
years in this setting. 
-Recommendations like average-risk category for general 
population 
Average-Risk Category or Low Risk Category 
- Bloom's Syndrome 
- II307K APC Polymorphism 
-"Breast-colon cancer" syndrome (BRCA1 ) 
- General population at age 50 without: previous 
history of colorectal cancer or adenoma, one or more 
first-degree relatives 
- Colonoscopy starting in the early third decade of life. 
- Genetic test has little impact upon clinical management. 
- Screening is not recommented. 
Colonoscopy is considered the "gold standard". It is 
recommended every 10 years. Other recommended 
techniques include: Fecal Occult Blood Testing (FOBT), 
Flexible Sigmoidoscopy (FS), Double-Contrast Barium 
Enema (DCBE), Stool-Based DNA Testing. 
Won-Seok Jo & Chung, 2004; Bromer & Weinberg, 2004 
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2.4 Symptoms of Colorectal Cancer 
The symptoms of colorectal cancer depend on the stage of the disease and 
the area of the colon that is involved. The problem with colorectal cancer is 
that it may present with no symptoms at all in early stages, or its symptoms 
are also found in other conditions such as ulcers, gallstones, haemorrhoids or 
reactions to certain foods - conditions far less serious than colorectal cancer. 
The majority of patients present either with abdominal symptoms such as 
abdominal discomfort, a persistent (6 weeks) change in bowel habits, 
particularly looser stools or increased frequency, or symptoms of anaemia 
such as weakness and fatigue, rectal bleeding (especially if it is not 
associated with anal symptoms such as itching, pain or soreness) or mucus 
discharge per rectum. Persons whose cancer involves the rectum may 
experience a feeling of rectal fullness, painful spasms, change in bowel 
movements, and change in the diameter of stools. Pain, diarrhoea or 
vomiting may be other symptoms of colorectal cancer (Thompson & Wells, 
2006; Bell, 2005; Skibber et al.„ 2001; Hoebler, 1997). 
2.5 Diagnosis of Colorectal Cancer 
Early diagnosis is essential in maximizing the chance of survival (Bernhard 
& Hunry, 1998). Unfortunately, the diagnosis of colorectal cancer is often 
delayed due to the wide range of gastrointestinal problems common to the 
general population (Holliday & Hardcastle, 1979) as most symptoms are 
concerned with elderly populations (Curless, et al., 1994). The main 
diagnostic and screening method for colorectal carcinoma is colonoscopy. 
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Colonoscopy has the advantage of visual examination of the entire colon 
with the option of biopsies to be taken or polyps to be removed at the time of 
the procedure. This examination may be suggested after positive results 
obtained by other diagnostic tests (Bell, 2005; Bromer & Weinberg, 2005). 
Fecal Occult Blood Testing is usually used for detecting hidden blood in the 
stool. It has advantage that it is inexpensive and easy to accomplish but is 
not sensitive enough for detecting polyps and colorectal cancers since at 
many times both produce false positive and false negative results (Bromer & 
Weinberg, 2005; Hoebler, 1997). 
Flexible Sigmoidoscopy is also a visual examination of the rectum and lower 
third of the colon. The double-contrast barium enema is also a valuable 
diagnostic procedure of colorectal cancer and has a rate greater than 90% 
accuracy for detecting colon cancer and polyps 6 to 10 mm (Bromer & 
Weinberg, 2004). 
More recently, genetic tests that detect DNA alterations are used in the 
screening of the high-risk groups (Bromer & Weinberg, 2005; Won-Seok Jo 
& Chung, 2005). 
2.6 Staging Classifications and Prognostic Features 
The need for a staging system which would determine the treatment choice, 
allow comparisons among different surgical treatments, and determine 
prognosis, led to the first classification system which was introduced by 
Dukes in the 1930s (Table 3.2). Dukes' staging system has been modified 
many times over the years in order to include additional prognostic factors 
beyond the depth of tumor invasion and extent of lymph node metastases 
(Skibber et al., 2001; Hoebler, 1997).The American Joint Committee on 
20 
Cancer (AJCC) has developed the Tumour, Node, Metastasis (TNM) staging 
system for colorectal cancer that is compatible with Dukes system but it 
adds greater precision in identification of prognostic subgroups (Table 3.3). 
The T N M system describes the degree the tumour - usually started as a 
polyp and change in situ carcinoma - extent of invasion into gastrointestinal 
mucosa, the number and site of regional lymph nodes involved, as well as 
the spread of the cancer to other areas of the body. The T N M system also 
classifies a tumour based on histological grade, including four levels from 
well-differentiated to undifferentiated. 
As with most cancers, the stage of colorectal cancer at the time of diagnosis 
or at the time that treatment started is the most reliable prognostic factor. 
Furthermore, other independent prognostic factors for survival have been 
identified such as age, gender, carcinoembryonic antigen (CEA) level, 
vascular invasion, DNA content, tumour grade, (Skibber et al., 2001). 




Pathological description Five- year 
survival rate 
A Cancer confined to mucosa and submucosa >90% 
B l Cancer extends into the muscularis 85% 
B2 Cancer extends into or through the serosa 70%-85% 
C Cancer involves the regional lymph nodes 30%-60% 
D Cancer has metastasized to distant organs or 
structures 
5% 
Source: Mayer RJ :Tumours of the large and small intestine. In Isseibacher KJ , Braunwald E, Wilson JD, et 
al (Eds): Harrison's Principles of Internai Medicine (ed 13). New York, McGraw-Hill,1994,p 1428 
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Table 2.3: Colorectal cancer stage classification and grouping. American Joint Committee 
on Cancer (AJCC), (1997). 
Pathologic description AJCC (1997) Astler-Coller Modification 
Duke's Stage 
Carcinoma in situ (Tis) 
NO: No regional lymph node 
metastasis. 
MO: No distant metastasis 
Stage 0:Tis, NO, M O Stage 0 
Tumour invades submucosa (Tl) Stage I :T l ,NO,MO Stage I-A 
Tumour invades muscularis 
propria (T2) 
Stage I:T2, NO, M O Stagel-Bl 
Tumour invades muscularis 
propria into subserosa or 
nonperitonealized perirectal 
tissues <T3) 
StageII:T3, NO, M O Stage II-B2 
Tumour directly invades other 
organs or structures or perforates 
visceral peritoneum (or both) (T4) 
StageII:T4, NO,MO Stage II-B3 
Any degree of bowel wall invasion 
with regional node metastasis, 
without distant metastasis (Any T) 
N l : Metastasis in 1 to 3 pericolic 
or perirectal lymph nodes 
N2: Metastasis in 4 or more 
pericolic or perirectal lymph nodes 
N3: Metastasis in any lymph 
nodes along the course of a named 
vascular trunk 
Stage m : Any T , N l - 3 , M O Stage III-C1,C2 
Any degree of bowel invasion 
with or without nodal metastasis 
but with any distant metastasis 
M l : Distant metastasis 
Stage IV: any T, any N , any M l Stage IV-D 
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2.7 Curative Procedures for Colorectal Cancer 
Surgical intervention is the first line treatment of cancer of the colon and 
rectum. The location and the extent of the malignancy will determine the 
type of surgical resection (Skibber et al., 2001; Zaheer et al., 1998; Steele & 
Osteen, 1986). It can be used alone or in combination with radiotherapy and 
chemotherapy (CancerBACUP, 2001). 
The usual surgical intervention of tumour in the cecum and ascending colon 
is the high hemicolectomy, whereas carcinoma of the descending and 
sigmoid colon is surgically resected by left hemicolectomy. A transverse 
colectomy is the procedure of choice when the lesion involves the middle 
and left transverse colon (CancerBUCUP, 2001; Hoebler, 1997). 
The surgical intervention for rectal carcinoma has changed during the last 
decade. For proximal and midrectal adenocarcinomas, a low anterior 
resection has become the technique of choice as sphincter function is 
preserved (Skibber et al., 2001; Hoebler, 1997; Sprangers et al., 1995). 
Tumours situated in the lower part of the rectum (i.e., 0-5cm from the anal 
verge) usually require abdominoperineal resection resulting in a permanent 
colostomy. In the past few years advances in surgical techniques have 
resulted in the decrease of the number of patients requiring a permanent 
colostomy (Sprangers et al., 1995; Heald, 1980). Often a colostomy is 
temporary and usually a second operation carried out for rejoining the two 
open ends (O' Leary et al., 2001). 
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Lately, prophylactic surgery has been suggested for those patients with 
confirmed family adenomatous polyposis. Several surgical options are 
suggested such as proctocolectomy with an ileostomy, proctocolectomy with 
an ileoanal pouch reconstruction or colectomy without removing the rectum 
and an ileorectal anastomosis (Thompson & Wells, 2006). 
The surgical treatment for colorectal cancer is used either with curative or 
palliative intervention. Palliative surgery involves different techniques such 
as surgical bypass, loop colostomy or loop ileostomy, and stent placement 
(Thompson & Wells, 2006). 
Adjuvant therapy, such as chemotherapy is offered to colon cancer patients 
for eliminating the probability of disease relapse, palliative symptoms and 
cancer-related death. Although a series of large randomized studies have 
shown that adjuvant chemotherapy reduces recurrence and improves 
survival in patients with stage III disease, much debate exists of patients' 
benefit in stage II disease. Since the results remain controversial in stage II 
patients with high-risk characteristics, adjuvant therapy can reasonably be 
offered (Chau & Cunningham, 2002). Concerning advanced (metastatic) 
colorectal cancer the situation has changed dramatically over the years. New 
drugs such as cytoxic agents (irinotecan, oxaliplatin, oral fluoropyrimidines) 
have contributed to improved outcomes for patients with metastatic 
colorectal cancer, while agents acting on novel targets or molecular markers 
might play a role in the treatment of advanced colon cancer (Cutsem & 
Verslype, 2002). 
Combined modality therapy (chemotherapy plus concurrent pelvic radiation) 
is the standard postoperative adjuvant therapy for rectal cancer patients with 
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T3 and or N l to N2 stage disease (National Institute of Health Consensus 
Conference, 1990). Such a combination decreases local recurrence and 
improves overall survival (Wolmark et al., 1990). Also, in other therapeutic 
settings adjuvant combined modality therapy used preoperatively in T3 
rectal cancer increase the chance of sphincter preservation (Minsky, 2002). 
2.8 Summary and Conclusions 
Colorectal cancer remains one of the most commonly diagnosed 
malignancies in US as in Europe with about one million new cases in the 
world each year. In Greece, colorectal cancer with 3,769 incident cases and 
2,031 deaths in 2002 remains an important public health problem. 
Factors that contribute to the pathogenesis of the disease are many. Age, 
genetics, diet, environment, inflammatory bowel conditions are known risk 
factors for colorectal cancer. 
Current screening mechanisms for detecting high, intermediate and low risk 
people for colorectal cancer, as well as modern surgical interventions, have 
contributed significantly to improved long-term survival and enhanced 
quality of life. Improvements in survival have required attention to explore 
the experience as well as the needs of patients after they have finished 
treatment for their disease. Surgical techniques, in particular, remain the 
main therapeutic choice for colorectal cancer, and have contributed to 
changes in patients' physical and sexual functioning; very often with long-
term impact on their overall quality of life. 
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In chapter 3 the relevant literature is reviewed for an in depth understanding 
of the long-term impact of the disease and its treatment on patients who 
survive colorectal cancer. It explains why it is important to explore the 
perceived quality of life of Greek colorectal cancer patients. 
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CHAPTER 3 
HEALTH-RELATED QUALITY OF LIFE IN LONG-TERM 
COLORECTAL CANCER SURVIVORS: LITERATURE 
REVIEW 
3.1 Introduction 
Critical examination of the literature is a crucial point in starting to set the 
objectives of this study. Understanding the HRQOL of colorectal cancer 
survivors is important for the understanding of the full impact of the disease 
on patients and their families. Despite the prevalence of colorectal cancer in 
the western world, the knowledge about the patients' HRQOL over time and 
the late-effects of colorectal cancer treatment is very limited. Most studies 
until now have focused on examining the HRQOL in colorectal cancer 
patients within one year post-surgery. The data available on the quality of 
life of this population beyond one year post-surgery is less obvious (Ramsey 
et al., 2000; Sahay et al., 2000). 
Three key objectives will be considered by this review: First, it will identify 
the major predictors associated with HRQOL of colorectal cancer patients 
over time. Second, it will describe the main dimensions of HRQOL as they 
are experienced by survivors. Third, it will examine how the survivors 
perceive their overall HRQOL in comparison with a healthy population. 
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3.2 Methods 
The literature search was carried out using the following electronic 
databases: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), PubMED, Applied Social Sciences Index and Abstracts 
(ASSIA), The Cochrane Database of Systematic Reviews (CDSR), and 
PsycINFO. Key words combined on these database searches were: quality of 
life, Health-Related Quality of life, colorectal cancer, survivors, long-term or 
post-treatment, qualitative research, focus group, interviews. These terms 
were applied to searches in both headings and in the abstract text. The search 
was kept both as consistent and as wide as possible together with manual 
searching in order to ensure a maximum number of relevant articles. Each 
search was set over the time period, 1990-2007. 
3.3 Research Purposes of Evaluation of Quality of Life in 
Colorectal Cancer Patients 
Evaluation of the HRQOL in colorectal oncology has been achieved by a 
range of research approaches. 
Firstly, HRQOL studies have described the nature and the extent of disease 
problems with physical and psychosocial symptoms (Sprangers, 1999) and 
others have compared the cancer-related symptoms and treatment-related 
symptoms (Sprangers, 1999). 
Secondly, the HRQOL of colorectal cancer patients has been compared with 
the HRQOL of other patients with cancer or benign diseases or a healthy 
population, to focus on the impact of colorectal cancer and the long-term 
effects of cancer treatment on survivors (Dunn et al., 2003; Sprangers, 
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1999). Moreover, the evaluation of effectiveness of different treatments, 
using clinical randomized trials, has been established with cost-effectiveness 
studies in which the cost of survival gain is weighed against the quality of 
that gain (Sprangers, 1999). Also, quality of life information is essential in 
palliative care setting in order to enlighten patients' important concerns 
(Sprangers, 1999). 
Finally, some research suggests that the evaluation of baseline HRQOL may 
is a predictor of survival (Efficace et ah, 2006; Dunn et al., 2003; Maisey et 
al., 2002; Sprangers, 1999). 
3.4 Predictors of Health-Related Quality of Life in Colorectal 
Cancer Survivors 
Research suggests a number of factors associated with the perceived 
HRQOL of colorectal cancer patients. These factors refer to certain disease 
or treatment characteristics such as the stage of the disease, the type of 
surgery or disease recurrence and certain demographic characteristics such 
as age, gender, educational level or income. Also, the time since diagnosis 
and support received have been confirmed as factors that modified the 
perceived HRQOL of colorectal cancer survivors (Dunn et al., 2003). 
According to one author: "better understanding of how these factors 
combine to determine long-term HRQOL would assist with clinical decision-
making, especially in a situation in which maximization of HRQOL is the 
goal of medical intervention" (Anthony et al., 2003 p.l 19-120). 
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3.4.1 Long-term Effect of Surgery on Health-Related Quality 
of Life 
Since the different surgical techniques (anterior resection with preservation 
of the sphincter function or abdominoperineal excision that results in a 
colostomy) involved in the treatment of the cancer of the colon or rectum 
lead to similar mortality and morbidity rates, an important issue for 
consideration is how these different surgical techniques affect the patients' 
quality of life (Sprangers et al., 1995). 
There is a body of literature which suggests that the quality of life of people 
with a colostomy was considerably inferior to those without a colostomy 
(Engel et al., 2003; Kuzu et al., 2002; Camilleri-Brennan & Steele, 1998; 
Sprangers et al., 1995; MacDonald & Anderson, 1985; Mac Donald & 
Anderson, 1984; Williams & Johnston, 1983; Delvin et al., 1971). Sprangers 
et al. (1995) reviewed 17 studies which focused on those that directly 
compared patients' reported quality of life after having stoma and non-stoma 
interventions. The results of all of these studies refer to the long-term effect 
of surgery on HRQOL. The time elapsed since surgery varied widely within 
these studies between 1 and 10 years or more than 10 years. The results also 
showed that stoma and non-stoma patients both report limitations in several 
domains of quality of life including physical functioning, psychological 
well-being as well as social and sexual functioning. In addition, stoma 
patients were generally found to have a greater degree of impairment in all 
of the above quality of life domains. 
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Although Sprangers et al.'s (1995) findings were confirmed by Camilleri-
Brennan & Steeles' 1998 review, more recently a number of researchers 
have failed to agree with these findings and have questioned the conclusions 
(e.g. Pachler & Wille-Jorgensen, 2005; Grumann et al., 2001; Allal et al., 
2000; Koller & Lorenz, 1998). However, similar findings are reflected in a 
prospective research study by Bekkers et al. (1997) that indicated stoma 
patients do not encounter more problems in daily life than non-stoma patient 
four years after surgery. 
Several researchers have noted the need to consider carefully the possible 
methodological limitations of research in this area which may be responsible 
for the variance in findings (Pachler & Wille-Jorgensen, 2005; Camilleri-
Brennan & Steele, 1998; Sprangers et al., 1995). This will be discussed in 
further detail at a later stage. 
In a recent study by Grumann et al. (2001) twenty-three patients underwent 
abdominoperineal resection resulting in permanent colostomy compared 
with fifty patients who underwent anterior resection which did not result in a 
colostomy. Quality of life was measured before surgery (baseline 
assessment) and then 6 to 9 months and 12 to 15 months post-surgery. 
Surprisingly, patients with a permanent colostomy tended to have better 
quality of life across several quality of life domains as it is measured by the 
EORTC QLQ-30 and CR38 colorectal cancer specific instrument than 
patients without a colostomy. Although these findings were not statistically 
significant Grumann et al. (2001) suggest further investigation and 
explanation of such results given that the small sample size and the missing 
items constitute some limitations of the study. Grumman et al also evaluated 
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if the level of anastomosis -from both low and high anterior resections -
affected patients' quality of life. Interestingly the results showed that low 
anterior resection patients experienced significantly poorer QOL than 
patients with high anterior resection anastomosis. Despite the fact that these 
findings contradict most of the findings of "traditional" studies, similar 
findings have been reported elsewhere. 
For example, more recently The Cochrane Collaboration reviewed relevant 
published studies in order to compare the quality of life in rectal cancer 
patients with or without permanent colostomy (Pachler & Wille-Jorgensen, 
2005). In this review study thirty potential researches were identified. 
Eleven met the inclusion criteria that identified studies which used self-
reported, validated multidimensional quality of life questionnaires and were 
filled in by the individual or a relative. Among the included studies six 
found no significant difference in overall quality of life between patients 
with a colostomy and without a colostomy appliance (Harisi et al., 2004; 
Rauch et al., 2004; Camilleri-Brennan, 2002; Hamashima, 2002; Grumann et 
al., 2001; Allai et al., 2000). A study by Jess et al. (2002) also suggested that 
"a stoma only slightly affected the patients QOL" (Pachler & Wille-
Jorgensen, 2005, p.g 7). Four studies suggested that stoma patients were 
affected significantly by their disease in all QOL dimensions. As the 
findings in this review study vary significantly, the authors highlighted the 
lack of a definitive conclusion about whether QOL is more impaired in 
patients with a permanent stoma compared to those patients without a stoma 
due to a lack of evidence to support the assumption that stoma patients fare 
less well than non-stoma patients. The authors also suggested that well 
designed and executed prospective studies with baseline data and 
32 
preoperative values for QOL are required in order to address the long-term 
impact on Heath-Related Quality of Life in the future (Pachler & Wille-
Jorgensen, 2005). 
Physical Functioning 
Despite improvements in surgical techniques used for therapy of colorectal 
cancer, a number of physical side-effects may negatively impact patients' 
quality of life over time. Cancer patients with or without a stoma were 
troubled by frequent or irregular bowel movements, diarrhoea and faecal 
leakage (Lewis et al., 1995; Sprangers et al., 1995; Williams & Johnston, 
1983). Although bowel function usually improves during the first year post 
surgery (Frigell et al., 1990), in some cases bowel problems can remain 
beyond this (Engel et al., 2003; Lewis et al., 1995). Irregular or 
unpredictable bowel habits often prevent patients from leaving their home, 
or doing certain activities, due to a fear of having an accident leading them 
to social isolation and further impairment to their quality of life (Sprangers 
etal., 1995). 
Other physical symptoms commonly experienced by colorectal cancer 
patients include flatulence, urinary problems such as micturition, retention 
and dysuria, constipation problems or sleeplessness due to irregular bowel 
movement (Camilleri-Brennan, 1998; Sprangers et al., 1995). Studies 
suggest that the degree to which these problems are experienced by 
colorectal cancer patients depends on some independent factors such as age -
Camilleri-Brennan ( 1998) concluded that urinary problems generally 
increase with age -or the level of anastomosis (high or low anterior 
resection) (Engel et al., 2003; Grumann et a l , 2001; Camilleri-Brennan, 
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1998). Engel et al. (2003) in a four-year prospective study showed that in the 
first three years patients with low anterior resection had significantly worse 
defecation scores than those patients with high anterior resection. 
Sprangers et al. (1995) also report that the degree to which all these 
symptoms are experienced in stoma and non-stoma patients varies. For 
example, research has showed that stoma patients may report more problems 
with gas and urinary function (Engel et al., 2003; Sprangers et al., 1995) 
while non-stoma patients report more constipation and gastrointestinal tract 
problems (Rauch et al., 2004; Engel et al., 2003; Allai et al., 2000; Sprangers 
et al., 1995). Ramsey et al. (2002) also reports that, although long-term 
survivors may experience a relatively high QOL, diarrhoea in non-stoma 
patients remains a problem. Sixteen percent report two or more bowel 
movements a day and 49% report chronic recurrent diarrhoea. Grumann et 
al. (2001), however, also reported that patients who had a permanent stoma 
reported less fatigue, gastrointestinal symptoms, sleeplessness, and 
significantly better scores for constipation and diarrhea compared to patients 
who had undergone sphincter-conserving surgery. 
Despite advances in stoma surgery and in stoma care, complications with 
stomas are an important potential source of ongoing problems. Studies 
exploring the long-term complications of colostomy have found that 
approximately 30% of patients develop problems related with their stoma 
and 10% of patients required at least one further surgical procedure to 
correct a complication (Fielding & Padmanabhan, 1994). Anthony et al. 
(2003) in a longitudinal prospective study indicated that surgical 
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complications can influence, both negatively and significantly, HRQOL one 
year after surgery. 
Social Functioning 
Some time ago Delvin et al. (1971) compared patients who had undergone 
surgery resulting in a stoma with those who underwent sphincter-preserving 
surgery and found that a high proportion of stoma patients experienced 
considérable social problems which related to employment and social 
isolation. These results were replicated by Williams & Johnston (1983) who 
reported that stoma patients returning to work often faced diffïculties with 
the Stomas which caused them to leave work in contrast with non-stoma 
patients who were more likely to return to work and remain in their job. 
Sprangers et al. (1995) in the literature review study point out that the 
operational définition of social functioning used across studies varies 
considerably. It may include a variety of dimensions such as employment, 
frequency of social contacts, quality of relationships and restrictions in 
social activities due to the effect of illness or treatment. This impairment is 
sometimes common between stoma and non-stoma patients. In particular, 
stoma patients were more restricted in visiting cinémas and leisure pursuits. 
Such findings suggest that restriction from outside activities may be related 
to the fear of being a nuisance to others or to general embarrassment of 
having a stoma (Sprangers et al., 1995). Sprangers et al. review (1995) drew 
attention to the fact that several of the studies included, which purported to 
measure social functioning, used non-standardised study specific 
questionnaires. 
35 
Qualitative studies on describing quality of life in colorectal cancer patients 
are very limited. A literature search by Dunn et al. (2005) identifies only 
seven qualitative articles relevant to quality of life experienced by people 
with colorectal cancer. Dunn et al. (2005) using interviews (15 interviews-
six males, nine females) and focus group data tried to gain an understanding 
of what was important to participants in terms of their own experience with 
colorectal cancer and their quality of life within the past 18 months. 
Concerning social life some participants reported that it had not been 
adversely affected by the diagnosis and treatment; however they felt less 
comfortable in engaging activities where they may not be able to access 
toilet facilities with ease. Some other participants reported "reduced 
socialization, primarily due to tiredness, but a couple of participants said that 
they deliberately avoided friends because they were now treated differently 
to what they had been before getting i l l " . Given that most participants had 
retired, employment problems and vocational matters were not raised. Only 
one woman, who was suffering from an advanced stage of the disease, 
reported that she could not return to full time work after the cancer 
diagnosis. 
Similarly, in another qualitative study (39 interviews contacted short and 
long-term colorectal cancer survivors) the loss of ability to socialize was an 
important theme to emerge (Rozmovits & Ziebland, 2004). Changes in the 
control of bowel habits, inconvenience of chronic constipation or changes in 
dietery habits were identified by a great number of the interviewees as 
persistent problems. They impact considerably on people's abilities to travel, 
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socialize, eat away from home, or engage in leisure pursuits (Rozmovits & 
Ziebland, 2004). 
Also, many authors emphasise the relevance of age to the level of social 
activity and social network, especially given that colorectal cancer patients 
are often elderly and may be restricted in their activities and ability to 
perform roles due to a general decline in physical health and the normal 
ageing process (Trentham-Dietz et al., 2003; Ferrell & Ferrell, 1998). 
Sexual Functioning 
An important area of consideration relevant to quality of life is that of sexual 
functioning. Several authors have reported on the potential negative impact 
of cancer treatment on sexual expression (Dunn et al., 2005; Brown & 
Randle, 2005; Rozmovits & Ziebtand, 2004; Engel et al., 2003; Grumann et 
al., 2001; Allal et al., 2000; Camilleri-Brennan & Steel, 1998; Havenga et 
al., 1996; Sprangers et al., 1995). Problems in sexual functioning may be the 
result of medical treatment, psychological factors or a combination of both. 
However, there is considerable variance in the prevalence estimates of 
sexual problems among colorectal cancer patients within different studies 
(Sprangers et al., 1995). 
There are a number of reports that the surgical procedures used to treat 
colorectal cancer, either abdominoperineal resection or low anterior 
resection, may result in damage to pelvic nerves which supply the genitals, 
resulting in sexual dysfunction. The types of sexual problems most 
commonly found in patients following these operations include erectile and 
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ejaculatory dysfunction in men - although other symptoms such as a loss of 
desire, diminished sexual activity and anorgasmia may also occur (Sprangers 
et al., 1995). For women, given that their sexual dysfunction after surgery 
has been relatively ignored in the literature, the main problems are cessation 
of intercourse, anorgasmia and pain during sexual intercourse, known as 
dyspareunia - however, thèse are more prévalent among stoma patients 
(Camilleri-Brennan, 1998; Shcover, 1998; Bambrick et al., 1996). In maie 
patients loss of erectile capacity may be accompanied by a loss of fertility 
(Schover, 1998). 
Several authors have concluded that the prevalence of sexual dysfunction is 
high among stoma patients compared to patients whose surgical treatment 
did not involve the formation of a stoma (Engel et al., 2003; Sprangers et al., 
1995; Koukouras et al., 1991). Allai et al. (2000) reported that sexual 
functioning was low for both groups -stoma and non-stoma- included in their 
study while there were notably high scores in relation to sexual dysfunction 
in maies although statistical significance was not achieved. 
In a very récent study by Hendren et al. (2005) highly sensitive male and 
female sexual functioning instruments (Female Sexual Function Index or 
International Index of Erectile Function) were administered to eighty one 
women and ninety nine men to evaluate levels of sexual activities before 
surgery, after surgery and during "the last 4 weeks" in patients following 
surgery for rectal cancer. A percentage 29% of women and 45% of men 
reported that "surgery made their sexual life worse". Spécifie sexual 
problems in women included lowered libido 41%, arousal 29%, lubrication 
56%, orgasm 35%, and dyspareunia 46%. In men lowered libido 47%, 
38 
impotence 32% and partial impotence 52%, orgasm 41%, and ejaculation 
43% were recorded. Both genders reported a more negative body image. 
80% of women reported that the ostomy caused a negative change to their 
sexual life. They stated that they were afraid their appliance may leak, or the 
ostomy make noise, causing them to feel embarrassed, and so they were less 
spontaneous. In men, the ostomy caused a negative change in sexual life for 
85.7% while 92% of them reported one or more specific sexual problems 
after surgery. 
Surgery may also cause sexual dysfunction indirectly through related side-
effects. For example, post-operative pain is related to the problems of 
relaxing and enjoying physical intimacy. On the other hand, negative body 
image and bowel problems are likely to affect both sexual desire and 
confidence (Hendren et al., 2005; Moyer & Salovey, 1997; Schag et al., 
1994). 
Radiotherapy also has been reported to increase the likelihood of damage 
being caused to the urogenital nerves and organs also resulting in 
impairment of sexual functioning (Hendren et al., 2005; Mannaerts et al., 
2001). It also contributes to fatigue and loss of libido which may indirectly 
disrupt sexual functioning in the first year or so following surgery (Schover 
et a l , 1993). 
Sexual dysfunction may occur for reasons other than surgical treatment or 
radiation therapy. For instance, sometimes they may also be related to 
difficulties with psychological adjustment (Schover et al., 1993), with 
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depression and anxiety being known to have a negative impact on sexual 
functioning (Teusch, 1995). 
Sexual functioning is also determined by a range of other variables and 
Hendren et al., (2005) suggest that sexual function is multifactorial. 
Preoperative sexually inactivity and older age were significant independent 
predictors of current sexual inactivity (Hendren et al., 2005). It is important 
to consider the relevance of age when exploring the impact of treatment on 
sexual functioning among colorectal cancer patients. Given that the majority 
is likely to be aged between sixty and seventy years of age their level of 
sexual interest and sexual capacity may already have declined independent 
of the effect of treatment. 
Psychological Functioning 
In a review of papers investigating psychological functioning in colorectal 
cancer, Sprangers et al. (1995) showed that general psychological 
dysfunction may include depression, loneliness, suicidal thoughts, feelings 
of stigma and low self-esteem. Also, they concluded that these findings were 
significantly more prevalent in stoma patients (from 10 percent to 54 percent 
) than in non-stoma patients (from 3 percent to 43 percent). Williams and 
Johnston (1983) also reported a 32 percent prevalence of depression 
following an abdominoperineal resection, compared with 10 percent 
prevalence after anterior resection. However, the definition of psychological 
functioning employed in these studies varied considerably. In some cases 
unstandardised measures with unknown reliability and validity were used 
(Sprangers et al„ 1995). Tsunoda et al. (2005), when examining the 
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psychological distress and its relationship with quality of life dimensions in 
colorectal cancer patients, concluded that the emotional functioning 
dimension, as measured by a generic quality of life instrument such as the 
EORTC QLQ-C30, predominantly assess anxiety but the use of additional 
instruments is also necessary for the assessment of depression in outpatients 
with colorectal cancer (Tsunoda et al., 2005). 
An early study by McDonald and Anderson (1984) assessed the stigma of 
having rectal cancer. Half of the patients reported signs of feeling 
stigmatized as reflected in decreased attractiveness, avoidance of other 
people and feeling different. More symptoms were seen in younger patients 
and in those with colostomy while stigma was particularly prevalent in 
women. 
It is well known that patients with a diagnosis of cancer are at increased risk 
of depression; particularly those patients who suffer from pain and physical 
disability (Hopwood & Stephens, 2000; Massie & Holland, 1992). While 
some data indicates that depression behaviours affect a number of aspects in 
patients' life, such as health status, quality of life, or working role (Pasquini 
& Biondi, 2007), other studies have also linked depressive disorders with 
survival or cancer progression (Onitilo et al., 2006; Prieto et al., 2005; Faller 
et al., 1999). On the other hand, even if cancer patients' psychological 
distress decreases over time, a substantial number may continue to 
experience anxiety and depression during follow-up (Watson et al., 2005; 
Howard & Harvey, 1998). A study by Schag et al. (1994) concluded that 
patients who survived lung, colon and prostate cancer have experienced 
psychological distress during the disease-free phase of their illness. 
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Furthermore, Ramsey et al. (2002), using a depression rating scale, 
concluded that people who had survived beyond 5 years after colorectal 
cancer had higher rates of depression in comparison with age-matched 
populations. Depression was also reported as being highest among younger, 
and female, stoma patients (MacDonald & Anderson, 1984). 
Careful consideration needs to be given to the methodological issues 
involved in these studies. The assessment of depression in cancer patients is 
difficult because symptoms of depression are often similar to those of the 
physical illness or its treatments. Many scales used to measure depressive 
symptomatology include items relating to tiredness, loss of appetite and 
sleep disturbance - all of which may be symptoms of the cancer itself or 
side-effects of treatment (Trask, 2004). Such findings, therefore, need to be 
treated with some caution. 
3.4.2 Stage of the Disease at Diagnosis 
Although the stage at diagnosis is strongly related to the length of survival of 
colorectal cancer patients - when diagnosed in an early stage, the disease has 
a 5-year survival rate of 90% (American Cancer Society, 2000) - this factor 
may have an association with QOL of long-term survivors. Both the stage 
and site of colorectal cancer at diagnosis are associated with symptoms and 
treatment modalities used and, subsequently, with alteration in quality of 
life. 
Ramsey et al. (2000) found that people with colorectal cancer with T N M 
Stage I and Stage IV disease experienced relatively uniform increases and 
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decreases respectively in quality of life from the time of the diagnosis. 
Patients with Stage II and III disease experienced an initial decline in then-
quality of life, which then improved over time. Also, a survey of female 
long-term colorectal cancer survivors by Trentham-Dietz et al. (2003) 
concluded that the stage of the disease at diagnosis was not significantly 
associated with current heath status. They reported that most patients who 
were diagnosed at an earlier stage may resume their regular lifestyle after 
treatment. 
3.4.3 Time since Diagnosis 
Studies have showed that the time since diagnosis may also be associated 
with quality of life in colorectal cancer patients. As the time from diagnosis 
lengthens quality of life appears to improve for these patients (Ramsey et al., 
2002; Ramsey et al., 2000; Schag et al., 1994). 
A study of 27 long-term, 33 intermediate-term and 57 short-term survivors 
of colon cancer concluded that quality of life, and particularly its 
psychosocial domains, tend to improve as length of survival increased 
(Schag et al., 1994). 
Ramsey and colleagues (2000) carried out a community-based sample of 
173 survivors who participated in the study and completed the Functional 
Assessment of Cancer Therapy Scales for Colorectal Cancer (FACT-C) and 
the Health Utilities Index (HUI) Mark III questionnaires to examine how 
HRQOL varied as a function of stage at diagnosis and time since diagnosis. 
They suggested that for all T N M stages of the disease, the impact of 
colorectal carcinoma on HRQOL was greatest in the first 2-3 years from 
initial diagnosis. After this time, HRQOL was relatively uniform and 
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remained relatively high in all stages of the disease except stage IV. The 
subscale scores of FACT-C suggested that emotional components of 
HRQOL improved significantly over time, however, functional and social 
well being were impacted most and improved little across all stages as the 
time from diagnosis lengthened. Pain also remained a substantial problem 
and did not improve with time. HRQOL also declined for patients during 
their last year of life and for patients who had recently experienced surgery 
for their disease. However, this survey had some limitations as respondents 
had been healthier than non-respondents and advanced age was the only 
factor significantly associated with the non-respondents. The researchers 
suggest that re-sampling would be necessary to include patients with 
advanced stage disease and a more distant history of colorectal cancer. 
3.4.4. Disease Recurrence 
Unfortunately, recurrence of rectal cancer after potentially curative surgery 
is also a major problem as recurrence may be local or distant, and commonly 
arises in the liver. The incidence of tumour recurrence varies from centre to 
centre. Local recurrence occurs in up to one third of patients after surgery 
and most tumours recur within the first two years post-operatively (Esnaola 
et al., 2002; Camilleri-Brennan & Steele, 2001). It is suggested that the 
experience of recurrence in cancer patients is likely to be more distressing 
than the initial diagnosis (Mahon, Cella & Donovan, 1990). The presence of 
recurrence in rectal cancer patients is likely to lead to a poorer HRQOL but 
few studies are available that can confirm this hypothesis. It is not known 
which quality of life dimensions are affected and to what extent the patients' 
quality of life is impaired. Camilleri-Brennan and Steele (2001) showed that 
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most dimensions of HRQOL of patients with recurrent disease were 
significantly lower than those in remission. 
3.4.5 Demographic Characteristics 
Age, Comorbidities and Gender 
As previously discussed, the physical component of QOL in colorectal 
cancer is strongly associated with age. For example, many urinary problems 
or problems concerning sexual function increase with age. In addition, 
younger or female stoma patients may experience more initial depression, 
stigmatization and feelings of being different than males and older patients 
(Mc Donald & Anderson, 1984). The age variable is also suggested in 
Devlin's early study (1971) reporting that 50 percent of stoma patients who 
felt socially isolated were over 65 years old. Gender differences were also 
found by Northhouse et al. (2000) in a prospective study of the adjustment 
of patients and their spouses to colon cancer. Women were found to report 
more distress, more role problems and less marital satisfaction. 
On the other hand, a major methodological issue in many long-term QOL 
studies is the distinction between the effect of the disease itself on QOL and 
the effect of age or other comorbidities, since the probability of having a 
chronic disease or functional limitation also increases with age. This 
distinction for long-term colorectal cancer studies is very important since the 
incidence rates of the disease rise with age and over 40% of cases occur in 
subjects over the age of 74 years (Gotay & Muraoka, 1998). 
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Trentham-Dietz et al. (2003) in a sample of 307 women, with a mean age of 
72 years and an average survival time of 9 years, showed that the physical 
component of HRQOL, as it is measured by Short-Form 36 Health Status 
Survey, was significantly lower for participants of greater age. The degree to 
which cancer survivors were able to participate in physical activities (such as 
walking, routine self-care) and the extent to which activities or time 
involved in their social "role" (of, e.g., employee or spouse) are limited is 
associated strongly with age. However, the factor most strongly associated 
with QOL in long -term colorectal survivors is the existence of other 
diseases experienced together with cancer: "Spearman correlation 
coefficients were significant (p<0.001) between the number of co-morbid 
conditions and all SF-36 domain and summary scales" (Trentham-Dietz et 
al., 2003, p.345). 
These co-morbid conditions included arthritis or rheumatism (57%), 
hypertension (46%), depression or anxiety (19%), and bone break or 
osteoporosis (18%). However, this study used statistical techniques that do 
not enable us to conclude a causal relationship between depression or other 
comorbidities and HRQOL. 
The largest study assessing HRQOL in long-term colorectal survivors by 
Mosconi et al. (2002), suggested that comorbidity and age had a larger 
impact on HRQOL. Females had a poorer overall HRQOL than males with 
more evidence in the physical component of HRQOL. 
In agreement with previous studies Ramsey et al. (2002), with a population 
of 227 colorectal cancer survivors and an average age 74 years, reported that 
a substantial number of non-cancer comorbidities (overall 77,5% reported at 
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least one comorbid condition) were strongly and negatively associated with 
all measures of HRQOL using multivariate regression analysis. 
Educational level and Income. 
Little evidence emerges from the literature describing the effect of 
household income and educational level upon the quality of life in colorectal 
cancer patients. 
One study by Trentham-Dietz et al. (2003) showed that the overall mental 
health status of female survivors were lower in those patients with a lower 
level of education. Moreover, lower income status may be associated with 
poorer outcomes for pain, social and emotional well-being dimensions of 
quality of life scale according to Ramsey et al. (2000). 
In addition, Ramsey et al. (2002) also reported that lower socioeconomic 
status was a risk factor for depression; while higher levels of income were 
significantly associated with more favorable scores for depression. 
3.4.6 Social Support Received 
Studies have shown that social support for cancer patients seems to be 
associated with better quality of life (Sultan et al., 2004; Sapp et al., 2003). 
Social support encompasses many different and varing forms including 
emotional or instrumental support. Emotional support refers to individuals 
who are available to listen, sympathize, and make the individual feel valued. 
Instrumental support refers to the assistance to the activities of daily life or 
with household chores. Emotional support may be considered the most 
helpful and the type that patients needs more (Sultan et al., 2004). 
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While information is available on the association between social support and 
quality of life for some cancer sites (Michael et al., 2002; Courtens et al., 
1996) there is limited information on the association between social support 
and quality of life in colorectal cancer patients. A study by Sapp et al. 
(2003), which included 259 female colorectal cancer survivors, evaluated the 
correlation between social network and HRQOL of study population. 
Findings demonstrated that social network was associated significantly with 
HRQOL and in particular with mental health. Similarly, Sultan et al. (2004) 
showed that the emotional and instrumental support was associated with 
higher mental component scores with the Medical Outcomes Study Short-
Form instrument. 
However, information is very limited on how the support that patients 
receive from a partner influences their quality of life. 
Qualitative studies have shown that the main source of support for colorectal 
cancer patients includes family and friends - in particular for emotional and 
instrumental support (Sahay et al., 2000; Forsberg et al., 1996; Forsberg & 
Cedermark, 1996). The support that colorectal cancer patients received from 
their family or friends seem to influence their quality of life. In particular, 
the relationship between colorectal cancer patients and their spouse is related 
to peoples' quality of life scores (Forsberg et al., 1996; Forsberg & 
Cedermark, 1996). Patients who live with a family express higher perceived 
well-being than those who live alone (Forsberg et al., 1996; Forsberg and 
Cedermark, 1996). Northhouse et al. (2000), when examining the factors 
that affect adjustment to the disease, showed that role adjustment problems 
were strongly predicted by similar problems in spouses. 
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Understanding how social support, especially emotional support, influences 
peoples' quality of life is important because the social environment can 
change and appropriate psychological interventions can improve patients' 
quality of life. 
3.5 Overall Effect of Colorectal Cancer Disease and Treatment 
on Survivors' Quality of Life 
Studies have compared colorectal survivors' Health-Related Quality of Life 
with that of similar aged/sex-matched people in the general population 
(Arndt et al., 2004; Kopp et al., 2004; Rauch et al., 2004; Trentham-Dietz et 
al., 2003; Mosconi et al., 2002). Surprisingly, these studies have showed that 
the impact of colorectal cancer on patients' quality of life over a period of 
time is not necessarily negative. Colorectal survivors report a more satisfied 
HRQOL, very often comparable with those of general population in most 
HRQOL domains (Arndt et al., 2004; Rauch et al., 2004; Trentham-Dietz et 
al., 2003; Mosconi et al., 2002). Arndt et al. (2004) tried to identify how, 1 
year after diagnosis of colorectal cancer, survivors cope with the awareness 
of living with a chronic and potentially life-threatening disease in 
comparison with men and women of the general population. HRQOL scores 
of a population-based cohort of 309 patients were compared with published 
reference data of the EORTC-QLC30 questionnaire from the general 
population. The results showed that overall HRQOL and physical 
functioning of patients is comparable to population norms even if deficits in 
emotional and social functioning continue to exist. Similarly, Mosconi et al. 
49 
(2002) report that no significant difference was found for the overall 
HRQOL of 197 colorectal cancer survivors when compared (according to 
age and sex) with those of the Italian population as long as no serious co-
morbidity or relapse appeared. 
These findings could be interpreted as a widespread selection bias or as a 
result of a positive coping strategy and processes that cancer survivors used 
for "reframing" their standard of health. For example, a patient with bone 
metastasis may state a "good" physical functioning that may mean they are 
happy since the condition does not get worse. Patients may change their 
personal values in this new reality and obtain a new understanding of what 
now constitutes an acceptable quality of life. This phenomenon has been 
described as "response shift" and is used for interpreting unexpected quality 
of life findings (Sprangers et al., 2002; Sprangers & Schwartz, 1999; 
Sprangers et al., 1996). 
An adaptation process to disease and treatment of colon cancer patients is 
confirmed by Bernhard et al. (1999) whose findings showed that these 
patients may reframe their perception in estimating HRQOL substantially 
after surgical resection, adjuvant chemotherapy or observation. Although an 
understanding of the response shift phenomenon is very important for 
patient care and HRQOL research, it has rarely been studied empirically and 
needs further investigation (Sprangers et al., 1996). 
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3.6 Summary and Conclusions 
The primary purpose of this review was to examine the long-term 
consequences of colorectal cancer disease and cancer treatment on patients' 
life. The research to date has paid little attention to the late-effects of 
colorectal cancer while data from a Greek population are not available. 
Similarly, there is uncertainty of the variables which apparently contribute to 
high or low quality of life in patients over time. On the basis of this 
investigation, it appears that variables, such as stage at diagnosis, time since 
diagnosis, type of surgery, recurrence, depression, age and comorbidities, 
gender, educational level, and income may modify the level of patients' 
HRQOL. Independent of the quality of research that explores these 
variables, the effect that these variables have on the overall HRQOL is 
unclear. Particularly, there is ongoing confusion on how HRQOL differs 
between people with a colostomy appliance and people without a colostomy 
appliance. It is not obvious that stoma patients experience a low HRQOL 
while sometimes they appeared to have a quality of life comparable to a 
healthy population. On the other hand, although depression symptoms are 
mentioned as one problem that colorectal cancer patients may experience at 
follow-up, it is rarely discussed in the literature and no specific information 
was found on the possible effect of depression symptoms on patients' 
HRQOL. 
There is also an issue regarding the limitations of the measures used to 
assess the impact of colorectal cancer disease and treatment on the lives of 
people who suffer from it, which needs to be taken into account in 
researching this area. 
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CHAPTER 4 
QUALITY OF LIFE: CONCEPTS AND METHODS 
4.1. Introduction. 
Düring the last 30 years, there has been increasing interest in the concept of 
quality of life (QOL) and its application in evaluating the outcome of health 
care. This is particularly evident for chronic and life-limiting diseases, where 
by definition, eure is unachievable. 
As such, there is increasing recognition that assessment of QOL is required 
to complement traditional outcomes such as survival and treatment toxicity. 
The proliferation of interest in quality of life is clear. There is a plethora of 
publications in the health, psychological and social sciences literature 
devoted to understanding, assessing and interpreting QOL. In addition, there 
are an ever-increasing number of professional societies and Journals devoted 
to this research field. The phrase "quality of life" has become commonplace 
in the vocabulary of health Professionals, researchers, and indeed, society in 
general. Enthusiasm continues despite the inherent difficulties and 
complexities in trying to understand, assess and interpret approaches to 
capturing the perspective of patient. One major criticism of previous studies 
purporting to assess "QOL" is the lack of attention given to understanding 
its conceptual basis. 
This chapter reviews the current understanding and the rationale for 
consideration of QOL focusing on follow main areas: 
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1. What is the need and demand for QOL assessment? 
2. What constitutes QOL within the context of health, illness and cancer 
experience? 
3. How has the conceptual basis of Health-Related Quality of Life been 
constructed and debated in the literature? 
4. How has Health Related Quality of Life been assessed in the context of 
the cancer experience? 
4.2.0 The conceptual basis of Quality of Life. 
4.2.1 The historical basis of Quality of life 
In public life, social and human sciences the term QOL derives from the 
1960s and was used routinely in order to describe the "liveability"of towns 
or cities, assess the aims and effects of social policy and generally refer to 
the social scientific index of well-being of population (Rapley, 2003). 
Although the concept became popular during 1960s it has a long history and 
has its roots can be traced back to the Greek ancient philosopher Socrates, 
who said that an unexamined life is a life that not worth living (Plato, 1903). 
In the first half of the twentieth century QOL was correlated with the 
material level that a country can achieve; the higher that level in a country, 
the better the life of its citizens. The need to measure the level of quality was 
bom and one of the first tools of QOL measurement came from economists 
who used the Gross National Product (GNP) as an indicator for QOL 
(Veenhoven, 1996). 
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The need for developing broader indicators of QOL beyond economical 
growth emerged in 1960s, when it started to become clear that the happiness 
of a society or a population could not be determined only by the quantity of 
goods consumed. A movement towards "social indicators" of a good life 
became more populär and objective social conditions such as health, life 
expectancy, unemployment rate, poverty rate, school attendance and 
environment began to be measured and used as indicators of social progress 
(Rapley, 2003). Despite advances in socio-economie conditions, and the fact 
that the 1960s and 1970s were characterized as a period of prosperity, 
research findings showed that from 1957 to 1972 the happiness of general 
population steadily declined (Campbell, 1976). 
The need for new indicators for 'a good life' were clear and in the 1980s the 
interest of QOL as a construct moved from the population to an individuai 
level while issues about culture, personal values, self reports of life 
satisfaction or dissatisfaction or happiness, health satisfaction and the 
subjective sense of people about their individuai lives began to emerge 
(Rapley, 2003; Kahn & Juster, 2002; Ware, 1991). 
Since then, interest in QOL became a reality and the most sustained efforts 
in social and human sciences focused on defining, describing and 
understanding quality of life while a number of conceptual approaches to 
QOL assessment started to be developed. 
In 1990s the QOL literature became an arena for controversy about 
conceptual issues that related to cultural, religious and personal values which 
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might influence its influence and perception. Moreover, methods and the 
meaning of QOL measurement were also debated issues. 
Hughes et al. (1995) identify 44 separate QOL définitions between 1970 and 
1993. Antaki and Rapley (1996) identify over 2500 journal articles 
specifying "quality of life" as a keyword in the preceding three years. In 
Google the "quality of life" term returned about 3,410,000 webpages 
(Rapley, 2003). 
Moreover, the development of professional societies (e.g. the International 
Society for Quality of Life Research) and the establishment of specialty 
Journals (e.g. Quality of Life Research), offer further évidence of increasing 
interest in the concept. 
Despite the plethora of efforts within literature to define QOL, the concept 
remains vague while research in the field has been marked by numerous 
problems in measurement and uncertainties about its changing pattern over 
the life course. 
In order to become more comprehensive, an abstract concept as QOL now 
has many sub-areas of research. Since health is among "the most valued 
states, and among the most important areas of life" (Bowling, 2001, p. 5), 
the term Health Related Quality of Life has become a familiär field in 
medicine and its assessment an important medicai goal. 
In particular, the interest of medicai scientists has moved away from the 
functional ability of patients towards subjective well-being while the most 
récent research field requires new approaches beyond the traditional 
methods used in medicine. 
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4.2.2 Defining Quality of Life 
As the interest in QOL has moved from populations to individual people, 
and from objective life conditions to subjective personal values and 
aspirations, the construct begins to be correlated with terms such as "well-
being", "happiness" or "life-satisfaction". But any attempt at describing 
QOL using these terms includes very broad definitions. For instance, QOL 
has been defined as "the extent to which a person's hopes and ambitions are 
matched and fulfilled by experience" (Gerson, 1976) or that QOL 
encompasses qualities such as the degree to which an individual succeeds in 
accomplishing his desires (Caiman, 1984). 
Many others similar or broader definitions of QOL are also available in the 
literature. These heterogenic and abstract descriptions of QOL across the 
social scientific literature contribute to the complexity of the construct and 
lead researchers to specify societies' and individuals' quality of life within 
"domains" or "components" for specific purposes of measurement (Rapley, 
2003). 
More recently, multidimensional definitions of quality of life have been 
adopted. The World Health Organization defines QOL as "individuals' 
perceptions of their position in life in the context of the cultural and value 
system in which they live and in relation to their goals, standards, and 
concerns" (WHO, 1993, p. 1). 
More specifically, at the subjective individual level, quality of life, as 
defined by Cummins (1997, p. 6) is "both objective and subjective, each 
axis being the aggregate of seven domains: material well-being, health, 
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producîivity, inûmacy, safety, Community and emotional well-being. 
Objective domains comprise culturally relevant measures of objective well-
being. Subjective domains comprise domain satisfaction weighted by their 
importance to the individual" 
4.2.3 Moving towards a définition of Quality of Life in context 
to health and illness 
In health settings, the multidimensional aspect of thèse définitions means 
that the impact of illness on patients' life must be evaluated subjectively 
within broad cultural, environmental, and social contexts. (Cella et al., 
2002). 
One of the most debated issues in the literature remains the possibility of 
such définitions being operationalized into the scientific measurement of 
quality of life and proving useful in everyday clinical practice. 
Koller et al. (2005, p. 186) point out that thèse définitions are so ideal that 
they cannot be practical from a clinical point of view. Particularly, they 
wonder, "Which doctor would be able to "treat" the cultural context of 
his/her patients ? " 
4.2.4 Health-Related Quality of Life 
Concurrently there has been a change in the way health and disease has been 
viewed within medicine. Traditionally, the effect of the disease and the 
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outcome in health care has been measured in terms of mortality and 
morbidity rates. The length of life, or deaths, was the main objective 
measures of health status outcomes before World War II. Here the emphasis 
is on the pathogenic abnormalities of diseases, with ill-health described 
within a negative context (Bowling, 2001). 
Some years later, advances in medicine have changed the démographie 
characteristics as well as the health profile of population, in particularly in 
industrialized countries. The elderly population has increased together with 
chronic diseases such as cancer, heart disease or diabètes and degenerative 
diseases. Few cures are achieved for chronic and degenerative disease while 
laboratory data is increasingly inadéquate to capture important effects of 
many new interventions on patients' QOL (Fitzpatrick et al., 1998)). 
This new reality has also changed the way that health and disease have to be 
viewed in modem medicine. 
Doctors re-consider their goals about the outcomes of médical care as new 
types of scientific évidence about health begin to be investigated (Sullivan, 
2003). There have also been increasing moves to view health as a positive 
construet. 
The World Health Organization (WHO) in 1947 defined health as "a 
complète State of physical, mental, and social well-being and not merely 
absence of disease" (p.29). 
Even if the complète absence of disease can not be a realistic goal in the 
clinical arena, this définition has been considered the foundation for the 
concept of HRQOL and its measurement. (Koller et al., 2005; Cella et al., 
2002; Aaronson, 1991c). 
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Health outcomes research, based on this definition for health, wish to 
highlight holistic evaluation of patients' physical and psychosocial well-
being and have settled on the main goal as the importance placed on the 
patients' point of view in evaluating medical care. Patients give their 
subjective information about perceived health and quality of life while a 
number of terms have been adopted into the literature to describe the health 
related quality of life (HRQOL) from the patients' perspective (Rapley, 
2003; Sullivan, 2003; Testa & Nackley, 1994). 
Most of these terms are concerned with those aspects (domains or 
components) of HRQOL that are important to patients and are experienced 
as a result of illness and medical procedures. (Cella et al., 2002; Aaronson et 
a l , 1996; Cella, 1995; Moinpour, 1994). Table 4.1 demonstrates some 
different perspectives that describe Health-Related Quality of Life. 
The purpose of HRQOL assessment will determine which of the available 
definitions have to be adopted, as well as the way HRQOL is understood 
(Rapley, 2003; Cella, 1997). For example, a health economist's interests lie 
in the economic impact of the disease on patients' lives, whilst a 
sociologists' perspective might consider HRQOL as the gap between 
achievement and expectations (Fitzpatrick et al., 1998). 
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Table 4.1: Descriptions and included dimensions of Heath-Related Quality of Life 
Description Dimensions/Domains Source 
A state of complete physical, mental, 
and social well-being and not merely 




World Health Organization, 1947, p.29 
An individual's perceptions of well-
being that stem from satisfaction or 
dissatisfaction with dimensions of tife 
that are important to the individuai 
Health and functioning 
Psychological/spiritual 
Family 
Social and economie 
Ferrans & Powers, 1985, p.16 
Patients* appraisal of and satisfaction 
with their current tevel of functioning 
compared to what they perceive to be 











Cella & Tulsky, 1990, pp. 30-31 
A personal statement of the positivity 







Grant, Padilla, Ferrell & Rhiner, 1990, p. 
261 
The perception of the impact of the 
disease is both subjective and 
culturally bound 
Physical functioning 
Emotional functioning, or 
psychological functioning 
Social function 
Symptom of disease and its treatment 
Clinch & Schipper, 1993, pp. 62-63 
An individual's perception of their 
position in life in the context of the 
culture and value Systems in which 
they live and in relation to their goals, 
expectations values and concems. 
Physical health 
Psychological state 
Level of independence 
Social relationship 
Personal beliefs 
Relationship to the environment 
WHOQOLgroup, 1993, p. l 
Physical, Psychological, social and 
spiritual well-being 
Economie impact of illness 
Taylor, Jones, & Bums, 1995, p.195 
Quality of life... is those aspects of an 
individual's subjective expérience that 
relate both directly and indirectly to 
health, disease, disability, and 
impairment...health related quality of 
life is the gap between our 
expectations of health and our 
expérience of it. 
Carretal.,2001(b),p. 1240 
"QOL encompasses not only disease 
Symptoms and functional 
conséquences (eg, impairment in 
activities of daily life (ADLs), but also 
subjective life satisfaction, happiness, 
and overall value one places on life at 
any given time". 
Cella et al., 2002, p.SIO 
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4.2.5 Conceptualization and measurement of HRQOL 
Since there in no a generally acceptée définition of HRQOL, within most of 
the available studies it is impossible to identify a strong theoretical basis for 
the concept. Many inconsistencies and ambiguities remain in the literature 
and a number of conceptual and methodological problems arise particularly 
when the assessment of HRQOL is attempted (Fitzpatrick et al., 1998; 
Aaronson et al., 1991b). 
Even if most experts consider that the concept is complex and vague, they 
have agreed on basic "conceptualization principles" for the construct that 
should be included in any HRQOL measurement. 
In the cancer field particularly, it is generally agreed that any health-related 
quality of life measurement used with cancer patients should be 
multidimensional (Aaronson et al., 1996; Cella, 1994; O'Boyle et al., 1992; 
Zhan, 1992; Aaronson, 1991b; Katz, 1987) and subjective (Cohen et al., 
1996; Bowling, 1995; Cella, 1994; Aaronson et al., 1991c). 
Also, the dynamic nature of the quality of life has been identified by a 
number of researchers such as psychologists, sociologists, and health care 
providers, even if this aspect is very often is overlooked in the literature 
(Alison et al., 1997). 
People change their perception of their health outcome, or their expectations 
over time, in terms of existing factors, patients' timing or spécifie life 
circumstances (Carr et al., 2001b; Alison et al., 1997; Caïman, 1984). 
Therefore, patients' with an apparently similar health status may have 
différent perceptions of their HRQOL. 
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HRQOL as a Multi-Dimensional Construct. 
Clearly, it would be inappropriate and overwhelming to incorporate ali of 
the potential dimensions relevant to quality of life in one study. The selected 
domains that constitute patients' quality of life are an important issue that 
has brought many authors to a debate in the literature about defining the 
domains and variables that illustrate HRQOL (King et al., 1997). Several 
researchers have focused on four main domains in their evaluation of 
HRQOL in cancer patients which include: physical well-being, 
psychological well-being, social functioning and disease-related and 
treatment-related symptoms. (King et al., 1997; Aaronson et al., 1996; Cella, 
1994; Moinpour, 1994; Ferrans, 1990; Ferrell, 1990). More recently there 
has also been an increase interest in including spirituality in the core set of 
HRQOL (Taylor, 2003; Cohen et al., 2000; Ferrell et a l , 1992a; Ferrell et 
al., 1992b). 
Table 4.2 demonstrates a variety of important life domains that may 
contribute to the concept. 
The specific purpose of HRQOL assessment will determine the hierarchy of 
the selective domains and will drive researchers to either include or not 
include other important perceived quality of life aspects such as 
occupational functioning, the stigma of cancer, happiness with care, 
fìnancial satisfaction, expectations of recovery and level of optimism or 
others (Cella et al., 2002; Higginson & Carr, 2001; Koller et al., 2000). A 
criticism of previous approaches to HRQOL evaluation in medicine is that 
they give priority to physical functioning and symptoms while other 
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important life domains are not considered as important (Fallowfield et al., 
1990). A conceptual model by Ferrans in 1990 demonstrated the hierarchical 
relationship between global HRQOL and the four major domains and 
specific aspects of the domains in cancer patients. Ferrans' model 
distinguishes clearly between the domains and provides a strong example of 
the connection between theory and research (Vallerand & Payne, 2003). 
Also, should one wish to assess HRQOL, it is necessary to keep in mind the 
interrelationship among the constituent domains (Aaronson et al., 1991c) 
and that the relationship among all of these aspects may vary between 
individual patients (Bernheim, 1999). For example, the psychological effect 
of the disease may have an important impact on physical well-being and 
social functioning but not be a common effect in all patients. 
One of the purposes of this study is to evaluate the impact of colorectal 
cancer disease on the lives of patients; the above four main domains 
(physical well-being, psychological well-being, social functioning and 
disease-related and treatment-related symptoms) are considered important. 
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Self-care activities (e.g bathing, dressing) 
Ability to perform every- day activities (Walking uphill/upstairs, household) 
Disease Symptoms (e.g pain, appetite, fatigue) 
Treatment side-effects 
Psychological Functioning 
Mood state (dépression, anxiety, fear, joy) 
Psychological well-being (happy, pleased, life satisfaction) 
Self-esteem, self-image 
Cognitive status (memory, concentration, perception, confusion) 
Social and Role functioning 
Interpersonal relationships (visits with friends and relatives, family, work and school relationship) 
Sexual functioning 
Performance usuai role activities (work, school, carry out hobbies and interests) 
Satisfaction with care 
Information and communication 
Support from health providers 
General Health Perceptions 
Self-rating of health 
Self-rating ofQOL 
HRQOL as a Subjective Construct 
The HRQOL perspective that wishes to assess quality of outcomes in 
medicai care, and go beyond objective clinical or biological outcome data, 
has to reflect the importance of patients' feelings and satisfaction to any 
health care or médical intervention. Thus the patients* perspective about 
their perceived health care or their préférences for treatment must be 
reflected within any HRQOL assessment. 
Since most researchers agrée on the subjective and individualized nature of 
QOL they support the view that that answers about HRQOL should be 
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selected directly by patients (Fitzsimmons et al., 1999; Kassa, 1995; Selbyet 
al., 1992). Studies have also shown differences among the rating of HRQOL 
given by patients, family members and health care providers. (King et al., 
1995;Osoba, 1994). 
In particular the psychosocial aspect of HRQOL may vary significantly 
between patients and proxy or health professionals and may be biased by 
these individuals' own standards of desirable QOL (Osoba, 1994). 
A recent review of 23 studies by Sneeuw et al. (2002) indicates that 
judgments that are made by significant others and health care providers 
concerning various aspects of patients' HRQOL are reasonably accurate 
while a proxy may often recognize more HRQOL problems than patients 
themselves. Also, "proxy ratings tend to be in greater agreement with those 
of patients for physical HRQOL domains compared to psychosocial 
domains" (p. 1141). 
It is also important to consider limitations of self-reported data such as 
missing data, language problems, cultural differences and patients burden 
(Osoba, 1994). 
Approaches to assessment HRQOL 
Even if the conceptual "principles" of HRQOL have been accepted by most 
researchers, the approach taken to assess the concept will differ and mainly 
be determined by the scope of assessment. 
Two main methods have been adapted for gathering multidimensional and 
patients-based HRQOL data. 
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First, is the use of standardized structured questionnaires in which important 
aspects of HRQOL are presented as items or scales (quantitative 
measurement). The second method is the use of interviews in which the 
main goal of the measure is to gain the individual's perspective of HRQOL 
and gather patient-centred QOL data (qualitative measurement). A 
combination of both methods can also be used for gathering HRQOL data 
for different research purposes. 
The use of standardized measures is intended to produce values (usually 
numerical) in order to reflect a 'good' or 'bad' HRQOL. Therefore, this 
method can provide quantifiable data that can be expressed as an aggregate 
score or dimension score, item score or a global score (Osoba et al., 1991b). 
The psychometric property of the measurement is very important within any 
proposed instrument that must be tested in order to ensure adequate validity, 
reliability, and clinical responsiveness. Some of the advantages of self-
assessment questionnaires are that they are easy to administer and complete 
so that they are applicable to large population of subjects. Also, the 
establishment norms permit comparisons among different cultural groups 
and populations - such as cancer survivors (Haberman and Bush, 2003). 
The qualitative approach focuses more on the assumption that each 
individual has their own particular definition of what constitutes quality of 
life and this definition may vary among individuals, and more subtly may 
vary further with the individual under specific life circumstances. A number 
of qualitative approaches have been used to measure individual perspective 
of quality of life including a case study (Silverman, 2005), grounded theory 
and phenomenology (Lowe and Rapin, 1994; Benner, 1985). 
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Types of HRQOL Instruments 
A variety of reliable and valid instruments that purport to evaluate HRQOL 
are available. The plethora of instruments means that there is not a 'gold 
standard' or a criterion which everyone accepts as being the best measure of 
HRQOL or the best measure of the impact of ail diseases, or cancer, on 
quality of life (Cella et al., 2002; Osoba et al., 1991b). 
In particular for cancer, the variety of treatments, as well as the variety of 
outcomes and meanings attached to quality of life itself, may explain the 
lack of a single instrument for use in ail situations. To the question, "which 
HRQOL measure should be used or which ofthe available questionnaires is 
the best?" there is no a single answer (Cella, 1997). The scope of the 
assessment should be first determined by the population of interest, the 
outcome of interest and the characteristics of the instruments available 
(Haberman & Bush, 2003; Cella et al., 2002; Osoba, 1991b). 
If the purpose of interest is, for example, to gain spécifie information into 
clinical practice (e.g. in clinical décision making, in predicting survival, 
improving quality of care), or in managed care settings, or for policy 
décision making or to evaluate treatments into clinical trials or patients* 
préférences for one treatment or préférence for various health status, then the 
appropriate instrument has to be selected (Cella et al., 2002; Higginson & 
Carr, 2001). 
The HRQOL measures are divided into two broad catégories: health profile 
(descriptive) questionnaires and utilities questionnaires. Health profile 
questionnaires are generic or spécifie (e.g. disease spécifie -as cancer 
spécifie- or dimension spécifie). Utilities questionnaires are generic and used 
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for economic evaluation of HRQOL and for assessing the patient 
preferences. 
Advantages and disadvantages of some of them are demonstrated in Table 4. 
3. 
Generic health profile measures include items that are general enough, or are 
intended for use not only across a wide range of chronic disease but also the 
general population. Generic tools often give a score in a number of 
dimensions and may then be summarized into a single score. This type of 
instrument is useful in determining whether a patient-population has 
returned to the same quality of life as the general population. They also 
permit comparisons across different diseases and conditions or different 
interventions. Two of the most widely used generic measures are the 
Medical Outcome Survey (MOS) Short-Form (SF-36) (SF-36 Ware et al., 
1993) and the Nottingham Health Profile (NHP) (Hunt et al., 1985). 
When the scope of inquiry is to identify every possible symptom and side-
effect of a procedure or to identify clinically important changes - particularly 
in clinical trials - then a disease specific or treatment specific instrument is 
required. For example, within the field of cancer clinical trials, HRQOL 
assessment has become increasingly popular as a key endpoint. So, in most 
interventions against cancer the quality of survival should be taken into 
account (Bowling, 2001; Fitzsimmons, 2000; Aaronson et al., 1996; Cella, 
1994; Slevin, 1992; Department of Health, 1992). This consideration is very 
important in case there is no potential cure and the palliative care and 
HRQOL are the primary endpoints (Girling et al., 2003). 
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Dimension specific instruments have also been designed to assess specific 
dimensions of HRQOL that are not included in disease specific or generic 
instruments, The Beck Depression Inventory (Beck et al., 1961) and the 
McGill Pain Questionnaire (Melzack, 1975) are two examples. 
Another strategy for assessing HRQOL combines a generic or "core" 
instrument with a disease or treatment specific module. Such a combination 
ensures the advantages of both while minimizing the limitations of each. So, 
this permits cross-study comparisons and assess clinical changes for a 
specific condition (Cella et al., 2002). 
At present two research programmes, The European Organization for 
Research and Treatment of Cancer (EORTC) and David Cella in US have 
developed the EORTC QLQ modular approach to HRQOL and the 
Functional Assessment of Cancer Therapy (FACT) system of HRQOL 
assessment accordingly. Both systems are primary designed for cancer 
diseases and a number of specific cancer modules are now available 
(including breast, lung, head and neck, colorectal and others). They fulfill 
methodological, psychometric and other criteria in the development of their 
scales and subscales which are the most widely used. 
Utility approaches derive from health economics and decision theories. They 
seek to produce a summary score for a particular state of quality of life 
without reporting symptom severity or functional impairment and are 
equivalent to a numerical value for decision making (Bowling, 2001; Cella, 
1997; Goodwin, 1991; Osoba, 1991b). Patients may be asked to express 
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their health status with a scale of 0-10 in which 0 is death or worst quality of 
life and 10 is perfect health or highest quality of life. Utilities are also used. 
with groups of subjëcts evaluating préférences for policy décisions or 
allocation of health care resources or to groups of patients for treatment 
décision (Berzon, 1998). 
Within clinical trials the assessment of patients' préférences distinguishes 
those who are in favour of one treatment over another when both have 
équivalent survival outcomes. (Bowling, 2001; Cella, 1997; Osoba, 1991b). 
Furthermore, they allow the évaluation of the effect of treatment on quality-
adjusted life year (QALYs) (standard gamble-time trade off techniques) 
indicating what risk patients could take in order to gain their preferred health 
standards (Goodwin, 1991; Osoba, 1991b). However, this latter use of 
assessment of patients' préférences into décision making raises many 
methodological and ethical issues. For example, ail aspects of health cannot 
be including in a single number (Bowling, 2001; Cella, 1997; Till, 1991). 
Also, patients vary significantly in understanding of personal risks to their 
health. These may include, for example, old people or those who may have 
"unrealistic optimism", patients who are physically handicapped, socially 
isolated or have lost motivation and may accept the greater risk of a radical 
treatment over other people with différent expectations (Bowling, 2001; Carr 
& Higginson, 2001; Till , 1991). The Quality-Adjusted Time Without 
Symptoms and Toxicity (Q-TWIST) is the only utility approach that was 
developed specifically for cancer patients. Also, the EuroQol, the Visual 
Analog Scale and the Quality-Adjusted Life Years (QALYs) are some more 
examples of utility measures. 
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Individualized measures have also been developed such as the Schedule for 
the Evaluation of Individualized Quality of Life (SEIQOL) (O'Boyle et al., 
1992) and the Patients Generate Index (Ruta et al., 1994). Although thèse 
measures have not widely been used, and a number of methodological 
obstacles have to be overcome, they have been receiving increasing attention 
lately (Scientific Advisor Committee of the Medicai Outcomes Trust, 2002; 
Carr & Higginson, 2001). 
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Table 4.3: Advantages and Disadvantages of HRQOL Instruments. 
Examples of HRQOL Instrument Advantages Disadvantages 
Generic (examples). 
SF-36 (Ware et al. 1993). 
SIP (Bengeretal 1976). 
NHP (Hunt et al. 1985). 
Provide an overall health status. 
Used in a wide variety of population 
or conditions. 
Permit cross-study comparisons. 
Normative data often available. 
Widely tested for validity and 
reliability. 
Short version often available. 
Identify unsuspected findings. 
Sensitivity to comorbid conditions. 
Do not detect important clinical 
changes in QOL. 
Emphasis on functional status. 
Lack of specificity. 
Disease specific (Cancer specific). 
RSCL(de Haesetal. 1992). 
FACT(Cel laeta l . 1993). 
EORTC QLQ-C30 (Aaronson et al. 
1993). 
FLIC (Schipper et al. 1984). 
CARES (Schagetal. 1990) 
Describe specific disease problems 
and benefit due to treatment 
Allow clinically important changes 
over time. 
Relevant to patients. 
Used in clinical trials. 
Strong relation to physical disease 
findings. 
Some provides a module specific to 
certain cancer location. 
Lack of cross-study comparison 
between different conditions. 
Lack of normative data and cultural 
norms. 
Rarely captures all aspects of 
functional status and well-being. 
Fail to distinguish between treated 
and untreated patients. 
Dimension specific. 
BDI (Beck et al. 1961). 
McGi l l Pain (Melzack 1975). 
HADS (Zigmond and Snaith 1983. 
Anxiety and Dipression Scale (Radioff 
1997). 
Describe in details the domain of 
interest. 
Used across range of patients 
populations 
Cross-study comparison. 
Used as screening tools. 
Does not capture multidimensional 
aspect of HRQOL. 
Not primarily designed as outcome 
measures. 
Individual. 
SEIQOL (O'Boyle et al.1993). 
Capture individual perception. 
Content validity. 
Responsive to change in individuals 
across time. 
Trained interviewer for 
administration. 
Applicable to limited population. 
Validity and reliability requires 
further assessment. 
Utility. 
Q-TWIST (Gelber (1991). 
Captures individual perception. 
Allow cost-benefit analysis. 
Produce single score. 
Does not capture multidimensional 
aspect of HRQOL. 
Requires statistical interpretation. 
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Choosing a HRQOL Instrument 
In a systematic review of literature on HRQOL Fitzpatrick et al. (1998) 
suggested eight requirements that should be directed at an instrument when 
it is purposed as an outcome measure (Table 2.4). Thèse refer to the general 
principles of psychometric theory and should be addressed by any researcher 
who may wish to develop a new scale (Cella et al., 2002). 
Table 4.4. Eight questions That Need to be addressed in Relation to a 
Patient-Based Outcome Measure Being Considering for a Clinical Trial 
(Fitzpatrick et al. 1998) 
1. Is the content of the instrument appropriate to the questions that the 
clinical trial is intended to address? (Appropriateness). 
2. Does the instrument produce results that are reproducible and internally 
consistent? (Reliability). 
3. Does the instrument measure what it claims to measure? (Validity). 
4. Does the instrument detect changes over time that matter to patients? 
(Responsiveness). 
5. How precise are the scores of the instrument? (Précision). 
6. How interprétable are the scores of the instrument? (Interpretability). 
7. Is the instrument acceptable to patients? (Acceptability). 
8. Is the instrument easy to administer and process? (Feasibility). 
Instruments that have been developed throughout mis process and meet ail 
thèse standards could be used with more confidence by researchers. A brief 
synopsis of thèse questions is demonstrated next. 
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The first considération should be to ensure that the instrument is suitable for 
the intended purpose. The generic or the disease-specific measures, for 
example, purported to capture the most important and relevant aspects of 
quality of life to a specific patients group (Cella et al., 2002). 
Reliability of the instrument refers to the existence of error-random or 
systematic after a measurement. In fact, reliability is synonymous with 
repeatability and consistency. A question that could be addressed and may 
express the reliability of a measure would be: "does the test measure 
produce the same results (consistent results) when repeated in the same 
population?" Reliability can be determined using a variety of methods. The 
test-retest method assesses the reliability (stability) of a measure and 
détermines whether similar results are obtained (at two separate time points 
in time), when the test measure is administered to the same population. 
Similarly the inter-rater method assesses whether similar scores are obtained 
by différent observers. However, a number of biases can occur, for example, 
the time between two administrations should be chosen with care. If the 
disease progression changes rapidly or patients undergo treatment, the 
quality of life measure can be expected to remain stable for a short time. On 
the other hand, when the time of measuring is too short the respondents may 
remember their last responses (Streiner and Norman, 2003). 
The internai consistency is also a method for assessing the reliability of a 
measure and is an important concept particularly for multi scales. The term 
refers to the homogeneity of the items of a scale, to the degree that items 
correlated with one another and with the overall scale score. High 
corrélation among items is the évidence that a measure is internally 
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consistent. The more comprehensive statistical test for the internal 
consistency is Cronbach's alpha coefficient (values range from 0 to 1 but a 
correlation coefficient above 0.70 is important). But, a high value of 
Cronbach alpha (0.9-0.999) may mean that the same question is asked more 
than once. Finally, one should have in mind the reliability of a measure is 
not a fixed property in any one measure, but is instead a property that may 
be used with certain people under certain conditions (Streiner and Norman, 
1995; Hays et al., 1998). Thus, it may not produce generalizable results and 
should be reevaluated in new applications (Cella, 1997). 
The validity of an instrument refers to its ability to measure what it claims to 
measure, for instance, quality of life. In many fields of measurement, the 
validity of an instrument is established by comparing it with a "gold 
standard" or to a superior measure and the new tool provides evidence of 
criterion validity. In psychometrics there are no gold standards, so other 
techniques have developed in which the validity of an instrument is 
examined indirectly (Streiner and Norman, 2003). 
So, the face validity examines the degree to which a measure appears 
clinically important and sufficiently appropriate to the setting being 
measured - including patients with cancer. Does the tool contain questions 
that are appropriate to the area that is measured, and is this area covered 
completely? (Streiner and Norman, 2003). 
Criterion validity is usually established by correlating the scale data results 
with a pre-existing standardized measure of the same construct (convergent 
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validity) - sirice the gold standard does not exist - or with the results of other 
parallel measure (concurrent validity) (Streiner and Norman, 2003). 
Construct validity refers to the ability of a measure to produce results that 
confimi the theory or the hypothèses. If, for example, a theoretical model 
supports that weakness correlated with the stage of patients' disease or with 
muscle strength etc. and a measure confirms the above theory having high 
scores (indicating weakness) for people with advanced disease or muscle 
debility, then the measure présents some construct validity. Factor analysis 
is an approach that contributes to construct validity confirming the 
multidimensional nature of HRQOL measures (Hays et al., 1998). 
Responsiveness to change or sensitivity is also an important requirement of a 
measure, particularly in clinical trials. Clinically meaningful changes refer to 
those that are expected to occur with tirrie; for example, improving or 
worsening health status or changes correlating to the proposed treatment and 
side-effects. Many criticisms exist about the sensitivity of available 
standardized measures given mat they may capture only something of the 
overall HRQOL of individuai patients. They may capture the clinical 
changes in patients' functional level but they are unlikely to reflect changes 
in other important aspects of HRQOL such as family support, sexuality, 
spirituality or other important components of care or other outcomes of 
treatment. Such criticism leads some authors to find difficulties in 
interpreting the scores of many of these measures (Carr & Higginson, 2001; 
Bowling, 1995). However, as discussed previously, although such aspects 
might not be useful as outcome measures, they might serve as explanatory 
variables. As with reliability and validity, the sensitivity of an instrument 
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can be also established by a number of statistical approaches. Thèse include 
corrélation of changes in QOL with patients' clinical status or calculation of 
effect-size (Streiner and Norman, 2003). 
The précision of a measurement is very important since they wish to express 
subjective responses as numerical values. This is assessed through the 
response catégories used in the instrument (Likert scales or Visual Analogue 
scales) (Osoba, 1991). 
Interpretability of instruments is a relatively new area that has now begun to 
be explored in the clinical arena. This is concerned with the ability of an 
instrument to interpret what changes in HRQOL are clinically significant 
(Lydick and Yawn, 1998). Small numerical changes, for example, in 
HRQOL may have a high level of statistical significance in a large 
population. Many authors agrée that the level of statistical significance may 
fail to reflect the clinical relevance from a patient perspective of changes in 
HRQOL scores (Efficace et al., 2004; Osoba, 1999; Cella, 1997; Osoba, 
1991b). The assessment of subjective significance information, or the 
examination of the différences in mean scores between studies of patients, 
are two approaches used in assessing the interpretability of instruments 
(Osoba, 1999). Other approaches are the establishment cut-off points for 
clinical intervention (e.g. dépression scale) that dérive from normal 
population or from other disease populations (Weissman et al, 1997) or the 
use of clinical anchors or distribution-based techniques (Funk et al., 2004). 
During the last two décades a new approach has been taken in the 
construction and scoring of instruments. It is based on the "item response 
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theory" (LRT) that provides a number of methodological advantages and 
contributes to the development of Item Banks and computerized adaptive 
assessment (Ware, 2003a; Cella, 2002; Hays, 1998). The acceptability of a 
measure, either by patients or by staff, is a very important property for any 
measure. The length of a questionnaire and time taken to complete are 
important aspects. Questionnaires that take less than 10 or 15 minutes to 
answer are considered brief and may be more préférable to patients with 
cancer than long questionnaires (Osoba, 1991). Missing data is a problem, 
particularly for long-term follow-up measures, leading to serious problems 
in the analysis and interprétation of the results. Patients may miss out items 
for many reasons (including not understanding the item) or they may be 
unsure about the most appropriate response options, or feel that some items 
are not relevant to them (Conroy, 2003). 
The feasibility of using the HRQOL assessment is also an important issue 
and barriers have been described in carrying out assessment. Some of them 
related to the time that is demanded for the assessment, the financial support 
needed, the perceived lack of an appropriate instrument and the belief that 
HRQOL assessment is unrealistic (Osoba, 1991a). Also, any HRQOL 
assessment demands ethical considération with respect to informed consent 
and confidentiality of data. This may require an in-depth knowledge by 
research staff on collecting HRQOL data. 
78 
4.3 Summary and conclusions 
The assessment of QOL within health care has become an interesting area of 
research in récent years. Although there is debate with regard to the 
conceptualization of QOL, there has been a prolifération of interest in the 
assessment of Health-Related Quality of Life (HRQOL) as an outcome of 
disease and treatment. Assessment of quality of life has changed the interest 
of quantity of life to quality of life. 
This has resulted in a wealth of instruments that purport to assess aspects of 
HRQOL. Considération of the type of instruments and their properties is 
fondamental in choosing an instrument for any HRQOL measure. One of the 
main issues of concern is whether an instrument is appropriate for use in a 
particular patient group. A disease spécifie instrument promises to be if it 
covers important issues for a particular disease and is responsive to changes 
over time. Therefore, a considération of an appropriate assessment of 
HRQOL in survivors of cancer of the colon and rectum as well as an 





This study utilized a cross-sectional survey designed to assess the current 
state of the quality of life of long-term Greek colorectal cancer survivors. It 
focused on the disease-related factors and factors regarding patients' 
characteristics that might modify the level of HRQOL. 
For these research purposes, a self-administered generic and cancer specific 
multidimensional HRQOL instrument was used as well as dimension specific 
instruments. 
Presented in this section are the research questions, the objectives and 
hypotheses as well as the procedures and design of the study. Included are: 
description of the criteria instruments, procedures for translation of the 
research instruments, estimated sample size of the research and data analysis. 
5.2 Research questions 
The research questions of this study are: 
1. How do Greek colorectal cancer patients perceive their HRQOL during the 
post-treatmentysurvivorship phase? 
2. What factors (clinical, demographic) may influence Greek colorectal 
cancer patients HRQOL? 
3. How do HRQOL measures change for patients with colorectal cancer of 
different stages at diagnosis, and at different times since diagnosis? 
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5.3 Objectives 
To address the research questions, specific objectives were set: 
1. To assess specific dimensions of HRQOL such as the physical 
functioning, the emotional/mental functioning, the social/family functioning 
and the functional well-being in Greek colorectal cancer survivors following 
treatment as measured by FACT-C and MOS Short-form 36 instruments. 
2. To determine the overall HRQOL of Greek colorectal cancer survivors as 
measured by the FACT-C instrument. 
3. To identify specific factors that might contribute to patients' HRQOL. The 
independent variables were: stage of the disease at diagnosis, time since 
diagnosis, colostomy appliance, disease recurrence, depression as 
comorbidity, relationship with the partner and certain demographic 
characteristics such as age, gender, marital status, educational lever and 
income. 
5.4 Hypotheses 
Hypothesis 1: The overall HRQOL would be higher for those patients further 
from diagnosis and with early disease stage. 
Hypothesis 2: The HRQOL of patients with a colostomy appliance would be 
lower than those without a colostomy appliance. 
Hypothesis 3: The HRQOL of patients who experienced remission of the 
disease would be better than that of patients with recurrent disease. 
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Hypothesis 4: Increased age, depression, poor communication with partner 
and lower income status would be associated significantly with poorer 
outcomes on the HRQOL of cancer survivors. 
5.5 Plan of investigation 
A survey design was decided for the present study because the main purpose 
of the study was to describe the overall and dimension specific HRQOL 
(physical well-being, emotional well-being, social functioning, disease 
specific dimension) of a patient's population, and to compare HRQOL 
between groups (stoma patients with non stoma patients or patients with 
recurrence or metastasis with patients without recurrence or metastasis). 
Furthermore, a cross-sectional survey design permits of making comparisons 
over time among HRQOL of patients at different times since diagnosis and 
different disease stages that was one of the objectives of this study. 
A range of measures were required in order to address the objectives of the 
study. For investigating the impact of disease and treatment on HRQOL 
domains and overall HRQOL, the primary objective of the study, required a 
quality of life measure specific to colorectal cancer patients. The "core" 
Functional Assessment of Cancer Therapy-General (FACT-G) was used (a 
generic, cancer-specific HRQOL instrument) together with its colorectal 
cancer "module" (FACT-C) (Appendix 9). One of the advantages of this 
measure, in addition to its responsiveness to disease-related changes in 
HRQOL, is that it provides scores for the overall QOL of the research 
population. 
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It was decided to use the mental component of the generic quality of life 
instrument Medical Outcome Study Short Form Health Survey (SF-36) 
(Appendix 11). 
In order to explore independent variables that may influence or determine 
patients' HRQOL demographic data were gathered directly from the patients 
(age, gender, marital status, income, educational level) (Appendix 7). In 
addition, disease and treatment data were gathered from medical notes (stage 
at diagnosis, time since diagnosis, treatment choice, recurrence) in order to 
allow HRQOL comparisons between gender, age groups, income categories, 
educational levels, stoma patients with non- stoma and correlations among 
HRQOL variables e.g. how disease characteristics such as disease stage, time 
since diagnosis or patients' characteristics are related to one another. 
The relationship between depression and HRQOL was also explored by the 
use of the depression measure The Center for Epidemiology Studies 
Depression Scale (CES-D) (Appendix 13). 
The support that patients perceived by their partner as well as how it was 
related with their quality of life was investigated by the psychological scale 
The Enriching and Nurturing Relationship Issues, Communication and 
Happiness (ENRICH) which measures the level of communication between 
couples (Appendix 15). 
A l l instruments except ENRICH had officially been adapted and translated 
into Modem Greek language. The official Greek translated version of FACT-
C (version 4) scale was obtained by the official body the Functional 
83 
Assessment of Chronic Illness Therapy (FACIT) Measurement System, 
Center on Outcomes, Research, and Education (CORE) together with 
permission for its use. 
The SF-36 and the CES-D scales have been officially translated and 
validated into Greek by Pappa et al. (2005) and by Foundoulakis et al. 
(2001). 
For the ENRICH instrument a translation process was required by the 
researcher that is described at the section below. 
The Consent Form was translated into Greek from the original form by this 
author. The letter that invited patients to participate, the information sheet, as 
well as the demographic data questionnaire were originally written in 
Modem Greek and were translated in English and then were checked by the 
academic supervisor. 
A pilot study was carried out in which a small number of colorectal cancer 
survivors were interviewed in order to assess the clarity and acceptability of 
the research instruments that also is described at the section below. 
Sample size calculation was made by STATISTICA, a software programme 
details of which are described in the section below. 
5.5.1 Translation of the ENRICH research instrument. 
The Greek version of the 10-items communication scale of the ENRICH 
instrument (Appendix 15) was obtained by following standard translation 
procedures. The first step of the translation process involved forward 
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translations of the original English questionnaire into Greek by two 
translators who were native speakers of Greek. Each translator produced one 
translation of the ENRICH items and established a list of translations of the 
response choices. Translators were to place emphasis on conceptual and 
culturally-sensitive rather than literal equivalence. Differences in translations 
were discussed, alternatives were documented and a target translation of 
ENRICH was produced. The forward translation was given to two translators 
who were native speakers of English and spoke Greek, who translated the 
questionnaire back into English. The translations were discussed for 
equivalence, and modifications were made to some translations. 
There were differences between forward and backward translation regarding 
the phrase "silent treatment" of item 2 of the instrument. During the forward 
translation the above phrase was translated into Greek as (adiaforia) and 
during backward translation process the word (adiaforia) translated back to 
English as "indifference". It was decided to translate the phrase "silent 
treatment" as (adiaforia) since in Greek this word means the lack of interest 
or attention. 
Finally, the modified forward translated instrument was pilot tested with a 
small group of colorectal cancer patients (N=10). Respondents completed the 
questionnaire and were asked if they found any items difficult to understand 
or the answer, confusing or upsetting. Generally all items were well accepted 
by patients without any problems in understanding. The only problem that 
emerged by pilot testing was about the group of patients who were divorced 
or was widow/widower since the communication scale of the ENRICH 
questionnaire investigates the relationship between partners. As one of the 
purposes of this study was to investigate the independent variables that 
contribute to patients' quality of life it was decided that anyone person who 
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was close to patients and could be a support, or hot, to them would be 
accepted as the person who contributes to his/her quality of life. The 
communication scale of the ENRICH instrument was, however, administered 
to those patients who lived without a partner asking them to reply to the 
questions in case an important person did support them. In this case the 
phrase "my partner" that used in some items of the instrument modified to 
"this person" for this category of patient. 
5.5.2 Pilot testing 
The research questionnaires were administered to colorectal cancer survivors 
for pilot testing before administering to the research population. 
Methods 
Identification of Patients 
Ten colorectal cancer patients coming to the clinic for follow-up examination 
were approached by the researcher and interviewed with their physician's 
permission. Patients who took part in the pilot study were identified as being 
suitable according to the same eligibility criteria set for the research study. 
Purposeful sampling allowed a cross section of subjects to be identified. So, 
patients were recruited who represented different Duke's stages, treatment 
choices, different times from diagnosis (early-term, middle and long term 
survival), and a variety of socio-demographic characteristics. The table 5.1 
below shows the socio-demographic and clinical features of the pilot 
patients. 
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Table 5.1 Socio-demographic and clinical features of the Patients (n=10) 
A G E (mean) 62.5 years (27-76) 
S E X 6 maie, 4 female 
M A R I T A I . S T A T U S 9 married, 1 widow 
O C C U P A T I O N 4 retired 
2 housewives 
4 full-time workers 
T I M E S I N C E D I A G N O S I S Long-term: 5 
Mid-term: 2 
Earl-term: 3 
S T A G E 3 Stage B , 
7 stage C 
T R E A T M E N T I N T E R V E N T I O N Surgical resection,: 10 
Colostomy:2 
Chemotherapy: 1 
Radiation therapy: 2 
R E C U R R E N C E / M E T A S T A S I S Liver:2 
Liver and Lung:2 
Recruitment and data collection 
The researcher was introduced to patients identified as being eligible and 
discussed the study with them in a private room. They were informed of the 
aim of pilot testing, conduct of the study and were asked to participate. 
Patients who opted to take part in the testing were asked to examine and 
"think aloud" as they completed the questionnaires in order to gather their 
perceptions of the instrument's completion taking into account the following: 
1. Whether they had difficulties in replying to the questions 
2. Whether there were items that they found confusing 
3. Whether difficult words were used 
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4. How they would have rephrased a confusing question 
5. Whether they had problems distinguishing between the points within the 
answer scale. 
6. Whether they felt that any questions were irrelevant to their current health 
situation. 
7. Whether there were too many questions or whether some of them should 
not have been included, thus avoiding overload. 
8. They were also asked if they found some questions a distressing reminder 
of their period of illness. 
The researcher kept notes for each patient's comments according to the 
above. 
Results 
Fourteen patients were initially identified as being suitable for the pilot 
study. Two patients immediately declined to take part because they not had 
time to be interviewed and two others were withdrawn due to illness. 
Therefore, ten patients eventually participated in the pilot testing. 
In general, the patients were positive about the questionnaires. Most found 
the questionnaires clearly worded without facing any serious problems in 
replying to the items. 
Although most patients found psychological issues very relevant and 
important to be asked they felt that questions about physical health tended to 
repeat often. Taking into account mis comment it was decided to take out the 
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physical component of SF-36 questionnaire in order to minimize patients' 
burden. SF-36 physical component was selected to be excluded because the 
SF-36 questionnaire does not produce a score for overall QOL. In order to 
address a primary purpose of the study the FACT-C questionnaire was 
preserved as it produces a summary score for overall QOL. So, only the 
mental component of SF-36 questionnaire included in the study. 
Two patients suggested that the list of occupations /jobs that were included in 
the démographie data questionnaire was limited. According to this comment, 
in the Employment Status list was added the option "other job". 
One man found the wording of items C8 and C9 of FACT-C instrument 
(ostomia) and (orthostomia) (stoma area) not very clear and suggested to 
rephrase them into (colostomia). Since this would have not changed the 
overall meaning of the items as well as the fact that the word (colostomia) is 
a colloquial word and widely used in Greek language for expressing this 
meaning, it was decided to adapt thèse items according to patient's 
suggestion. 
Two patients faced problems in the understanding of the word (naftia) 
(nausea) in FACT-C instrument GP2 item. It was decided to keep the word 
(naftia) and to add the translation of the word into Greek for those people 
who may face any problem about its meaning. So, the GP2 item became (eho 
naftia e tassi gia emeto) (I feel nauseated). 
One woman found the GP3 item of FACT-C instrument confusing. When she 
was asked what made it so she answered that she faced difficulty in 
understanding the phrase (fissikis mou katastasis) (my physical condition). 
When the phrase changed to (somatikis mou katastasis) (my bodily 
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condition) she did not face any problem. So, this phrase was changed to the 
above suggestion taking into account that it is a phrase that focuses on 
problems that related to physical well-being. Thus it is familiar to everyone 
and did not change the meaning of the phrase. 
Two patients mentioned that SF-36 and CED-S instruments should have used 
a bigger font and larger spacing between the lines. According to them, and 
given that the research population would be older people, changes were made 
to the font and spaces in all instruments. 
Changes made by pilot study results concerning the ENRICH instrument 
were described in detail in a previous section. 
5.5.3 Sample size 
Concerning sample size, the Power and Sample size calculation subroutine of 
the statistical software programme <STATISTICA> was employed to 
establish the parameters for analyzing sample size for multiple regression. 
The question to be answered was the following: How big a sample size 
would we need to have a power of 0.80 and Type I Error (Alpha)= 0.05, in a 
situation where there are 9 predictor variables (age, sex, stage at diagnosis, 
time since diagnosis, economical status, educational level, colostomy, 
metastasis, depression)? 
In a study of HRQOL evaluation for long-term survivors, Ramsey et al. 
(2002) used multiple regression with HRQOL measures as dependent 
variables (health utility index, SF-36, FACT-C self evaluation). Time since 
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diagnosis, income, co-morbidity, and chronic diarrhea were included as 
predictor variables. The proportion of variation explained (R ) was modest 
and ranged from 12.5% (for HUI) to 22.8% (for self-evaluation). Thus, a 
value of sample R2=18% can be considered realistic. 
For thèse figures, a sample size (N) equal to 137 is estimated to be sufficient 
for 9 predictor variables in order to achieve a power of 0.80, assuming that 
the population coefficient of détermination (P2) is equal to 0.35, thus 
rejecting the null hypothesis that P2<R2 The value of P 2 (=0.35) can be 
considered satisfactory, since it explains one third of the variance in QOL 
accounted for by the régression. 
5.5.4 Participants 
Since the population of interest of the present study was colorectal cancer 
survivors, colorectal cancer patients from the archives of two Athenian 
institutions were identified. The institutions were one public oncology 
hospital and one private oncology clinic. This was done in order to obtain 
socioeconomic heterogeneity among patients. The public hospital most 
commonly provided its services to a population of low socioeconomic level 
whereas the private clinic cared for patients of middle and upper-middle 
socioeconomic level. Also, the archives from which the data were collected 
involve patients from all over Greece and of both sexes, who satisfy the 
inclusion criteria. Therefore, it was a sample that except of the socio-
demographic heterogeneity among people (different income categories and 
educational levels) it involved patients with various medical conditions. So, 
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patients from all disease stages as well as from all periods of time since 
diagnosis were included into the study. 
So, 145 Greek patients of both sexes, diagnosed with cancer of the colon and 
rectum who had survived at least 1 year from initial diagnosis were 
investigated. 
Survival from colorectal cancer was determined in time periods from the date 
of initial diagnosis: "Early-term" (1 year post treatment), "Middle-term" (2-4 
years post treatment) and "Long-term" (>5 years post treatment). 
The demographic characteristics of the study sample (age, gender, marital 
status, educational level, employment status, income) as well as and the 
medical characteristics (disease stage, diagnosis, time since initial diagnosis, 
type of therapy, stoma, non-stoma patients, reccurence, metastasis) are 
presented below in table 5.2. and in table 5.3. 
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Table: 5.2 Demographic characteristics of colorectal cancer survivors (N=l45) 
No % 
Gender 
Male 87 60 
Female 58. 40 
Age (yrs) 
<60 67 46.2 
61-70 45 31.0 
>70 33 22.8 
Marital Status 
Single 9 6.2 
Married 114 78.6 
Divorced 9 6.2 
Widowed 13 9.0 
Education 
Primary school 30 20.7 
Secondary School 53 36.6 
College/University 62 42.7 
Employment Status 
Unemployed 2 1.4 
Household 15 10.3 
Retired 73 50.3 
Clerk Officer 23 15.9 
Skilled workman 1 0.7 
Farmer 1 0.7 
Work in their own job 17 11.7 
Other 6 4.1 
Not working due to disease 7 4.8 
Family Income (euros per month) 
<440 14 10.8 
440-880 27 20.8 
881-1,467 28 21.5 
1,467-2,347 33 25.4 
>2,347 28 21.5 
Missing 15 
Residence 
Athens 109 75.2 
Province 36 24.8 
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Table 5.3: Disease-related characteristics of the sample (N=145) 
No % 
Diagnosis 
Colon cancer 100 69.0 
Rectum cancer 45 31.0 
Disease stage at diagnosis 
Stage B 
Stage C 55 37.9 
Stage D 79 54.5 
11 7.6 
Years since diagnosis 
1-2 36 24.8 
2-4 75 51.7 
>5 34 23.5 
Type of therapy 
Colectomy 142 97.9 
Adjuvant Chemotherapy 139 95.8 
Adjuvant Radiation Therapy 42 29.0 
Ostomy 22 15.2 
Metastasis 38 26.2 
Récurrence 8 5.5 
Eligibility was determined by the inclusion and exclusion criteria below. 
Inclusion criteria 
a. Cancer of colon and rectum was a confirmed diagnosis and the primary 
malignancy. 
b. Patients had survived at least 1 year since the time of diagnosis. 
c. They were over the âge of 18 at time of diagnosis. 
d. Dukes B, C, or D tumor stage were confirmed. 
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e. They had not received any treatment (surgery, chemotherapy, radiation 
therapy) for their disease in the past month. Since the main purpose of the 
study was to capture the late effects of the disease and its treatment on 
patients' quality of life since any treatment had been completed, the short 
term side-effects of any treatment would contribute to the difficulty in 
capturing the late effects of the disease on cancer survivors. It was supposed 
that a time of one month would be sufficient for any short side-effects to 
have ceased. 
Exclusion criteria 
a. Diffìculties in reading or understanding Greek. 
b. A second non-colorectal carcinoma-felated malignancy. 
c. Patients with known évidence of cognitive impairment or severe mental 
illness. 
5.5.5 Recruitment and data collection strategy 
The survey was conducted between March 2003 and July 2006. The eligible 
patients were identified from the period of the last 12 years; that is between 
1993 and the end of2005. 
Permission for having access to the public hospital archive was obtained 
from the director of the institutions and information relating to general health 
status, type of disease, disease stage, type of surgery, and other adjuvant 
therapy (chemotherapy or radiation therapy that follow surgery) received was 
obtained from medicai case notes. Permission was also obtained from 
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subjects' physicians before the individuals were contacted and consent 
gained. The consent form was also obtained from the patients. 
From the first archive those patients who met ail eligibility criteria were 
selected. A i l selected patients were contacted by phone in order to monitor 
the population that had died or changed address. Because the response rate 
was low, particularly due to those subjects with advanced disease and those 
who might were moved, re-sampling through the use of the second archive 
was necessary. 
During téléphone communication, the investigator had the opportunity to 
screen patients' ability to speak and understand Greek. The téléphone 
respondents were informed about the research purposes as well as the fact 
that permission to contact them and use of their personal data (name, 
téléphone number, address) had been obtained from their physicians. Those 
patients who accepted to learn more about the study were sent by mail a 
letter marked "Private and Confidential" with a letter, a detailed information 
sheet with a reply slip. In the patient's letter, direct contact détails were given 
for the researcher, including a 24 answer phone if patients had any queries or 
concerns (APENDIX 1, 2). The information sheet included détails about the 
aim of the research the significance of their participation as well as 
instructions on how to complète the questionnaires (APENDIX 3, 4). One 
week after sending the letter and the information sheet a téléphone contact 
would confirm that patients had received it. During téléphone 
communication the investigator had the opportunity to discuss any aspect of 
the study in a further détail. For people who did not receive the letter a new 
one was sent. 
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Participants who accepted to participate in the study and fmally returned the 
reply slip were sent a Research package by mail. 
After two weeks, non-respondents were sent a second research package and 
reminder to complète. Four patients declined to complète the survey at this 
time and were not contacted again. 
5.5.6 Response rate 
Through the archive survey, 362 eligible patients were identified and 
contacted by phone. Of the patients contacted, 196 answered the phone call 
(54.1%). Five of them had difficultés in communication due to low 
educational level or because of advanced âge. So, the information sheet and 
the reply slip were sent to 191 eligible patients. One hundred and forty nine 
patients accepted the invitation to participate in the study by sending the 
reply slip and so they received the Research Questionnaires. Nineteen 
patients needed a reminder to complète. In total, from those patients who had 
been sent the letter, the information sheet and the reply slip one hundred and 
forty five (145) patients returned the completed questionnaires (response rate 
75.9 %). 
5.5.7 HRQOL assessment administration 
Patients were asked to complète the Research Package that included: 
a. A consent form (APPENDIX 5, 6) 
b. A Démographie data questionnaire (APPENDIX 7, 8). 
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c. A copy of the research questionnaires (FACT-C, SF-36, CES-D, 
ENRICH) (APPENDIX 9-16). (Detailed description of these questionnaires 
and the rationale for their use is discussed in the section below). 
d. Two stamped addressed envelopes: one for returning the completed 
questionnaires and the other for returning the signed consent form. The 
signed consent form was returned separately for ensuring the anonymity of 
the completed participants' questionnaires. 
5.6 Description and validation of the instruments 
The Demographic data questionnaire included questions about: age, gender, 
marital status, educational level, employment status and income-factors that 
may influence patients' QOL. 
The Functional Assessment of Cancer Therapy (FACT) system is one of the 
most widely used QOL assessment system and its development commenced 
in 1987 by David Cella in the USA. The system has already been used by 
international research organizations. One of the important advantages has 
been the emphasis on cross-cultural development in a range of languages and 
cultures. The system contains the core generic instrument (FACT-G) that 
assesses health status of cancer patients in terms of 4 HRQOL dimensions: 
physical well-being (PWB, 7 items), emotional well-being (EWB, 6 items), 
social well-being (SWB, 7 items), and functional well-being (FWB, 7 items) 
(Cella et al., 1993). Disease-specific subscales have been developed to 
complement the FACT-G. Each subscale addresses concerns associated with 
the specific cancer. Colorectal Cancer Subscale (CCS) contains 9 items that 
assess issues related to the QOL of all disease stages in colorectal cancer 
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patients, covering a variety of areas such as stoma related issues, emotional 
status, social effect of illness and functional changes. Each item is rated on a 
5-point Likert type scale. The FACT-C instrument is a measure which 
combines the FACT-G with the 9-item colorectal cancer subscale (CCS). 
Scoring of FACT-C allows for the calculation of individuals' subscale scores 
which are then added to produce an overall QOL score; higher scores reflect 
better QOL. The summary scores range from 0 (worst possible) to 144 (best 
possible) (Ward et ah, 1999). 
In the original study (Cella et al., 1993) internal consistency of three out of 
five scales (PWB, FWB, and EWB) and total QOL score of FACT-C 
instrument was >0.70 (Cronbach's Alpha coefficient). The SWB was below 
this, with an Alpha coefficient of 0.69. Test-retest reliability on 70 patients 
was undertaken and the response rate was high at 86% and correlation 
coefficients ranged from 0.82-0.92 for all scales. In the validation of the 
colorectal cancer specific instrument, (FACT-C) (Ward et al., 1999) for both 
the English and Spanish versions, internal consistency was above 0.85 
(Cronbach's alpha coefficients) for the FACT-C total score and above 0.84 
for the FACT-G total score. So, the FACT-C evidenced good internal 
consistency reliability. 
As far as construct validity is concerned, the FACT-C was compared to other 
psychosocial measures. Correlational analyses showed a significant positive 
association with positive mood indicators and significant negative 
correlations with negative mood indicators. Therefore FACT-C has 
evidenced good concurrent validity (convergent). The FACT-C was able to 
distinguish between groups based on functional status and extent of disease. 
The FACT-C has also been found to be sensitive to change in functional 
status. The FACT-C (both English and Spanish versions) appears to be 
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sufficiently reliable and valid measure of HRQOL for use in research with 
colorectal cancer patients (Ward et al., 1999). The official Greek translated 
version of FACT-C (version 4) scale was obtained by the official body the 
Functional Assessment of Chronic Illness Therapy (FACIT) Measurement 
System, Center on Outcomes, Research, and Education (CORE) together 
with permission for its use. 
Medical Outcome Study Short-Form 36 Health Status Survey (MOS SF-36), 
version 1. The MOS SF-36 is a generic well-established instrument 
measuring HRQOL that measures physical, psychosocial functioning and 
morbidity due to health condition through eight health concepts: physical 
functioning, limitation in role functioning due to physical health problems, 
bodily pain, general mental health capturing feelings of nervousness, 
unhappiness and sadness, limitations in role functioning due to emotional 
problems, vitality, social functioning and general health perceptions (Ware et 
al., 2003b). The SF-36 instrument has been validated in many European 
countries such as France, Italy, Germany, Spain, U.K., Sweden, Denmark 
(Gandek &Ware, 1998). It has been validated in Greece and normative data 
from a Greek general population have been provided by Pappa et al. (2005). 
The SF-36 subscales have been reported to have satisfactory alpha reliability 
coefficients ranging from 0.73 to 0.94. (Ware et al., 2003b). 
In the Greek version, internal consistency, measured by Cronbach's alpha, 
ranged from 0.79 to 0.95. Item discriminant validity showed that items 
discriminated well across scales while the Greek version provides evidence 
of a distinction between sub-groups of respondents in terms of known socio-
demographic or clinical differences (Pappa et al., 2005). With regard to 
construct validity, Anagnostopoulos et al. (2005), using a structural equation 
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modeling method, confirmed the multidimensional structure of the SF-36 
observed in the U.S and many European countries, and underscored the 
feasibility of multinational comparisons of health status using this 
instrument. 
According to the pilot testing results of the present study only the mental 
component of SF-36 was administered that included a four-item vitality 
scale, a two item social functioning scale, a three-item scale measuring role 
limitations due to emotional problems and a five-item scale measuring 
mental health. For each item, responses were coded, summed and 
transformed into a scale ranging from 0 (worst possible health status) to 100 
(best possible health status) (Ware et al., 2003b). The physical component of 
SF-36 was not administered since it overlapped with the FACT-C 
questionnaire. 
The Enriching and Nurturing Relationship Issues, Communication and 
Happiness (ENRICH) is a self-administered 115-item instrument that 
describes marital dynamics for research (Olson et al., 1982). It contains 
twelve content categories which are as follows: Idealistic Distortion, Marital 
Satisfaction, Personality Issues, Communication, Conflict Resolution, 
Financial Management, Leisure Activities, Sexual Relationship, Children and 
Marriage Family and Friends, Equalitarian Roles and Religious Orientation. 
The communication scale of ENRICH was used for studying the impact of 
colorectal cancer on the relationship between colorectal cancer patients and 
their partner. It is a brief 10-item scale that measures individual's feelings, 
beliefs, and attitudes related to communication with her/his partner. Items 
focus on the level of comfort felt by both partners in being able to share 
important emotions and beliefs with each other, the perception of the 
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partner's way of giving and receiving information, and the respóndenos 
perception of how adequately she/he communicates with their partner. Each 
item is rated on a 5-point Likert type scale. (Olson et al., 1982). According to 
the author "high scores reflect the couple's awareness and satisfaction with 
the level and type of communication in their relationship. Low scores reflect 
a deficiency in the level of communication essential to satisfactorily maintain 
a relationship and focus on the need to work on improving their 
communication skills" (Olson, 1982, p.47). Since for seven items 2, 3, 4, 5, 
6, 7, 9, a high score indicated poor communication, these items were reverse-
scored in order to reflect good communication. The alpha reliabilities for all 
the ENRICH scales averaged 0.74 while test-retest reliability was assessed 
over a week period and the average reliability was 0.87 with a range from 
0.77 to 0.92 across all the categories. Because ENRICH instrument had not 
officially been translated into Modern Greek language a translation process 
was required by the researcher that is described in the section 5.5.1. 
The Center for Epidemiology Srudies Depression Scale (CES-D) is a 
unidimensional self-reported instrument, consisting of 20 items designed to 
measure depression symptomatology in patients with emphasis on the 
affective component of depressed mood (Radloff 1977). It is commonly 
used to measure depressive symptomatology in cáncer patients. It has been 
officially translated and validated in Greece (Foundoulakis et al., 2001) and 
its alpha reliability coefficient is quite satisfactory (a=0.95). The score is the 
sum of the 20 item weights. Each item is rated on a 4-point Likert type scale. 
CES-D valúes ranged from 0 to 60, with higher valúes indicating more 
depression symptoms. In screening srudies, a cut-off-score of >16 has been 
validated as identifying individual at high risk for depression in older adults 
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(Weissman et al., 1997) while for Greek population the cut off level is 23/24 
(Foundoulakis et al, 2001). 
5.7 Methods of data analysis 
The cross-sectional profile of patients included descriptive statistics and 
exploratory analysis. These included descriptive statistics of demographic 
and disease-related characteristics of the sample and description of mean 
values of HRQOL variables. 
Histograms related to scale variables (FACT-C, SF-36, CES-D, ENRICH) 
were performed for evaluating the normality of variables. Because 
histograms showed skewed HRQOL data, the non-parametric Kruskal-Wallis 
H test was used for comparing differences in HRQOL across colorectal 
cancer Dukes's stages and times since diagnosis. Differences in HRQOL 
between two group categories such as stoma patients and non-stoma patients 
or patients with metastasis and patients without metastasis were tested using 
the non-parametric Mann-Whitney U test. 
The method of data analysis utilized in this study for evaluating the effect of 
predictor variables on global HRQOL was the logistic regression analysis. 
The statistical programme utilized for the analysis of the data was the 
Statistical Package for the Social Sciences (SPSS) version 11. 
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5.8 Ethical considérations 
There are practical and ethical difficulties when doing research involving 
people with cancer and it is important to protect the rights of all study 
participants. One important factor that must be considered is fatigue, both 
mental and physical. For this reason, the researcher aimed to diminish 
respondent bürden by focusing data collection on specific issues (i.e. the 
relevant domains of HRQOL). 
Patients' médical records were reviewed and the researcher liaised with the 
relevant physicians before approaching suitable patients. Detailed records of 
the recruitment process were kept and identitied patients were approached 
and informed of the study and written information was given. Sufficient time 
of two weeks was given to allow patients to consider participation before 
informed consent was obtained. 
Patients were provided with a detailed information sheet about the purpose of 
study and a signed consent form was obtained. A copy of their signed 
consent form was sent to ail participants. A i l patients were informed that 
they would be able to withdraw from the research at any time and without 
giving reasons and without détriment to their care. Also, patients were 
informed about the possible effects that may be caused by their participation 
and what the potential risks might be. The possibility patients to find some of 
the questions upsetting or face difficulty in answering some of the questions 
or they may becoming tired was set. These potential issues were minimized 
by providing clear instructions on how to complete the questionnaires, and 
by providing a contact téléphone number if patients had any queries or 
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coricerns about the questionnaires. They were assured that ail data from this 
project would be confidential and would be used only for research purposes. 
The anonymity of the collected data would be also presented. So, a unique 
code number was be placed on each questionnaire and corresponded to a 
private médical record that the researcher kept for each patient. This code 
was only be accessible to the researcher and kept in a locked storage file, 
separate from the research data. Also, the anonymity of each patient was 
ensured by asking the patients to return the consent form separately from the 
questionnaires using the stamped addressed envelope that was enclosed in 
the research package. 
Participants were also informed that the investigator was a research student 
and permission to contact them and use their personal data (name, téléphone 
number, address) had been obtained from their physicians. They were also 
informed that the data may be used in written and oral présentations 
(Appendix 3,4). 
Permission from the relevant and necessary authorities had been granted to 
undertake the research, including ethical protection of participants, in the 
chosen study sites (Appendix 17, 18). Formai ethical approval process is not 
required to undertake research in Greece and Ethics Committee has not been 
established in the Greek hospitals in which the research took place. 
Also, ethical approval was not obtained from the University of Wales 
Swansea Research Ethics Committee because at the time that the research 
was undertaken the School of Health Sciences Research Ethics Committee 
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had not been established. Subsequently, approval was sought and obtained 





This chapter is directed toward providing answers to the research questions 
addressed in the Methods chapter._The data collected were analysed using 
the Statistical Package for the Social Sciences (SPSS) version 11. Statistical 
analysis was carried out using descriptive statistics. Appropriate non 
parametric tests such as Kruskal-Wallis H test and Mann-Whitney U tests 
were used for evaluating differences between group categories and 
continuous data. Furthermore, hierarchical logistic regression analysis was 
carried out for evaluating the effect of independent variables on a selected 
dependent variable. 
The present study was designed to answer the following questions: 
1. How do Greek colorectal cancer patients perceive their HRQOL during 
the post-treatment /survivorship phase? 
2. What factors (demographic or clinical) influence colorectal cancer 
patients HRQOL? 
3. How do HRQOL measures change for patients with colorectal cancer of 
different stages at diagnosis, and at different time since diagnosis? 
6.2 Demographic and disease-related characteristics of the 
respondents 
Table 6.1 summarizes the demographic characteristics of the respondents. 
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Table 6.1: Demographie characteristics of colorectal cancer survivors (N=145) 
No % 
Gender 
Male 87 60 
Female 58 40 
Age (yrs) 
<60 67 46.2 
61-70 45 31.0 
>70 33 22.8 
Marital Status 
Single 9 6.2 
Married 114 78.6 
Divorced 9 6.2 
Widowed 13 9.0 
Education 
Primary school 30 20.7 
Secondary School 53 36.6 
College/Uni versity 62 42.7 
Employment Status 
Unemployed 2 1.4 
Household 15 10.3 
Retired 73 50.3 
Clerk Officer 23 15.9 
Skilled workman 1 0.7 
Farmer 1 0.7 
Work in their own job 17 11.7 
Other 6 4.1 
Not working due to disease 7 4.8 
Family Income (euros per month) 
<440 14 10.8 
440-880 27 20.8 
881-1,467 28 21.5 
1,467-2,347 33 25.4 
>2,347 28 21.5 
Missing 15 
Residence 
Athens 109 75.2 
Province 36 24.8 
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Reflecting the fact that the incidence of colorectal cancer increases with age, 
more than half (53.8%) of the respondents were older than 60 years (range= 
27- 83 yrs, mean= 61.40, SD= 11.00) while 60% of them were male. In 
epidemiological studies the estimated ratio for men and women is 1.3:1 for 
colon cancer and 1.5:1 for rectal cancer respectively. In this case, the 
estimated ratio was 1.5:1. The distribution of the ages is presented in figure 
6.1. 
The majority of the respondents were married (78.6%) and well educated, 
with 36.6% reporting secondary education and 42.7 % reporting college/ 
university education. Half of the participants (50.3%) were retired and only 
4.8% reported unemployed due to the disease. Also, a minority of the 
respondents reported a low income status (10.8%) and the majority of the 
participants were (75.2%) living in the capital city of Athens. 
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Figure 6.1: Distribution of ages 
30 
25.0 35.0 45.0 55.0 65.0 75.0 85.0 
30.0 40.0 50.0 60.0 70.0 80.0 
AGE 
The âges of the participants were relatively normaly distributed while the 
majority of the respondents were older than 60 years. 
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The disease-related characteristics of the study sample are presented in 
Table 6.2. 
Table 6.2: Disease-related characteristics of the sample (N= 145) 
N % 
Diagnosis 
Colon cancer 100 69.0 
Rectum cancer 45 31.0 
Disease stage at 
diagnosis 
Stage B 55 37.9 
Stage C 79 54.5 
Stage D 11 7.6 
Years since diagnosis 
1-2 36 24.8 
2-4 75 51.7 
>5 34 23.5 
Type of therapy 
Colectomy 142 97.9 
Adjuvant Chemotherapy 139 95.8 
Adjuvant Radiation therapy 42 29.0 
Ostomy 22 15.2 
Metastasis 38 26.2 
Récurrence 8 5.5 
Most of the respondents were diagnosed with stage C (54.5%) and stage B 
(37.9%) of the disease (Figure 6.2). The time elapsed since the initial 
diagnosis was on average 3.2 ± 2.2 years (Figure 6.3) and the majority of 
patients had received both surgery (97.9%) and chemotherapy (95.8%). 
Metastases are recorded for 38 patients (26.2%). Less than one third of the 
sample had received radiation therapy while twenty two respondents (15.2 
%) had received a colostomy appliance. 
i l l 
Figure: 6.2: Disease stages at time of initial diagnosis 
Stage at cancer diagnosis 
The propotion of colorectal cancer stages (B, C and D) at time of initial 
diagnosis was prevalent for stages C (55%) and B (38%). 
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up to 1 yrs 
25.0% 
More than half of the patients survived 2-4 yrs from the time of the initial 
diagnosis while the proportion of patient who survived 5 yrs and beyond was 
22.9% and a propotion 25% survived up to 1 year. 
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6.3 Choice of statistical tests 
Histograms related to scale variables (FACT-C, SF-36, CES-D, ENRICH) 
were performed for evaluating the normality of distributions (Figure 6.4, 
Figure 6.5, Figure 6.6, Figure 6.7). Because the distributions were skewed 
non-parametric tests were performed to evaluate the unadjusted, stratified 
data. So, differences in HRQOL across colorectal cancer stages and times 
periods from diagnosis were compared using the Kruskal-Wallis H test. 
HRQOL differences between stoma and non stoma patients as well as 
between patients with recurrence or metastases and patients without 
recurrence or metastases were tested using the Mann-Whitney U test. Also, 
since the study data was skewed a non parametric logistic hierarchical 
regression analysis was carried out for evaluating the effect of predictor 
variables on global HRQOL. 
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60.00 70.00 80.00 90.00 100.00 110.00 120.00 130.00 
Total FACT-C 
This figure showed that the distribution of FACT-C total scores was 
negatively skewed. Therefore, the data was not normally distributed. 
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Figure 6.5: Frequency histogram for SF-36 mental health scale scores 
[I.DD 10.00 2D.0O 30.00 40.DO 50 00 60.00 70.00 80.00 90.00 
Mental Health (SF-36) 
The distribution of SF-36 scores was negatively skewed. Therefore, the data 
was not normally distributed. 
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Figure 6.6: Frequency histogram for CES-D scale scores 
30 HI 
1 I I I I I I I 
5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 
Depression (CES-D) 
The distribution of CES-D scores was positively skewed. Therefore, the data 
was not normally dìstrìbuted. 
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15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 
Partner Communication (ENRICH) 
The distribution of ENRICH scores was negatively skewed. Therefore, the 
data was not normally distributed. 
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6.4 Summary measures of research questionnaires 
Overall health related quality of life as measured by FACT-C questionnaire 
averaged 109.46 (SD=17.15, range= 58-132). In gênerai, respondents rated a 
summary measure of HRQOL as relatively high (possible range 0-144, 
mean=72). Dépressive symptomatology, as measured by CES-D, averaged 
9.85 (SD=9.10, range= 0-43) which is a low score given that the cut-off 
score for dépressive symptoms is 23/24. Communication scale of ENRICH 
instrument averaged 40.31 (SD=9.31, range= 11-50). The mental component 
of SF-36 does not produce a summary score. 
6.5 HRQOL by stage and time since diagnosis 
Tables 6.3, 6.4 and 6.5 list mean (SD) values and médian (ranges) values of 
the overall FACT-C HRQOL and FACT-C subscales by stage at diagnosis 
and time since diagnosis. 
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Table 6.3: Average Overall FACT-C Score by Stage and Time since Diagnosis 
Stage Time since diagnosis 

























x1 1.249 0.458 1.784 
Overall FACT-C scores (Table 6.3) did not differ substantially by stage at 
diagnosis and different times since diagnosis. A Kruskal-Wallis test 
indicated that patients with different disease stages at diagnosis did not differ 
significantly 1-2 years after diagnosis (p=0.536), 2-4 years after diagnosis 
(p=0.795) or more than 5 years after diagnosis 0?=0.410). Also, there is not a 
significant trend toward declining HRQOL for more advanced stages of 
colorectal cancer. 
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x2 0.013 0.730 0.787 0.368 0.178 
Examining all subscales of the FACT-C across all stages at diagnosis (Table 
6.4) a kruskal-Wallis test indicated that none of the HRQOL aspects of 
FACT-C were associated significantly with Duke's stages at diagnosis. For 
physical well-being p=0.69, social well-being /?=0.67, emotional well-being 
p=0.91; functional well-being p=0.83 and for colorectal cancer module 
p=0.99. 
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*• 0.162 0.561 4.432 1.453 0.160 
Examining all subscales of the FACT-C across all times since diagnosis 
(Table 6.5) a Kruskal-Wallis test indicated that none of the HRQOL aspects 
of FACT-C were associated significantly with different times from the initial 
diagnosis. So, for physical well-being /?=0.75, social well-being /?=0.10, 
emotional well-being /?=0.92, functional well-being p=0.48 and for 
colorectal cancer module /?=0.92. 
Table 6.6 list summary values of SF-36 HRQOL dimensions, Depression 
and ENRICH scales by stage at diagnosis. 
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Table 6.6: Mean (SD) SF-36 HRQOL Scores, Dépression Scores and ENRICH 
Scores by Stage at Diagnosis 
Stage at VT SF RE M H CES-D ENRICH 
diagnosis 
B 74.91 85.45 78.79 74.05 9.36 40.97 
(18.94) (18.94) (32.94) (19.66) (8.39) (8.69) 
C 73.12 80.38 70.99 75.16 10.27 40.41 
(22.52) (25.61) (37.60) (18.87) (9.46) (8.99) 
D 70.00 80.00 80.00 75.60 10.10 36.50 
(30.18) (25.14) (35.83) (20.26) (10.52) (13.52) 
0.012 1.818 1.788 0.100 0.167 0.751 
There is little variation in SF-36 HRQOL mean scores, CES-D, and 
ENRICH mean scores after stratification by stage at diagnosis (Table 6.4). 
Kruskal-Wallis test showed that this variation is not statistically significant 
at the 5% level in the vitality scale (VT) (/?=0.99), social functioning scale 
(SF) (/?=0.40), rôle emotional scale (RE) (p= 0.40), mental health scale 
(MH) (p=0.10), CES-D scale (p=0.92) and ENRICH scale (/?=0.68) in stages 
at diagnosis. 
Table 6.7 list summary values of SF-36 HRQOL dimensions, Dépression 
and Communication scales by time since diagnosis. 
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Table 6.7: SF-36 HRQOL Scores, Dépression Scores and Communication Scores by Time 
Since Diagnosis 
Time since VT SF RË MH CES-D ENRICH 
diagnosis 
1-2 years 72.36 86.11 73.15 75.39 9.90 40.56 
(25.20) (20.87) (37.22) (19.48) (10.17) (10.31) 
2-4 Years 72.80 79.67 77.48 74.31 9.27 40.42 
(21.94) (26.70) (36.22) (19.55) (8.35) (8.89) 
£ 5 years 76.72 84.09 69.79 75.15 11.38 39.50 
(18.88) (19.08) (33.18) (15.38) (9.57) (9.71) 
x2 0.214 0.592 2.381 0.080 1.891 0.377 
There is also little variation in SF-36 HRQOL mean scores, CES-D, and 
ENRICH scores after stratification by différent times from the initial 
diagnosis (Table 6.7). Kruskal-Wallis test showed that this variation is not 
statistically significant at the 5% level in the vitality scale (VT) (p=0.89), 
social functioning scale (SF) (p=0.74), rôle emotional scale (RE) (p=0.30), 
mental health scale (MH) (0.96), CES-D scale (p=0.38) and ENRICH scale 
(/?=0.82) in times since diagnosis. 
6. 6 Socio-demographic variables and FACT-C HRQOL 
The FACT-C dimension scores and overall QOL score according to a 
selected list of socio-demographic variables are reported in Table 6.8. 
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Table 6.8: FACT-C mean values (SD), médian values and (ranges) according to a selected 
list of socio-demographic variables 
Variable Physical well- Social/family Emotional Functional Colorectal Overall QOL 
being well-being well-being well-being module 
Gender 
Maie 2.73(3.55) 20.99(4.14) 4.24(4.23) 21.92(5.77) 5.05(4.01) 111.37 15.15) 
1.0 (0-14) 22.0 (0-24) 3.0 (0-16) 23.0 (0-28) 4.0 (0-19) 113 (58-132) 
Female 4.04(5.02) 20.51(3,97) 5.12(4.92) 21.68(5.68) 5.10(3.93) 106.14(19.92) 
2.0 (0-20) 22.0 (8-24) 4.0 (0-19) 23.5 (7-28) 4.0(0-15) 110(58-131) 
Age 
<60 2.47(3.39) 20.62(4.30) 4.334.20) 22.24(5.68) 5.13(3.87) 111.32(14.08) 
1.0 (0-14) 22.0 (0-24) 4.0 (0-19) 24.0 (0-28) 4.0 (0-16) 113 (60-131) 
61-70 4.42 (5.03) 21.00(3.69) 4.59(4.73) 21.39(5.46) 5.49(4.43) 106.81(19.79) 
3.0 (0-20) 23.0(10-24) 3.0 (0-13) 23.0 (8-28) 4.0 (0-19) 1 11 (58-132) 
>70 3.46 (4.39) 20.96(4.17) 5.16(5.00) 21.58(6.25) 5.41(3.55) 109.18(19.61) 
2.0 (0-16) 22.0 (8-24) 4.0 (0-16) 24.0 (7-28) 4.0 (0-13) 113 (67-132) 
Income 
<440 31(6.43) 10.08(5.23) 6.21(6.04) 20.00(6.38) 5.21(4.77) 101.25(22.70) 
3.0 (0-20) 20.0 (8-24) 4.5 (0-19) 21.0 (7-28) 4.5 (0-15) 104.5 (58-131) 
440-880 4.52(5.05) 19.58(4.66) 6.18(5.54) 19.77(6.18) 6.42(4.06) 100.00(20.50) 
3.0 (0-16) 20.5 (6-24) 4.0 (0-16) 20.0 (8-28) 6.5(1-16) 104(58-130) 
881-1,467 2.78(4.10) 21.11(3.68) 4.56(4.17) 21.72(6.86) 4.93(3.32) 110.72(16.09) 
1.0 (0-17) 22.0(10-24) 4.0 (0-15) 24.0 (0-28) 4.0 (0-13) 113 (66-128) 
1,468-2,347 2.19(2.37) 22.03(1.85) 4.03(4.05) 23.67(3.64) 4.61(2.94) 115.71(9.75) 
2.0 (0-10) 22.0(18-24) 3.0 (0-14) 24.0(12-28) 5.0 (0-13) 115 (95-132) 
> 2,347 3.38(4.05 20.87(5.11) 3.85(3.01) 22.04(6.33) 5.37(4.95) 110.36(16.36) 
1.5 (0-13)) 22.0 (0-24) 4.0 (0-11) 23.0 (0-28) 4.0 (0-19) 110(60-130) 
Marital status 
Single 2.56(3.54) 20.25(5.25) 5.11(4.40) 19.78(9.73) 4.00(4.42) 107.50 
1.0(0-11) 22.5 (8-24) 4.0 (0-12) 22.0 (0-28) 3.0 (0-15) 109.5 (67-132) 
Marri ed 3.31(4.29) 21.38(3.46) .4.35(4.31) 22.19(5.20) 5.14(3.86) 110.32 
2.0 (0-20) 22.0 (0-24) 4.0 (0-16) 24.0 (0-28) 4.0 (0-19) 113.5 (58-132) 
Divorced 4.57(5.88) 14.33(6.25) 5.44(6.10) 20.75(6.84) 7.37(5.45) 102.40 
2.0 (0-14) 14.0(6-24) 2.0 (0-15) 22.5 (8-28) 4.5 (2-16) 110(58-127) 
Widowed 2.90(3.21) 18.12(4.05 5.69(5.45) 20.92(5.88) 3.54(2.940 104.17(14.44) 
2.0(0-10) 19.0(10-24) 5.0 (0-19) 22.0 (9-28) 3.0 (0-9) 106.5 (88-127) 
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In colorectal cancer patients, among the socio-demographic variables 
significant differences were observed between income and marital status 
grouped categories. In the income categories the median difference between 
patients with low income (Mdn=\04) and patients with upper (Mdn=ll5) 
were significant at the 5% level for their overall QOL; Kruskal-Wallis 
^2(4)=9.44, /?=0.04<0.05. Also, a significant higher difference was found in 
social functioning aspect of HRQOL of married people compared also with 
divorced people; Kruskal-Wallis x2(4)=13.751, /?=0.003<0.05. No evident 
difference in any HRQOL aspects and overall QOL was observed for 
variables describing age and gender options. 
6.7 The association between treatment and HRQOL: Stoma 
and non stoma patients 
Participants were grouped by type of surgery: sphincter-saving resection and 
sphincter sacrificing. Median values and ranges were then obtained on the 
FACT-C sub-scales and overall FACT-C HRQOL for patients whose 
sphincter was conserved and for those patients whose sphincter was 
sacrificed. The results of Mann-Whitney U test are shown below in Table 
6.9. 
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Table 6.9: FACT-C sub-scales and overall FACT-C mean, median values and 
ranges and Mann-Whitney U Tests 
Subscales Type of Median U Z Sig. (2-tailed) 
surgery1 (Ranges) 
Physical SC 1.5 (0-17) 
Functioning SS 4.0 (0-20) 837 -1.92 0.05* 
Social well- SC 22 (0-24) 
being ss 22 (16-24) 110 -452 0.65 
Emotional sc 4.0 (0-19) 
well-being ss 4.0 (0-16) 914. -1.61 0.10 
Functional sc 24 (0-28) 
Well-being ss 21 (11-28) 100 -1.23 0.21 
Colorectal sc 4.0 (0-16) 
module ss 5.0 (0-19) 921 -1.09 0.27 
Overall sc 113 (58-132) 
ss 102.5 (5-130) 645 -2.05 0.04* 
*p< 0.05 
1 SC=sphincter conserving (Non-stoma patients), SS=sphincter sacrificing (Stoma 
patients) 
Overall HRQOL 
The overall QOL of patients with a colostomy appliance was statistically 
significantly lower in comparison with those without a colostomy appliance 
U=645,p< 0.05, (Table 6.9). 
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Physical functioning 
This subscale included questions relating to the side-effects of the treatment 
such as nausea, fatigue, pain or the degree to which a patient feels i l l . There 
was a significant difference between stoma and non-stoma patients in 
reported level of physical functioning, U=837, /?=0.05, (Table 6.9). 
Social/family well-being 
This subscale included questions related to the extent to which an individual 
received support by friends/family about his/her illness. Also, it included an 
item related with patients' satisfaction about their sexual life. No significant 
difference was found in the level of total social functioning of FACT-C 
instrument between stoma and non-stoma groups U=110, /?>0.05, (Table 
6.9). Also, no significant difference was found between the two groups 
concerning the social functioning of SF-36 subscale. 
Regarding the sexual life of participants, responses to the sexual enjoyment 
item were available for 9 out of 22 (40.9%) stoma patients and for 81 out of 
121 (66.9%) non-stoma patients. The proportion of stoma patients who did 
not respond about sexual functioning was significantly greater than the 
proportion of non stoma patients who did not respond to this item, x (1)= 
5.41;p=0.020. 
Among those with a colostomy appliance who did not respond to the sexual 
life item, 69.2% were female, 15.4% were widowed (the proportion of 
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widowed participants in the total sample was 9%), while their mean age was 
64.6 years. 
Emotional well-being 
Mean scores and the results of independent samples t-test for the emotional 
well-being subscale of the FACT-C are showed in Table 6.9. This subscale 
consisted of items relating to worries about the outcome of patients* illness 
such as death or worry that the health condition may get worse. 
There were no significant différences between the stoma and non-stoma 
group on the FACT-C emotional well-being subscale U=914, p>0.05, or on 
the subscales of mental component of SF-36 instrument and CES-D scale. 
In emotional sub-scale of FACT-C instrument a statistically significant 
différence was found among stoma patients in the item related to the worry 
associated with death, U=915, p< 0.05. 
Functional well-being 
The role fünctioning sub-scale of the FACT-C is based on ratings about the 
extent to which the individuai is limited in doing work or in enjoying sleep, 
his/ her life, hobbies and leisure time activities. No significant différence 
was found between the two groups (stoma and non-stoma) on the role 
fünctioning sub-scale U=100,/?>0.05 (Table 6.9). 
129 
Colorectal cancer module 
The colorectal cancer sub-scale includes items related to colorectal cancer 
symptoms such as gastrointestinal problems (appetite, constipation, bowel 
movements, diarrhoea, and weight loss). Also, one item relates to the 
satisfaction with body appearance and two items relate to problems that are 
faced by patients with a colostomy appliance. These two items were only 
completed by patients with a stoma. 
No significant difference was found between stoma and non-stoma patients 
on the colorectal cancer sub-scale of the FACT -C, U=921, p>0.05, (Table 
6.9). 
Among those patients who completed the colostomy related items a 
proportion of 27.3% was embarrassed by ostomy appliance and a proportion 
of 18.2% faced problems in caring for the stoma. 
A significant difference was identified between the two groups on the body 
image item U=937, p< 0.05. This result indicated that the group of stoma 
patients was significantly more dissatisfied with their body image than 
patients without a stoma. 
6.8 The effect of metastasis on HRQOL 
FACT-C dimensions median values and ranges as well as overall FACT-C 
median values and ranges of patients with metastatic and no metastatic 
disease were also obtained. The results of Mann-Whitney U test are shown 
in Table 6.10. ' 
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Table 6.10: FACT-C and SF-36 sub-scales, overall FACT-C and CES-D median 













































































157 -1.78 0.07 
*/><0.05 
M: Metastatic Disease, NM: No Metastasis 
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The quality of life of patients with metastases was significantly lower for 
overall quality of life and for most dimensions of quality of life, than those 
of the matched sample of patients who were considered to be free of cancer. 
There were statistically significant differences in median values in overall 
HRQOL, physical functioning, emotional well-being, functional well-being, 
SF-36 social functioning and colorectal module in patients with metastasis: 
Overall HRQOL U=894, p< 0.05; physical functioning U=134, p< 0.05; 
emotional well-being U=147, p< 0.05; functional well-being U=124, p< 
0.05; social functioning U=152, p< 0.05; colorectal cancer module U=125, 
p<0.05. 
6.9 Effect of predictor variables on Overall QOL 
The main effect of a number of variables on overall HRQOL was examined 
by a multivariate regression analyses (Table 6.11). Overall HRQOL was 
used as a dichotomized categorical variable in the analyses (low overall 
HRQOL scores vs high overall HRQOL scores). Thus logistic regression 
models were used to estimate the odds ratio (OR) for each variable in the 
equation. In order to identify cases and outliers, Cook's distances (>1.0) and 
standardized residuals (>3.0 or <-3.0) were respectively computed and 
examined. Multicollinearity was detected by examined the standard errors 
(>2.0) for the estimeded coefficients (B). The results are shown as ORs with 
95% confidence intervals (CIs) for ORs. The fit of the models was judged by 
Hosmer-Lemeshow goodness-of- fit statistic. The models were considered 
acceptable if p>.05 for model chi-square, given mat a better model fit was 
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indicateci by a smaller différence in the observed and predicted values of the 
dépendent variable, and a nonsignificant chi-square value. 
Hierarchcal logistic régression analyses was conducted to fìnd out the 
significant predictors of overall HRQOL by controlling for démographie, 
disease-related variables as well as variables that related to the 
communication with partner and dépression. Five steps were taken: the 
démographie variables (âge, gender, residence, income, éducation) were 
entered first as independent variables, the disease-related variables (stage at 
diagnosis, time since diagnosis) were included in the second step, the 
variables stomia and métastases were included in the third step, while the 
ENRICH scale scores were included in the fourth step and in the last step the 
CES-D scale scores were introduced. There were no cases with large 
standardized residuals and there was one Cook's distances that was 
considered outlier. Multicollinearity or numerical problems were not 
detected, as none of the independent variables had a large standard error. 
The model chi-square value indicated that there was a statistically significant 
overall relationship between the dépendent variable and the set of 
independent variables, / 2 ( 11 )=37.951, p<0.001. The chi-square value 
associated with the Hosmer-Lemeshow test was x(8)=9.264, p=.321, 
indicating a good overall model fit. The Negelkerke R square was equal to 
0.464. 
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Table 6.11 Logistic régression on overall HRQOL; estimateci régression coefficients, 
standard errors and related statistics odds and 95% confidence intervais (CI) 
Explanatory 
variables 
B SE Wald p- value OR 95% CI 
Block 1 
Age 0.375 0.423 0.785 0.376 1.455 0.635, 3.335 
Gender -0.161 0.593 0.074 0.786 0.851 0.266, 2.719 
Residence 0.087 0.720 0.014 0.904 1.091 0.266,4.473 
Income 0.318 0.316 1.012 0.314 1.374 0.740, 2.552 
Education -0.346 0.350 0.976 0.323 0.708 0.356, 1.406 
Block 2 
Stage 0.036 0.552 0.004 0.948 1.037 0.351,3.061 
Time sinse -0.089 0.405 0.048 0.827 0.915 0.414, 2.024 
diagnosis 
Block 3 
Stomia 0.740 0.879 0.710 0.399 2.097 0.375, 11.735 
Métastases -1.040 0.741 1.971 0.160 0.353 0.083, 1.510 
Block 4 
Communication 0.014 0.029 0.0.233 0.629 1.014 0.957, 1.075 
with partner 
Block 5 
Depression -0.248 0.062 16.314 0.000 0.780 0.691,0.880 
Table 6.11 shows that, according to tha Wald criterio, the coefficient for 
dépression (B=-0.248) appeared to be significantly différent from zéro in 
predicting dépression, Wald=16.314, p< .001. The négative coefficient for 
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dépression itnplies that those patients who have high overall HRQOL values 
(coded 1 ) have lower scores on that variable relative to those who have low 
HRQOL scores (coded 0). By increasing the value of dépression by one unit, 
the odds of the participant having high HRQOL values decrease by a factor 
of 0.780, controlling for other variables in the model. The odds of having 
high HRQOL for participants with high dépression are 22% (=1-0.780). The 
classification accuracy rate was equal to 77.5% which is quite greater than 






The experience of colorectal cancer involves a complex mix of physical and 
psychosocial changes that is still poorly understood particularly for those 
patients who enter the "after treatment phase" of their disease. Interest in 
evaluating aspects of health that are related to Quality of Life (QOL) has 
increased in recent years in Greece as in other European countries. However, 
little is known about the way that Greek colorectal cancer patients perceive 
their quality of life years following diagnosis. 
Reviewing the relevant literature for this thesis it soon becomes apparent 
that there was need of a thorough investigation of the impact of colorectal 
cancer and treatment on specific dimensions of quality of life. This includes 
physical health, emotional or social functioning and overall HRQOL of 
Greek survivors of colon and rectum cancer, one and up to ten years after the 
diagnosis of their disease. This investigation should take into account the 
most common aspects of colorectal cancer experience and be based on 
patients' point of view about the current state of their quality of life. The 
study design that was developed should also include those factors that might 
influence the level of patients' quality of life. So, disease related factors as 
well as factors that are related to patients' characteristics may contribute to 
Greek colorectal cancer survivors' quality of life several years after 
diagnosis. The primary hypothesis was that time since diagnosis and early 
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disease stage at diagnosis were factors that could positively influence the 
level of patients' quality of life. Also, patients with an ostomy and patients 
who experienced a metastasis of their disease might experience a lower 
quality of life in comparison with those without a colostomy appliance or 
those patients who experienced life free of their illness respectively. Patients 
who experienced depression, poor communication with their partner or those 
older patients or with a low income might also be expected to experience 
poorer quality of life. 
In order to test the research hypotheses and research questions, 145 Greek 
outpatients were recruited into the study and data were gathered on their 
quality of life through the use of self-assessment questionnaires. 
Advances have been made in methods that describe patients' subjective 
well-being using standardized instruments. Several valid and reliable self-
assessment measures are available in the clinical oncology research setting 
such as generic or disease specific instruments. The FACT-C and the SF-36 
quality of life instruments were selected for exploring the quality of life in 
this research population. The FACT-C and the SF-36 instruments are 
popular in U.S as well as in Europe when quality of life is assessed. 
However, few applications of them are available for assessing health related 
quality of life in colorectal cancer survivors and neither used for assessing 
Greek's colorectal cancer survivor's quality of life. 
In this section is an overview of the significant findings of the study, a 
consideration of them in the light of existing research together with an 
examination of those findings that fail to support the hypotheses as well as 
limitations of the study. The implications of the study for practice as well as 
137 
recommendations for further research are explored further in the concluded 
section. 
7.2 Summary of main findings 
In this study no statistically significant differences were identified in the 
level of overall quality of life or among quality of life domains for colorectal 
cancer survivors at different stages at diagnosis and different times since 
diagnosis. This means that patients at all disease stages experienced a high 
quality of life years after diagnosis. 
Among disease-related and patients-related factors that would have an effect 
on patients' quality of life over time, vitality, social functioning and 
depression were most prevalent. Also, patients with low income had a 
significantly lower overall quality of life than those patients with upper 
income. Divorced patients experienced a poorer social functioning compared 
to that of married, single or widowed patients. 
Regarding the quality of life of patients following sphincter-conserving 
versus sphincter-sacrificing surgery, the results of this study confirmed the 
hypothesis that the overall quality of life of patients with a colostomy 
appliance would be significantly inferior to that of patients without a 
colostomy. Even thought no statistically significant differences were 
identified between the quality of life domains between the two groups 
significant differences were found between the two groups in terms of body 
. image, and worry about death. 
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The study findings confirmed the hypothesis that patients with metastases 
would experience a lower quality of life compared to patients who had 
experienced a remission of the disease. 
The findings most relevant to this study are discussed below and are 
compared with those previously reported in the literature. 
7.3 Discussion of main findings 
7.3.1 The effect of stage of colorectal cancer at diagnosis and 
the effect of time since diagnosis on long-term patients9 
HRQOL 
The results of this study did not confirm the hypothesis that the overall 
quality of life of colorectal cancer survivors would be higher for those 
patients at a longer time since diagnosis or early disease stage. The results of 
the current study showed that colorectal cancer patients who had survived at 
least 1 year from the time of diagnosis experienced relatively high health 
status independently of the stage at diagnosis. In the first two years after 
diagnosis, patients with Duke's B stage reported a relatively high level of 
quality of life that was found to be better than that of C or D stages. 
However, this difference was not statistically significant. The overall 
HRQOL after two years from diagnosis did not vary substantially between 
disease stages. As time after diagnosis increased from lyear to 2-4 years and 
more than 5 years patients seemed to experience deficits in social 
139 
functioning, but this finding was not statistically significant. Generally 
speaking, quality of life remained uniformly high among all disease stages 
as well as time since diagnosis. These results were confirmed by using both 
HRQOL survey tools such as FACT-C, and SF-36 and applying both 
univariate and multiple regression analyses. The number of studies that have 
evaluated the effect that stage of disease at diagnoses, and time since 
diagnosis, have on the overall colorectal cancer survivors quality of life, are 
very limited (Trentham-Dietz et al., 2003; Ramsey et al., 2002; Ramsey et 
al., 2000). Ramsey et al. (2002; 2000) researches were the only identified 
studies that used the FACT-C instrument for evaluating quality of life in 
survivors. 
Ramsey et al. (2000) who considered health-related quality of life through 
the FACT-C instrument, in line with the results of this study, showed little 
variation over time after stratification by stage at diagnosis. Similar results 
were found with multivariate regression analyses during which they did not 
find that health-related quality of life was significantly different in relation 
to disease at diagnosis, or for time since diagnosis. Also, in line with these 
findings, Ramsey et al. (2000) FACT C summary scores showed a non-
significant trend toward declining HRQOL for more advanced stages of 
colorectal cancer. Also, small sample sizes and the possibility that there was 
a response bias favoring healthier people were considered limitations by 
these authors. 
Similarly with the current study Ramsey et al. (2002), when exploring 
quality of life of U.S patients with cancer of colon and rectum who had 
survived at least 5 years after diagnosis, no differences were found among 
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patients at different disease stages either in multivariate regression analyses 
or in univariate analyses. Patients at or beyond 5 years since diagnosis 
appeared to have a relatively high health-related quality of life regardless of 
their initial stage at diagnosis. 
The findings of the current study were also confirmed by those presented by 
Trentham-Dietz et al. (2003) in a US female population. They concluded 
that over the long term, the initial stage at diagnosis did not play a dominant 
role in determining physical and mental health of patients, as measured by 
the SF-36 questionnaire, while other factors such as concurrent chronic 
medical conditions or body weight might play a more important role. 
Although the stage of colorectal cancer at diagnosis is related to the length 
of survival, this factor did not have a strong association with quality of life 
among Greek long-term colorectal cancer survivors in the present thesis. 
This showed that long-term cancer survivors had a substantially satisfied 
health-related quality of life with factors such as depression, vitality and 
social functioning playing a dominant role in determining patients' physical 
and emotional health. 
The results of the present study suggest that the impact of colorectal cancer 
and treatment on quality of life is not so devastating in those who survive 
longer. This finding is not so surprising since a number of authors have 
described quality of life as a dynamic process that changes over time as 
patients change their perceptions about their health status, or change their 
expectations in terms of specific life circumstances (Addington-Hall, 2001; 
Carr et al., 2001b; Alison et al., 1997; Caiman, 1984). 
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Several studies have presented well documented evidence that in self-
reported quality of life assessments individuals may use a number of 
psychological mechanisms, such as social comparisons, or reframing of their 
expectations about the negative impact that the disease has on their health 
status or their well-being (Hagedoorn et al., 2002; Carr et al., 2001; 
Sprangers and Schwartz 1999; Gotay & Muraoka, 1998). Such an adaptation 
process has been termed a "response shift" (Sprangers and Schwartz, 1999). 
Response shift reflects changes in internal standards, in values and life goals, 
or changes in conceptualization of quality of life over time (Sprangers & 
Schwartz, 1999). Although this phenomenon has received little attention 
until now, it may explain a number of unexpected quality of life findings 
regarding cancer survivors or patients with other chronic and life threatening 
illnesses. For example, the largest study conducted to date by Mosconi et al. 
(2000) in Italy showed that people's quality of life was comparable with that 
of a healthy population several years after diagnosis. 
Changes in the internal standards of colorectal cancer patients have also 
been explored by Bernhard et al. (2001; 1999). These studies showed that 
people with newly diagnosed colon cancer gradually changed their internal 
standards on which they based their health status and their quality of life 
estimation, either under radical resection or under adjuvant chemotherapy. 
However, before trying to interpret changes in patients' quality of life by 
adopting a response shift approach, some methodological issues should be 
taken into account. As Carr et al. (2001) noted, existing measures did not 
always take into account the expectations of people and may not distinguish 
between changes in the experience of disease, or changes in expectations of 
health. 
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7.3.2 Depression as a predictor variable of colorectal cancer 
patients' HRQOL 
In this study, among those factors that would predict patients' quality of life 
years after diagnosis, depressive symptoms were more prevalent even if the 
psychological distress appeared to have been decreased. 
From the literature, it is well known that the diagnosis of cancer is a risk 
factor for depression during the diagnostic, treatment or palliative care phase 
of the disease; particularly among patients who suffer by pain and physical 
disability (Hopwood & Stephens, 2000; Grassi & Rosti 1999; Grassi et al., 
1996; Massie & Holland, 1992). Pasquini and Biondi (2007), in a review 
study, examined the effect of depression on cancer patients and concluded 
that depression affected several aspects of life such as health status, quality 
of life, or working role. 
Even if numerous studies have evaluated depression during the treatment 
phase of cancer, some evidence has been found for the prevalence of 
depressive symptoms during cancer follow-up. A previous study on early 
breast cancer survivors showed that the prevalence of depression and anxiety 
was 15% one year after diagnosis and 45% after the diagnosis of recurrence 
(Burgess et al. 2005). 
To our knowledge, only two studies to date have investigated depressive 
symptoms in colorectal cancer survivors, using a standardized specific 
depression scale (Tsunoda et al., 2005; Ramsey et al., 2002). 
In Ramsey's et al. (2002) study cancer patients had higher rates of 
depression in comparison with a healthy population. Also, lower 
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socioeconomic status and the presence of multiple comorbid conditions were 
identified as risk factors for depression. Although Ramsey et al. (2002) did 
not present data at two or three years post diagnosis their study might 
indicate a need to identify patients who might be at greater risk of depression 
and to consider including this into their follow-up schedule. 
In a long-term Japanese colorectal cancer population, Tsunoda et al. (2005) 
concluded that depression - as measured by Hospital Anxiety and 
Depression Scale - had a strong impact on overall HRQOL dimensions for 
patients who had survived for at least 1 year since operation. Despite the 
cross-cultural differences between Western countries and Asian countries, 
Tsunoda et al. (2005) study highlighted the need for identifying depressive 
symptoms in the screening process of colorectal cancer outpatients. They 
also concluded that depression was not sufficiently evaluated by the 
emotional functioning subscale of the EORTC QLQ-C30 instrument and that 
the use of a depression specific scale was required. Even if the detection of 
depressive symptoms in Greek colorectal cancer outpatients was not the 
main aim of this study, the results showed that depressive symptoms, as 
measured by CES-D, were the strongest predictor of patients' quality of life. 
7.3.3 The overall effect of surgery on HRQOL: Stoma and non 
stoma patients 
A main result of this study is that colorectal cancer patients who undergo 
sphincter-sacrificing surgery resulting in a stoma have a poorer health-
related quality of life than those without a stoma. This is consistent with the 
results of a vast body of "traditional" research studies (Engel et al., 2003; 
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Kuzu et al., 2002; Camilleri-Brennan & Stele, 1998; Sprangers et al., 1995; 
Mac Donald & Anderson, 1984; Williams & Johnston, 1983; Delvin et al., 
1971). In contrast with the current study in which an overall quality of life 
score was obtained for stoma and non stoma participants, very few studies 
have produced a global health-related quality of life score and used well 
researched questionnaires. In Camilleri-Brennan and Steele's (1998) review 
from a total of 54 papers "in only three studies was global quality of life 
formally measured using a well researched questionnaire" (p. 1036). Most 
previous researchers have concluded that stoma patients had reduced well-
being in most quality of life domains and therefore an assumption was made 
that this reduction would reflect a total quality of life reduction (Camilleri-
Brennan & Steel, 1998; Sprangers et al., 1995) In the current study stoma 
patients had reduced well-being in all quality of life domains, except social 
functioning, compared to that of non-stoma patients, however, this reduction 
was not statistically significant. Even though the differences among quality 
of life domains were not statistically significant, when all these domains 
were combined to produce an overall quality of life effect, the difference 
between the two groups was statistically significant and stoma patients 
experienced an overall worse quality of life than non-stoma patients. Such a 
finding highlights the importance of obtaining overall scores for any quality 
of life measurement, since small impairments in specific domains cannot 
always show up the overall cumulative, impairment. 
Studies that provide a summary health-related quality of life score for 
patients with and without a stoma are very scarce and none have used the 
FACT-C instrument. So, a comparison between the overall quality of life 
scores of the present study and the total HRQOL scores of other studies 
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cannot be made. One identified study conducted by Ramsey et al. (2000) 
who explored the health-related quality of life of colorectal cancer survivors 
in the USA, and had used the FACT-C questionnaire, suggests that a 
colostomy does not significantly affect overall health-related quality of life. 
Since this study was not designed to explore differences between two groups 
(stoma and non-stoma) certain information about stoma patients such as age, 
gender or time since surgery was not available for making valid 
comparisons. The EORTC QLQ-C30/CR38 questionnaire, the one most 
commonly used in European countries unfortunately has not been designed 
to provide a total health-related quality of life score, consisting of the 
summation of individual sub-scale scores. On the contrary, it includes a 
visual analogue scale in which patient are asked to evaluate global health 
and quality of life in a scale from "very poor" to "excellent". In a recent 
review by Pachler and Wille-Jorgensen (2005) the findings of the included 
studies that had used the disease specific EORTC QLQ-C30/CR38 health-
related quality of life instrument on global HRQOL scores of stoma and 
non-stoma patients contradict and a firm conclusion on this issue could not 
be drawn. For example, a number of included studies concluded that non 
stoma patients experienced similar or poorer global HRQOL than stoma 
patients (Rauch et al., 2004; Grumann et al., 2001; Allai et al., 2000) while 
others supported that the formation of a colostomy impaired a patients' 
quality of life severely (Engel et al., 2003; Kuzu et al., 2002) 
Therefore, the literature to date has failed to show consistently that there is a 
difference in the overall health-related quality of life between stoma and 
non-stoma patient's life and that this is affected by the disease and treatment 
several years after diagnosis. In the present study specific health-related 
quality of life domains in stoma patients were not significantly affected even 
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several years after surgery but they remained in lower levels than that of the 
non stoma group. Improvements that may have occurred in many aspects of 
quality of life of stoma patients do not suggest that these patients experience 
had an overall higher quality of life. One interpretation of this finding is that 
stoma patients are likely to expect preoperatively that a colostomy will 
change negatively many aspects of their life. It may be that negative lay 
perceptions about colostomy appliance worried patients extremely about the 
consequences of the stoma on their future quality of life. However, after 
surgery, many stoma patients might realize that a colostomy did not affect 
their life as much as they had anticipated and so certain quality of life 
aspects was experienced as better and less traumatic. 
It is necessary to consider in detail all the other health-related quality of life 
domains which may also impact on patients' life. 
Physical functioning 
The fact that there was no statistically significant difference between stoma 
and non-stoma patients in relation to physical functioning is perhaps not 
surprising given the high rating of health status of the sample. Patients who 
had undergone curative surgery would not be expected to be significantly 
physically incapacitated as a result of their treatment at one year, or more 
than one year post surgery. In a prospective study Grumann et al. (2001) 
indicated that levels of physical functioning improved between 6 to 9 
months and 12 to 15 months post surgery, although no significant difference 
between stoma and non-stoma patients was found. As might be expected 
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Allai et al. (1999) found that although there were no significant différences 
between the two âge groups in terms of physical functioning, older patients 
tended to report lower scores indicating poorer physical functioning. This 
emphasizes the need to consider the possible effect of âge in reporting on 
this sub-scale. Grumann's et al. (2001) as well as Allai's et al. (1999) 
research findings evaluated the physical functioning of patients using the 
EORTC QLQ-C38 instrument which included one sub-scale that was 
completed by patients with a stoma, and one sub-scale which was completed 
by patients without a stoma. As thèse scales were not completed by both 
groups it was not possible to compare their mean scores using independent 
samples t-tests. 
Moreover, the FACT-C instrument used in the présent study includes two 
items more relevant to patients who expérience the side-effects of 
chemotherapy or radiation therapy such as nausea or vomiting and one item 
relevant to patients who suffer from pain. Patients included in the présent 
study were selected to have completed any curative treatment at least one 
month before completing the questionnaires. So, it was expected that 
patients would not expérience side-effects, of chemotherapy or radiation 
therapy during the survey. Taking this into account one would expect that 
the physical component of FACT-C questionnaire would not be completely 
relevant to survivors. However, it was decided initially to include in the 
study thèse "irrelevant" items because any changes made to the number of 
items would potentially alter the original psychometric properties of the 
instrument. Also, any change made to this component would have an effect 
on the total FACT-C quality of life score, since the total score was produced 
by adding the score of each component. 
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Social/family well-being 
A vast amount of research literature has reported that stoma patients often 
experienced reduced social functioning as a result of embarrassment, stigma 
and worry in relation to their stoma (Engel et al., 2003; Sprangers et al., 
1995; Williams & Johnston, 1983; Delvin et al., 1971). However, in a 
review Sprangers et al. (1995) noted that studies which had reported 
differences between stoma and non-stoma patients had tended to use a range 
of different indicators of social function such as employment, frequency of 
social contacts and quality of relationships. The variance of operational 
definition of social functioning used across studies might yield divergent 
results (Sprangers et al., 1995). 
The current study included a variety of social indicator variables for 
assessing the social activity of the participants. For instance, the 
social/family subscale of FACT-C instrument provides information on trie 
support that patients receive by friends or their family as well as the sexual 
functioning of patients. In addition, the SF-36 instrument provides 
information about the extent of social inactivity that patients experience 
because of specific physical or psychological problems. 
No significant difference was found between the two groups (stoma vs non-
stoma) in terms of their reported level of social functioning as measured by 
FACT-C and SF-36 instruments even if patients with a colostomy appliance 
had higher FACT-C mean score than patients without a stoma. The social 
functioning of stoma patients may not be influenced by the consequences of 
surgery because this may alter their social behavior. For example they may 
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reduce the time spent in social activities or may take care about the amount 
and kind of the food they consume during social events, thus preventing 
bowel disfunction (e.g. gas, faecal leakage). Furthermore, given that half of 
the patients of the current sample had retired (50.3%), employment problems 
or vocational matters were not raised. 
Before coming to conclusions it is important to consider a person's pre-
morbid social functioning in relation to quality within this life domain. 
Three recent studies have also reported no significant differences between 
stoma and non-stoma patients in terms of social functioning (Rauch et al., 
2004; Grumman et al., 2001; Allai et al., 2000). 
Sexual functioning 
Regarding sexual functioning of patients with and without a stoma, in the 
present study we could not have a clear scenario because there were a high 
proportion of stoma patients who declined to respond to the relevant 
question and so a formal statistical analysis was difficult to apply. Only nine 
stoma patients out of twenty-two responded to this item. It should be noted 
that this question was optional. Examining carefully the characteristics of 
stoma patients who did not respond to the sexual activity item it was 
apparent that non-respondents were mostly female and widowed. Also, their 
mean age was 64.6 years. The non-respondents' characteristics perhaps 
highlight the importance of taking into consideration a person's relationship 
status as well as age when interpreting any results regarding sexual 
functioning in the context of close relationships. 
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An assumption that one can make is that Greek women with a stoma and 
widowed patients may face difficulties about their sexual activity and may 
not be willing to discuss this issue. It is well known that a negative body 
image may negatively affect people's sexual functioning. In the current 
study the women with stoma who not respond to the sexual activity item, 
had a negative body image. Therefore, a negative body image that women 
with stoma experience may negatively affect their sexual life. 
Engel et al. (2003) suggested that it is difficult to evaluate the magnitude of 
sexual functioning without making a comparison to healthy population 
scores. Peoples' sexual capacity may decline because of age or due to other 
reasons. For instance, Greek women may differ in sexual satisfaction from 
men. Also, the questionnaire item related to sexual capacity included in the 
current study asked about the extent to which the patient was satisfied with 
sexual activity. The item did not refer to the effect the illness and treatment 
had on patients' sexual functioning. Pre-treatment scores among stoma and 
non-stoma patients, as well as information about the damage caused to the 
nerve responsible for sexual functioning, would be essential for a clearer 
scenario about the effect that treatment or other factors have on stoma and 
non-stoma patients' sexual life. For instance, Engel et al. (2003) showed that 
high-anterior resection patients and low-anterior resection patients had better 




In this study, no statistically significant différences were found between 
patients who had undergone either sphincter-conserving or sphincter-
sacrificing surgery in relation to thc psychological functioning domain as 
measured by the FACT-C instrument. Even though the différence in 
psychological well-being between the two groups was not statistically 
significant, stoma patients had lower mean scores than non-stoma patients. 
Also, when psychological functioning was assessed by the SF-36 
questionnaire, no statistically significant différences were observed between 
the two groups. Furthermore, no différence was found between the two 
groups in relation to the dépression scale. When examining the subscale 
items of FACT-C, was found (hat stoma patients were statistically more 
worried about death than the non stoma patients. 
The above data contradict the findings of previous studies which report that 
patients with a stoma are more anxious and depressed than patients who do 
not have a stoma (Sprangers et al., 1995; McDonald & Anderson, 1984; 
Williams & Johnston, 1983). On the other hand, récent studies have also 
reported no significant différences between the stoma and non-stoma groups 
in terms of emotional functioning (Grumann et al., 2001; Allai et al., 2000). 
Functional well-being 
The rôle functioning sub-scale may be regarded as a more appropriate index 
of quality of life for patients who are at least one year post surgery. Rôle 
functioning encompasses the extent to which patients are limited in doing 
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work, or daily activities, hobbies and leisure time activities. Consistent with 
the current study, other researchers have found no significant differences 
between sphincter-conserving and sphincter-sacrificing patients in terms of 
role functioning (Rauch et al., 2004; Grumann et al., 2001; Allal et al., 
2000). 
In the current study, the difference in the functional level between the two 
groups was not statistically significant, but again stoma patients experienced 
lower functional level than non-stoma patients. Bekkers et al. (1997) showed 
that stoma patients did not encounter more problems in daily life than non-
stoma patients four years after surgery. In the current study, 52% of patients 
had survived between 2 and 4 years and 23% of patients had survived 
beyond 5 years since diagnosis and only seven patients reported an inability 
to fully return to their work due to the disease. 
In addition, before drawing safe conclusions about the capacity of people to 
undertake everyday roles, it is important to consider the effect of age on the 
level of activities and ability to perform roles, taking into account the 
generally older adult age of colorectal cancer patients. Many older adults 
gradually become less active and have fewer roles as a result of their life 
stage, independently of the limitations related with their disease. In this 
sample more than half of patients were older than the age of 60 years and 
had retired. However, it is important to treat with caution the explanation 
that patients in this sample avoid undertaking some roles or stop their 
hobbies and leisure time activities due to their age; especially as many adults 
a similar age very often have important and demanding roles. 
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Colorectal cancer module (symptom sub-scale) 
Previous research has documented that many patients suffer from symptoms 
such as diarrhoea related to bowel functioning after surgical treatment 
(Engel et al., 2003; Lewis et al., 1995; Sprangers et al. 1995; Williams & 
Johnston, 1983). The research literature suggests that stoma patients tend to 
report more problems with gas and urinary function while non-stoma 
patients report more constipation (Engel et al., 2003). 
In contrast with these findings, no statistically significant differences were 
found between stoma and non-stoma groups on this subscale relating to any 
of these symptoms experienced by colorectal cancer patients; even though 
stoma patients' mean scores were indicative of low levels of colorectal 
cancer symptoms than non-stoma patients' mean scores. It should be noted 
that the symptom sub-scale of the FACT-C instrument includes items that 
related only to bowel functioning, and no item is concerned with urinary 
problems that may also be experienced by colorectal cancer patients. So, we 
cannot conclude about urinary problems experienced by patients in this 
sample. 
One explanation for these findings relates to the research literature that 
suggests that bowel function often improves within the first year post 
surgery (Frigell et al., 1990). The time interval of at least one year post 
surgery used in this study might mean that for many patients relief from such 
symptoms had already occurred by the time they completed the survey. 
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An alternative explanation is that improvements which have occurred in 
recent years in surgical techniques, as well as improvements in care of 
colorectal cancer patients are reflected in the current study. Such 
improvements might not be reflected in previous studies in which different, 
less optimal techniques might have been used. Such an explanation is 
supported by the findings of more recent studies conducted by Rauch et al., 
(2004), Grumann et al., (2001); Allal et al., (2000). Regarding non-stoma 
patients' symptoms, the level that the tumour is located is essential for 
obtaining a clear picture of symptoms experienced because it affects 
patients' bowel function (Engel et al., 2003; Kuzu et al., 2002). For example, 
in a four year prospective study (Engel et al., 2003) showed that in the first 3 
years, low-anterior resection patients had significantly worse defecation 
scores and less frequent or painful bowel movements than high-anterior 
resection patients. Similar results have also been supported by other 
researchers such as Kuzu et al. (2002) who showed that high-anterior 
resection patients had significantly better scores in other aspects of quality of 
life such as in mental health and vitality, compared with those with low-
anterior resection. In line with the current study, the number of other studies 
that have evaluated stoma and non-stoma patients' health-related quality of 
life, and have taken into account the level of anastomosis in patients with 
anterior resection, are very limited. Therefore, in non-stoma patients there 
are many differences in symptoms that patients experience and so 
comparison between stoma and non-stoma groups is difficult to make. For 
instance, if our sample had included more patients with high-anterior 
resection, defecation problems experienced due to low-anterior resection 
would not have been detected. 
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Satisfaction with body appearance 
In this study, patients who had undergone sphincter-sacrificing surgery 
resulting in a stoma, reported statistically significant more dissatisfaction 
with their body appearance compared to non-stoma patients. This is 
consistent with the findings of several research studies (Engel et al., 2003; 
Persson & Hellstrom 2002; Grumann et al., 2001; MacDonald & Anderson, 
1984; Williams & Johnston, 1983). Also, in this study, women with a stoma 
were found to experience more dissatisfaction with their body appearance 
compared to men. This body dissatisfaction may result in a difficulty that 
stoma women experienced with their sexual life. It has to be noted that the 
FACT-C instrument included only one item related to the satisfaction that 
colorectal cancer patients had with their body appearance. However, this 
item does not lead to a safe conclusion about body image perception. 
Research evidence regarding body image differences between sexes in 
colorectal cancer patients is scarce. Fallowfield et al. (1990) has suggested 
that patients who were given a choice of treatment appeared to do better 
psychologically, independently of the type of treatment chosen. Even if 
choice of treatment is not possible for all patients, it may be important to 
consider the potential effect of patients being prepared for the possibility of 
having a colostomy on subsequent body image satisfaction. 
7.3.4 The effect of metastasis on HRQOL 
Local or distant recurrence of colorectal cancer had a profound effect on 
Greek patients' quality of life. This finding is consistent with a study by 
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Camilleri-Brennan and Steel (2001) as well as a recently published 
population based study by Arndt et al. (2006). Indeed, in the current study, 
patients with récurrent disease faced not only physical limitations in their 
every day life, but also psychological and social well-being détérioration. 
The use of both health-related quality of life instruments, FACT-C and SF-
36 confirmed this finding. 
The interrelationship among HRQOL domains is an important issue. In this 
study, the physical effect of the disease evidently had an important impact 
on social, psychological or overall functioning of patients' life and should be 
noted as a key finding. 
7.4 Limitations of the présent study. 
Some methodological limitations of the présent study have to be noted. 
These limitations are related with the study design, the sample, as well as the 
study instruments. 
The study design 
There are a number of limitations of the cross-sectional design used in this 
study. This type of design does not provide a baseline measure from which 
to evaluate subséquent assessments. This made it difficult to accurately 
assess the extent to which impairments to quality of life had resulted from 
patients' cancer disease or cancer treatment rather than from other 
extraneous factors such as another illness or life event. For instance, if a 
patient suffered heart disease, it would not be possible to detect the extent to 
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which this might have affected his/her quality of life independently of 
his/her cancer or cancer treatment. Since other comorbidities might exist, the 
most appropriate approach might be to decide about the appropriateness of 
patients' inclusion to the study, based on an individual basis and carefully 
weighing up the impact of the relevant factors on quality of life. Apart from 
other comorbidities which might occur together with cancer, the effect of 
age on patients' quality of life is major issue. Particularly in patients with 
colon and rectal cancer, which is a disease of the elderly, the effect of age 
should be explored with caution. Furthermore, when assessing health-related 
quality of life of stoma and non-stoma patients, a retrospective design cannot 
give information on quality of life of patients before surgery, thus making 
comparison impossible. Thus, the advantage of a prospective study design 
which involves repeated measures at different times is that confounding 
variables may be more easily monitored and controlled for. 
Despite certain weaknesses that are inherent in the retrospective design of 
the present study, significant results were found. 
Representativeness of sample 
The majority of patients (60%) were Greek men while the mean age of 
patients in this sample was 61.40 years of age which are consistent with the 
average age range and sex reported for incidence of colorectal cancer in 
Greece. Although these characteristics make the sample more representative 
of the whole colorectal cancer population, the sampling was limited by 
consisting mainly of Greek patients. Therefore, the results found here may 
not be generalized to patients from other ethnic origins. No data were 
gathered on other ethnicities. Albanian immigrant patients for instance, who 
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consist of the majority of people from foreign counties who live in Greece, 
were not found in any archive used in this study, either the archives of the 
public hospital or those of the private oncology clinic. However, Albanians 
who immigrate to Greece are often of a younger age. Since colorectal cancer 
is a disease of the elderly it would be unlikely that colorectal cancer patients 
from Albania would included in this study. Extrapolation of the current 
findings to patients of other ethnicities should be made, therefore, only with 
caution. 
Also, the sample used in this study consisted of patients who had been 
treated for colorectal cancer at two Greek hospitals -one public and one 
private oncology clinic- for a period of the last 12 years. A l l patients who 
met the inclusion criteria were asked to participate. Although it was decided 
to recruit patients from two different hospitals in order to achieve 
socioeconomic heterogeneity among patients, the sample consisted mainly 
of patients who were well educated and their family income was above 
average. This may have occurred because the majority of participants-100 
out of 145-were recruited from the private oncology clinic. It is known that 
patients of middle and upper-middle socioeconomic level receive their care 
in the private health sector and may not necessarily represent the wider 
population of patients. 
One important issue is the potential for selection bias among patients who 
decided to participate in the study. A number of patients -46 out of 191-had 
refused to participate. Therefore, the response rate for this study was 75.9%. 
Although comparison between respondents and non-respondents indicated 
that the latter did not differ in demographic or disease related characteristics 
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from the former, it is possible that non-respondents experience different 
levels of quality of life, such as lower HRQOL, and this may have 
influenced the results of the present study. 
Moreover, one of the problems common in any investigation of quality of 
life in cancer patients, is the inherent sampling bias, in that only patients 
who have survived their treatment and who are well enough to participate 
are included in such studies. This may result in conclusions being made on 
the basis of unrepresentative samples. 
In addition to this, because this study has focused on long term survivors, 
few patients with advanced colorectal cancer or at a longer time since 
diagnosis have been included. So, there is the possibility that the respondents 
were in better health status in order to be able to respond to the survey. 
The study instruments 
The primary requirement of FACIT QOL instrument is that it should be 
suitable for use in an international setting, that is, the translated instrument 
should measure the same aspect of quality of life regardless of language 
version. Although the translation of the FACT-C instrument into Greek was 
obtained by the official FACIT organization body, there is not enough 
evidence that this translated version meets all the requirements of cross-
cultural equivalence. This translation may support the content (each item is 
relevant to the culture being studied) and semantic (each item has the same 
meaning after translation) equivalence of the instrument, but there is not 
sufficient evidence that conceptual equivalence (measurement of the same 
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theoretical construct) has been met. Also, little account has been made in 
considering the social, ethnic, religious or cultural background of the 
patients. The cross-cultural equivalence of HRQOL instruments has been 
largely overlooked to date. 
The purpose of using the FACT-C instrument was to gain an overall and 
dimension specific score of the quality of life for patients who have survived 
colorectal cancer, and of the impact that the disease and treatment have on 
their lives. However, the FACT-C instrument, like all the available 
instruments on quality of life today, has been designed primarily for clinical 
trials and may able to capture the most important and relevant changes after 
treatment or the long-term impact of the disease (Carr et al., 2001; Alison, 
1997; Caiman, 1984;). Although it includes sections on social, emotional 
and functional well-being, the questions were all focused on the cancer 
diagnosis. The study sample of patients did not have active disease and 
believed themselves free of cancer. Specifically, the dimension of physical 
functioning of the FACT-C instrument included questions that focused on a 
range of symptoms appropriate to cancer and cancer treatments. Therefore, 
these questions might not directly apply to the study sample. However, it 
was initially decided to include the "irrelevant" items into the study, because 
any changes made could potentially alter the original psychometric 
properties of the instrument. Also, any change made would have an effect on 
the total FACT-C quality of life score, since it was produced by the adding 
the score of each component. 
Furthermore, the communication scale of the Enrich instrument had been 
adapted and translated from English into modern Greek by this researcher 
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and évidence for its cultural sensitivity is not still available. Despite thèse 
limitations the study provides évidence of HRQOL and associated changes 
in a Greek context. 
7.5 Summary 
The patients in this study experienced a relatively high overall and 
dimension specific health-related quality of life years after diagnosis of the 
disease. This was characterized by depressive Symptoms affecting patients' 
quality of life, This is not surprising since patients might interpret their 
conditions through the sensé of a "response shift" leading to adaptation to 
their chronic disease. 
Whether the lower levels of overall quality of life in stoma patients is due to 
treatment side-effects, difficultés in psychological adjustment or both, the 
fact that thèse difficulties may exist long after initial diagnosis, requires 
further attention. 
Despite the limitations imposed by the cross-sectional design, the specific 
characteristics of the sample and the specific study instruments, important 




CONCLUSIONS AND RECOMMENDATIONS 
8.1 Summary of key findings 
In this study, an investigation of the experience of Greek colorectal cancer 
patients following treatment, with specific focus on health-related quality of 
life (HRQOL), was undertaken. With evidence suggesting that culture may 
be a major determinant of the experience of cancer, the present study gained 
an insight into the perspective of HRQOL in Greek patients who are 
surviving a diagnosis and treatment for cancer of colon and rectum. The 
main outcomes of this study are: Greek colorectal cancer survivors 
experience a high overall and dimension specific HRQOL, independently of 
the disease stage at diagnosis; depression and social activity constitute the 
strong predictors of patients' HRQOL over time; stoma patients experience 
an overall lower HRQOL than non stoma patients; metastasis has a negative 
effect on Greek patients quality of life. 
This study has contributed to the body of knowledge surrounding the 
HRQOL of Greek patients who had experienced cancer of colon and rectum 
in a number of ways. Therefore, it provides implications for practice into a 
Greek cultural context as well as recommendations for the assessment of 
HRQOL in colorectal cancer survivors. 
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8.2 Implication for practice 
In this study it has been found that depression is a predictor that could 
modify patients' quality of life over years. The timely identification and 
treatment of depressive symptoms in colorectal cancer patients would be 
very important for developing a strategy to prevent mental functioning in 
these patients. It could also provide an ongoing follow-up care on a more 
individualized basis for improving their overall quality of life. 
Also, physicians should not underestimate the cost of the sphincter 
sacrificing technique on patients' quality of life years after surgery. 
Furthermore, the existence of specialist stoma care nurses for caring patients 
suffering from colorectal cancer, with a permanent colostomy, are important, 
since stoma therapy nursing has not yet been established in Greece. 
Specialist stoma care nurses can assist rehabilitation starting from the 
preoperative stage, or as soon as possible after stoma surgery, in order to 
prevent late adverse effects of stoma surgery on patients' quality of life. 
Rehabilitation is an ongoing process that encompasses many aspects of life 
such as physical, emotional, cognitive or social functioning. Through this 
process, an adaptation strategy must be developed especially for supporting 
Greek women with a stoma and a poorer body image. 
Finally, one priority for nurses who care patients with recurrent disease 
would be to set goals for supporting both physical needs of the patients (e.g. 
pain relief) as well as the psychosocial aspects of their quality of life. 
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Table 8.1 summarizes the statistically significant, the important but not 
significant and insignificant key findings of the present study as well as the 
suggested implications. 
Table 8.1: Key findings and implications 
Statistically significant Undings Implications 
•Depressive symptoms are significant predictors of the 
overall HRQOL of colorectal cancer patients. 
•Patients with a low income experience an overall 
lower HRQOL. 
•The overall HRQOL of patients with a colostomy 
appliance is inferior to that of patients without a 
colostomy. 
•Stoma patients have more dissatisfaction with their 
body appearance compared to non-stoma and this 
dissatisfaction is more prevalent to women. 
•Stoma patients experience more worry associated 
with death than non-stoma patients. 
•Patients with a metastatic disease experience a lower 
overall as well as dimension-specific HRQOL than 
those who considered to be free of cancer. 
•Timely identification and treatment of depressive 
symptoms and strategies to assess negative 
psychosocial impact on patients post-operati vely. 
•Development a policy that would support patients 
of low income status. 
•Establishment specialist stoma care nurses in 
Greece for setting goals in pre-operative, post-
operative and rehabilitation stages. The specialist 
practitioner should adopt a patient-centred approach 
to care, ensuring that important aspects of care, such 
as the early teaching to stoma management skills, 
are not neglected. 
•Preoperative support of women with a stoma and 
development an adaptation strategy to a new body 
appearance by helping them to counteract the threats 
presented by the effects of surgery. 
•A patient-centred psychological care of stoma 
patients throughout the treatment process. 
•Establishment goals for supporting both physical 
needs of patients as well as psychosocial aspects of 
quality of life. 
Important but statistically insignificant findings Implications 
•Stoma patients have a reduced physical functioning, 
emotional well-being and functional well-being 
Preoperative, and post-operative holistic assessment 
of patients' needs, (physical, emotional, functional), 
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compared to non-stoma patients. 
•Women with a stoma and low body image may face 
difficulties in their sexual activity. 
as well effective communication between medical 
colleagues and stoma care nurses in order to 
optimize the process of rehabilitation. 
•Adaptation to a changed body image for preventing 
the indirect effects of stoma to sexual functioning. 
Statistically insignificant findings Implications 
•Colorectal cancer patients of different disease stages 
and at different time since diagnosis do not experience 
statistically significant differences at the level of their 
HRQOL. 
•Gender, and age as well as the level of 
communication between couples do not associated 
with outcomes on the HRQOL of survivors. 
Publishing the findings of the present study in Greek 
nursing journals or international nursing journals. 
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8.3 Recommendations for further research 
Further research in this area should be conducted within a multidisciplinary 
context. 
The present study has provided a high overall and dimension specific health-
related quality of life score for Greek colorectal cancer survivors. Since the 
number of studies that have investigated the overall health-related quality of 
life of colorectal cancer survivors is very limited, more longitudinal studies 
measuring total and dimension specific quality of life have to be designed, 
particularly for patients who have survived beyond one year after diagnosis. 
Factors that could influence patients' quality of life such as the existence of 
other comorbidities or a low income also have to be examined. Also, more 
patients with advanced stage disease and long history of colorectal cancer as 
well as of other ethnicities should be necessary to be included. 
This study has provided evidence that depressive symptoms predict Greek 
colorectal cancer survivors' quality of life. Lately, some researchers have 
tried to link the role of mood in survival. Onitilo et al. (2006) in a 8-year 
follow-up study demonstrated that the coexistence of cancer and depression 
is associated with an increased risk of death. Similar findings have been 
confirmed by Faller et al. (1999) in a lung cancer patients' study. These 
authors reported that emotional distress and depressive coping style 
predicted short survival. Although the impact of depression on mortality has 
not been definitely confirmed by Spiegel & Giese-Davis (2003) review 
study, the latter concluded that untreated depressive disorders might be a 
risk factor for cancer progression. 
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On the basis of the preceding evidence, the results of the present study 
highlight the need to evaluate the prevalence of depressive disorders in 
Greek colorectal cancer patients several years after the diagnosis, using 
specific standardized scales. Also, further work should focus on the risk 
factors for depressive symptoms in patients at follow-up. The exploration of 
the relationship between low income, comorbid conditions and depressive 
symptoms should be an aim of future studies. 
The cross-sectional nature of this study did not allow the evaluation of 
causal associations between depression and quality of life. For a further 
exploration of the causal effects of depression on quality of life, the use of 
prospective, longitudinal study designs would be required. 
The results of this study highlight the need for obtaining more information 
on the overall and dimension specific effects of stoma surgery on Greek 
patients' quality of life. Further work is needed for evaluating the sexual 
functioning as well as the body image of Greek women with a colostomy 
appliance through specific scales. Constructs such as body image or sexual 
activity should be taken into account in such an evaluation. 
Generally speaking, for obtaining a clear perception about the differences in 
quality of life between stoma and non-stoma patients, more work is needed 
that would include large prospective studies in which patients' quality of life 
should be evaluated before and after surgery. Also, there may be a difference 
in certain aspects of quality of life in patients who have undergone a low 
anterior resection compared to those who were given a high anterior 
resection. The investigation of the method of surgery (high versus low 
resection) would be an important addition to future research. 
168 
Another area for further research is related to the health-related quality of 
life instruments. As previously discussed, the available HRQOL instruments, 
even though provide evidence for validity or reliability, they have been 
designed for clinical trials. Therefore, they are of limited applicability to 
long-term survivors. Patients may feel that issues related to hope and fears 
about the future, worries about recurrence or adaptation to cancer, are 
problems of equal importance to the physical symptoms produced by cancer 
and its treatment at follow-up. The development of instruments that would 
cover issues more relevant to cancer survivors would be an important area 
for future research. Recent work conducted by Zebrack et al. (2005) reports 
on the development and the evaluation of a new instrument that measures 
aspects of long-term survivorship. However, further work is needed to 
confirm the psychometric properties of this instrument. 
Also, it has been agreed that HRQOL instruments may only capture aspects 
of subjective health status. A fundamental limitation is that whilst they 
capture issues that the developers of them consider as important, their 
importance to patients' concepts has been overlooked (Dijkers, 2003; Carr et 
al., 2001). In order to ensure that the quality of life approach used in this 
study reflect the health-related quality of life issues of most concern and 
relevance to a Greek cultural context, an in-depth insight into the experience 
of Greek patients surviving colorectal cancer would be another area for 
further work. 
Detailed information about Greek patients' quality of life can be obtained by 
structured and unstructured interview procedures in which a holistic point of 
view of patients' subjective well being is achieved. The combination of both 
qualitative and quantitative approaches would provide an in-depth 
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understanding on patients' perspective, giving at the same time the 
possibility to generalize and predict. 
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Study Title: Evaluation of quality of life of long-term survivors 
of bowel disease patients 
Dear (patient's full name) 
I am currently carrying out research into the quality of life in people who 
have had bowel disease. It is hope that by exploring this area we will better 
informed of patients' needs and will be able to improve the care offered in 
the future. I would like to invite you to take part in this study. Your 
participation is entirely voluntary. Your physicians are already aware of this 
research being carried out and permission was also obtained from them 
before I use your personal data. 
Before you décide whether you would like to participate, it is important that 
you understand why this study is being carried out and what it will involve. 
This letter and enclosed détails will give you information which you may 
wish to discuss with your family, friends and hospital staff. Please take time 
to décide whether or not you whish to participate. Please ask if anything is 
not clear or if you have any additional questions or queries about this study. 
You can contact me directly on 6945-463990. 
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Thank you for taking the time to read this and for considering taking part in 
this study. 
Yours sincerely 




MODERN GREEK TRANSLATION PATIENT'S LETTER 
nPOE TON AE0ENH 
Tirkoc U X ^ T Î Î Ç A^ioXóyr|OT| xrjç rcoioxrjxaç Çcof|ç aaGevcov rcovj é/ouv 
crcißicoaei arcó TT|V VOGO TOD rca/éoç evrépou. 
Ayarcr|xn; Kupía/Kúpie 
npóacpaxa ÔieÇaycn |iía épeuva rcávco axr|v 7roiÓTr|Ta Çcof|ç xoov av9pÓ7icov 01 
orcoíoi vóanaav Kai skaßav 0eparceía yia TT|V vóao xov rce/éoç evxépoi). 
EXrciÇouue on (xéaa arcó uaa xéxoia 8iepeúvrjar| 0a srciTÚxoo(ie KaAúxepri 
rcX,ripo(póprioT| yúpco arcó TIC aváyicec xcov aa0evcov Kai éxai 0a eíuaaxe ae 
0éar| va ßeX-rtcoaooue Tnv rcapexóuevri (ppovTÍoa yia TOUÇ U£À,À,OVTIKOOÇ 
aaOsveíc. 0a f|0eXa va aaç rcpoaKaXeaco va XaßeTe uipoç ae auxn xnv 
u,sAixr|. H auu.usTOxn °"aÇ £ i v a i evxeXcûç eGe>/jvxiKf|. O yiaxpoç rcou aaç 
rcapaKoA.ou0ei é%ei f|Ôr| evrju£pû)0£Î yia TT|V rcapoúoa épeuva. Arcó TOV 
yiaxpoç oaç erciorjç é/ca rcápeí TT|V aôeia yia va erciKoivcûviiaQ) uaÇi aaç Kai 
va xpr\<y\\iOKOir\(5(û xa rcpoaawuKá aaç ÔeÔo^ iéva. 
npoxoú arco<paaíaexe eáv 0a erci0U|ioúaaxe va auiiuexácrvexe Kpívexai 
aquavxiKO va yvcopíCexe xo aKorcó auxf|ç xr|ç |ieXéxrjç Kai xi auxf| 
rcepiXaußavei. 
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A D I Ó TO ypáuua tcaGcbç S7iiar|ç Kai oi smcrovaTiTOuevsc XsTtTouipeisc 0a aaç 
Öcoaoov Ká0e 7iA,T|po(pópr|ari TTIV orroía uTtopevxe va auÇr|TfiaeT8 UE TO 
oiKoyeveiaKÓ aaç nepipáXkov, TODÇ (piXouç aaç r\ UE TO 7ipoâ(û7ciKO TOO 
VOOOKOUEÚJU aaç. 
riapaKaX,û) aKECpTEÍTE u.8 ávsar| xpóvou eáv ETTUSUUEÍTE va OUWIETEXETE f) óy\. 
Eáv imáp/Ei K Ó T I rcou 5EV KaTavoefte r\ É /ETE o7ioi8aoiÍ7ioT£ arcopíec axerucá 
ue aorn, TT| (Í8X,STT| u.7iop£ÍTs va e7UKOiv(ovf|aETE uaCí uou 07toiaori7iOTe copa 
TT|Ç uépaç OTO 6945-463990. 
Xaç eo%apioT<b yia xo xpóvo TÍOM ÔiaGéaaTe yia va oiaßaaere auro TO 







TITLE: Evaluation of quality of life of long-term survivors of bowel 
disease patients 
Background to this study 
When we evaluate a new treatment (e.g. new drugs), one of the most 
important areas to consider is the impact on people' health and quality of 
life. Although much work has been undertaken investigating peoples' 
experience of disease during the diagnostic or treatment phase, we do not 
know many about the needs of patients as they enter the post-treatment of 
their journey as well as the late impact of disease and its treatment on their 
quality of life. 
The purpose of this study 
Knowledge of the experience of the patient with bowel disease would be 
useful to health care professional to prevent possible late effect of the 
disease during follow-up evaluation, or to policy makers to plan specific 
health care programs to improve quality of life. 
Why have I been chosen? 
The researcher wishes to explore the quality of life of patients who had 
survived their disease from one to several years ago. Patients were chosen to 
reflect a broad ränge of treatment received for bowel disease. 
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What will the study involved? 
If you décide to take part in the study you will be asked to complète a 
research pack which contains four questionnaires together with a 
démographie data sheet. This pack should take approximately 30 minutes to 
complète. 
Do I have to take part? 
No, taking part in this study is entirely voluntary. If you décide to take part, I 
will ask you to complète and sign a consent form giving permission. Even if 
you décide to take part, you will free to withdraw at any time and without 
giving reason. Your décision will not affect the médical care or treatment 
that you receive at any time. 
What are the potential risks for me becoming involved in this study? 
This study involves competing questionnaires which will ask you about your 
health and quality of life, and you may fînd this upsetting. You may also 
becoming tired or find difficulty in answering some of the questions. The 
researcher will try and minimize thèse potential issues by providing clear 
instructions on how to complète the questionnaires, and by providing a 
contact téléphone number if you have any queries or concerns about the 
questionnaires. 
What are the potential benefits for me becoming involved in this study? 
You may find that completing the questionnaires provides a chance to reflect 
upon your expérience. This study will provide other health professionals and 
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patients with a better understanding of the impact of your illness and 
treatment once treatment has been completed, and assist in providing 
treatment and care which improves patients' health and quality of life. 
What happens next? 
Since you carefully read this information and if you decide to take part you 
have to return the enclosed reply slip within a couple of weeks. This will 
allow you time to study the information and give you the opportunity to 
discuss the study with relatives or friends. A week from the day of sending 
you this letter I will contact you by téléphone in order to ensure that you 
have received it. If you already have received it we will have the opportunity 
to discuss any aspects of the study in further detail. 
If you agree to complete the questionnaires, I will send you the research 
pack and a second copy of the letter, information sheet as well as and a 
consent form. You will be asked to return the pack in a stamped addressed 
enveloped provided. You will also be asked to send the signed consent form 
to me in a separate stamped addressed envelope. This is to ensure that your 
anonymity is maintained. 
What if I change my mind about participating? 
You can change you mind about participating at any time. You can do this 
by contacting me directly on the contact number below or asking a relative, 
friend or health care professional to contact me on your behalf. Messages 
can be left at any time (including evenings, nights and weekends) on a 
voice-mail facility. You do not have to give any reason for withdrawing 
from the study. 
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Will my details be kept confidential? 
Al l Information that is collected about you during the course of this research 
study will be kept strictly confidential. A l l data will be anonymous and your 
data will be given a unique identification number. In addition, any 
information about you which leaves the hospital will have your name and 
address removed so that you can not be recognized from it. It will not be 
possible to identify you in any report or publication of this study. 
Who has reviewed this study? 
I am MPhil (research) Student based at the School of Health Sciences, 
University of Wales Swansea, Singleton Park, Swansea, SA2, 8PP, United 
Kingdom. This study has been reviewed by my academic Supervisor, Mrs 
Faye Kinsella, Lecture at the School of Health Science. 
If you have any questions or would like any further information please 
contact: 
Georgia Doga (Mrs) 
MPhil candidate 
Tel: 6945 463990 
If you decide to take part in the study you will be sent a copy of your signed 
consent form. 
Thank you for taking the time to read this information. 
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APPENDIX 4 
MODERN GREEK TRANSLATION OF INFORMATION 
SHEET 
ENHMEPÎÎTIKO «DYÄAAAIO 
TITAOL AÇioXoytiOTi T T I Ç TtoioriiTaç Çtoiïç TCOV aa6eva>v nov é/ovv 
zmpabaei ano n\v vöao rov îtaxéoç evrépov. 
A V T I K £ 1 ^ 8 V 0 avTf\ç rtyç nzk&n^ç 
Drav acjioXoyouue uia véa Geparceia (71.x véa (papuaKa), 0a 7tpS7iei va 
A&ßouu-E wi' öijnv uaç xov avTÎKTUTCo 7iou u.7topei ai>xf| va éxei OTT|V uyeia 
xrnv avGprimcov Kai arr|v Troiöxnxa XT|Ç Çcafjç xouç. Av Kai îtoAXéç épeuvsç 
ui/pi afjuepa éxouv eaxiaaei axo va ueX x^rjaouv XTJV eurceipia TCÙV aaOevœv 
Kaxà xnv oiayvcoaxitcri Kai 0epa7teuxiKf| (paon, xr]ç aaGéveiàç XOVJÇ, Ôev 
siuaaxe as Géarj va yvcopiÇoDue apKexa yia xiç avayKeç XÛ)V aa0evcbv Ka0<bç 
aDxoi UTiaivouv axr|v uexà ©sparcsia (paon, ai)xoi3 XOD xaÇicnovj Ka0cbç emanç 
Kai xov avxiKxiwro rcou UTEOpei va éxei TJ îôia T| aaOéveia Kai r| Geparceia XT|Ç 
axnv 7ïOiôxr|xa xn,ç C,(ûr\q xouç. 
L K O T T Ô Ç avrr\q T q ç 
H yva)OT| xr|ç euasipiaç xcov aa0svû)v ue xr| vöao xou Tiaxéoç evxépou 0a 
fjxav X P 1 ! 0 1 ^ 7 ! axouç £7iayy6A,uaxiec oyeiaç axo va Ttpotaxßouve niOavéç 
uaKpo7tpo0cau£ç 7capevépyeieç XT|Ç aa0éveiaç Kaxà xo X P 0 V 0 
STcavaÇioXôyriafiç xouç r\ axouç 7IOX,IXIKOÛÇ axeôiaaxéç axo va axeÔidaouv 
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eiÔiKd rcpoypánpaTa c p p o v r i ô a ç u y e i a ç y i a TT|V ße^xioxTri TT|Ç rcotÓTnrac Çcor|ç 
T0l)Ç. 
Tiara é/O) EmksyEÍ; 
M é a a arcó TT|V rcapoóaa é p e u v a K\ epea)vf|Tpia o K o r c e ú e i v a S i e p e v j v r | a e i Tr|v 
rcoiÓTnra Ç<ÛTJÇ TCÜV aaOevoòv rcou é^ouv erciÇf|aei ueiá a r c ó è v a é a > ç K a i 
apKeiá xpóvia a r c ó TÍ] Öiayvcoari TTJÇ aaOéveiaç TOUÇ. Oí aaOeveíc é / o u v 
erciXeyeí á a r e v a avrircpoccurceúouv uía eopeía Karriyopia 0 e p a r c e i œ v rcoo 
É%OVV A á p s i . 
Ti 9a rcepiXanpóvEi avrr\ i\ \IZXÉTX\; 
Eáv a r c o c p a a í a e T e v a Xaßexs u é p o ç a e a u n í TT|V é p e u v a 0 a a a ç Çr|TT|0ei v a 
rju(ircA.r|pa)oeT8 è v a epEUvqTiKÓ rcaKéio TO o r c o í o 0 a rcepié/ei T é a a s p a 
ep(OTr|p ,aToXóyia K a i è v a ( p i A X a Ô i o ue x a Ô r | u o y p a < p i K a a a ç x a p a K - n p i a T i K a . 
O xpóvoc rcou 0 a a r c a i T T | 0 e i y i a v a <jv\uzkr]péoETE amò TO rcaKéio 0 a s i v a i 
rcepircou 3 0 X^TCTÓ. 
Eiuai t)7toxp£(Ofi£voç/i) va Xápco uépoç; 
M r c o p 6 Í T 8 v a e r c i X é Ç e x e eáv e r c i O u u e Í T e f | ó%i v a r j u u u E T é x e T e a r r | v é p e u v a . 
Eáv a r c o ( p a o i a £ T £ v a a u p u e T é x e T e 9 a a a ç Çr |Tn0e i v a o u u r c X r i p c o a e T e Kai v a 
i)rcoypá\|/£T£ TO O / E T I K Ó é v T u r c o TO o r c o í o 0 a e r c i ß e ß a i c b v e i TT)V a u y K a T á 0 e a f | 
a a ç . Z e rc£pírcTQ)ari rcou arco<paaía£T£ v a C a p e r e u é p o ç 0 a £ Í G T £ e X e ú 0 e p o c / r | 
v a a v a i p é a E T S a u T f [ a a ç TT|V a r c ó ( p a a r ) o r c o i a 8 f | r c o T e a r i y j i f i TO e r c n % u f | a e T e 
Kai %(ûpiq v a EÍOTE i m o x p e œ u é v o ç / r i v a Ô c o a e T e eCr |yf |aeic. H a r c ó c p a a f i a a ç 
a u T T | ô e v 0 a £ T C T | p £ á a £ i CE K a u i a rcepircT(oar| TT|V ( p p o v c i Ô a u y e i a ç f | TT|V 
G e p a r c e i a rcoi) i a c o ç A á p e x e a e o r c o i a Ô f i r c o T e x p o v u c r j OTIYUTJ. 
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Le TTOIOVÇ rci9avovç K I V Ô V V O D Ç evoé/erai va urcoß^nGio «rvu-ueTé/ovraç ce 
avTrj TT | u-eXern,; 
H rcapoóaa ueXéir| rcepiXaußavei TT|V auurc>.f|pcüar| epcoir|paT.oA,oyi(ûv uéaa 
arcó xa orcoía KaXeíaxe va arcavxfiaexe ae Géuaia rcou aípopoúv xr|v uyeía 
aaç Kai XT|V rcoióxr|xa Çcor|ç aaç Kai evÔe/ouévcoç Kan léxoio aaç Káveí va 
aia0av0eÍT£ avaaxaxû)|xévoç/r|. 'lacoç vicoaexe Koupaouévoç/r| f| 
aviiueicorciaeie ôuaKoXieç axo va arcaviriaeie GE Karcoieç epcûxfiaeiç. H 
epeuvfjipia 9a rcpoorcaGfiaei va eXaxiOTorcoifïaei xiç rciGavoinieç va auußei 
Káxi arcó xa rcaparcávco Ôivovxaç aaç ÇeKaGapeç oorjyíec yia io rccoç rcpércei va 
auiircA,T|p(ûaex£ xa £poùTT|uaxo^óyia Kai Ôivoviaç aaç TT| ôuvaTOTnTa va 
erciKoivcovriaexe ir|ta(pco\aKtûç uaÇi xr|ç ae rcepírcxtoari rcou £%£!£ Kárcoia 
arcopía ú, QéXeie va pcoxfiaeie onoïjrcoTE axexíCeíai ue xa epcoiriuaioXoyia. 
Iloia rciOavá o(pé).r| 9a Xápco auu-fiETexovrac as auTq n\ ueXérri; 
'lacoç ßpeixe óxi uéaa arcó I T | auurcXf|pcoar| xcov ep(uxr|paioA,oyío)v aaç 
Ôiveiai ri euKaipía va eKcppáaeiE ITJV eurceipía aaç. ErcircXéov ai)xf| r| ueXéiri 
Ga 5coaei xr| 5uvaiÓTnia a£ ercayyeXuatiec uyeíac Kai aaGEVEÍc va 
KaxavoiíaoDV KaXúiepa TOV avxÍKTurco xriç aaGévEiá aaç óxav KáGe Geparceía 
é^ei oXoKXripcüGeí Kai va ßor|Gf|aei ae evaXXaKiiKf| Geparceía Kai (ppovxíoa rj 
orcoía Ga ße^iicovei xr|v uyeía xcov aaGevcóv m i rnv rcoióir|ia Çcof|ç. 
IIoio eívaí T O ETtófievo ßqua; 
Ecpóaov pe rcpoaoxn oiaßaaexe auxéç xiç rcXr|po(popieç Kai eáv arcoípaaíaeie 
va Xaßexe uépoç Ga rcpércei va erciaipéyeie io arcaviT|TiKÓ 5eX,iápio 
uéaa ae Óuo eßOouaoec. Kan xéioio Ga aaç Ôcoaei TO 'xpòvo rcou eaeiç 
XpeiaÇeore yia va ueÂ£if|aexe auiéç n ç rcXripocpopieç r\ va TIC auÇT|TT)aexe ue 
auyyevEÎç r| cpftouç. Mía eßOouaoa uerá -my arcoaxoÀ,ri TT|Ç rcapouaaç 
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EK\OTo\r\q 0a ETCIKOIVCUVÍ|0"CO laa í^ oaç xrjte^ wviKcoc yia va 87iißsßaicoacu óxi 
TT|v é/exe Aaßei. 'Exai 0a éxouus xr|v EUKaipia va GuÇr|if|coou£ iT^cproviKCûç 
Kai UE K Ó 0 8 XsrcxouépEia oxiôiircoxs a/exíCaxai UE auif) xr|v ueXéxr|. Eáv 
ouutptûvsixe va cjuurcXr|pcûa£i£ xa epcoxTiuaxoXóyia 0a oaç axeiXco 
laxuôpouuccoç xo rcaKÉxo UE xr|v épeuva, éva avxiypatpo auxf|ç ir|ç ErcioroXfjç 
Kai xo évxurco rr\q cn)YKaia0£of|ç caç. Acpoú cnjurc^r|pcûO£X£ xnv épeuva 0a 
7Cp87CSl Va 87ClOTpéySX8 XO 7iaK8XO Xa^ UOpOp-lKCUC XpT]aiU07COlÛ)VTaÇ XOV K8VÓ 
cpáKsAx) rcou 0a rcapa>.aß£X£ uéaa oxo rcaKÉxo. Aev xp£iác¡Eiai va KoXA,r]aex8 
ypauuaxóorjua oúi£ va ypayeie orov KEVÓ tpáKsXo XT)V 5IEÚ0UVOT| lou 
rcapaX,f|rcxri a(pou r\ 8IEÚ0UVOT| rcou 0a rjxaX,£Í o cpaKE^oç 0a urcápx£i r|Ôri 
ypauuévrj Ercávco xou. 
Mrcoptó va aXXá^ co yvcb|if| a/cTiKa fis rnv aufifiEToxn fiou <rrnv épeuva 
vai ñ óxi; 
'Exexe xriv ouvaxóxr|Ta va aXXaÇexe yvtùuri Kai va ut] auuuEiexexe axriv 
épeuva orcoia8f|rcoi£ axiypf) xo £rci0uuf|O"EiE. Mrcop£Íi£ va pou 
xnA.£(pcûvf|aexe aio voúuepo xr|X£íptúvou rcou 0a ßpeixe axo xéXoq auxrjç TT]Ç 
ETCIOTOATIÇ r\ va ÇrjxriaexE arcó (piXovq, ouvysveiç f| arcó xo yiaTpó aaç va xo 
Káveí £ K uépouç aaç. Ercioriç urcopeíie va acpfioexe ufivvua oxov auxóuaxo 
xriX£(pcûvr|Tf| O7ioiaôf|rcoxe copa (cn^rcEpiXaußavouevou ßpaÖia Kai 
SaßßaxoKUpiaKa). A£v EÍOTE ce m u í a rc£pírcxcoori urcoxp£Cùuévoç/r| va 
ôcorjEiE E¿jr|yr|a£ic yia xo A,óyo yia xov orcoío arcocpaaioaxe va UT| 
oupuexéxsxe. 
Oí rcXijpocpopfeç rcot) Ga Ôtooo 0a eivai eurcirmrimKEc; 
OAa xa axoixEÎa rcou 0a ouyKEvxpcoOoúv arcó auxf| xriv UEXÉXTI 0a Eivai 
arcóXuxa surciaxeuxiKá. OXa xa ÔEÔouéva 0a rcapauEÍvouv avcovuua Kai 0a 
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avayvcopíCoviai uéaa arcó èva KCÛÔIKO voúuspo. ErcuiAeov, axoi/sía rcou 
axexiÇovxai us saaç Kai rcou 8a rcepiéxouv xo óvoua aaç f| XT | 5isú0uvaf| aaç 
arcó XT|V aivyufi rcou 0a tpúyouv arcó xo /copo xou voaoKOueiou ôsv 0a 
urcápxei TI ôuvaioxnia va urcopeí va avayvcopiaxoúv óxi aaç avrjKouv. TsXoç 
as Kauía avacpopá r\ Ôriuoaieuari auxf|ç xr|ç ueÀ,éxr|ç Ôsv 0a eurcspisxsxs io 
óvouá aaç. 
IIoioç éxei Tiiv ercoTTTsia aimjç T Î ] Ç ]iékèm\q; 
Eiuai uexarcxuxiaKTi speuvr|xiKf| cpoixf]xpia axr|v Iypkr\ Erciaxr|utûv Yysiaç 
axo navsrciaif|uio xr|ç QuaXiaç SouovÇi (University of Wales Swansea), 
Singleton Park, Swansea, SA2, 8PP, UK. Tnv Ercorcxeia auxric xr|ç épsuvaç 
éxsi ri aKaôri|iaiKf| pou srcórcxpia Mrs Fay Kinsella, AéKxopaç xnç axoA,f|ç. 




Tr\X. 6945 463990 
Eáv arcoípaaíaexs va au|iusxéx£TS axnv épeuva 0a aaç axaXsi èva 
urcoysypauusvo avxiypatpo xr|Ç évxurcr|ç auyKaxaOsaTiç aaç. 





TITLE OF PROJECT: 
NAME OF LEAD RESEARCHER: 
PLEASE INITIAL YOUR CONSENT IN THE BOXES 
1 I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions. I confirm I 
have received information on how to contact the researcher. 
2 I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason, and without my médical 
care or legal rights being affected. 
3 I understand that sections of my medicai notes may be looked at by the 
researcher. I give permission for the researcher to have access to my 
records. 
4 I understand that all data will remain confidential and used for 
research purposes only. 
5. I wish to receive a summary of the study on completion 
6. I agree to take part in this study. 
Name of Patient _ _ _ _ _ _ _ _ _ _ _ 
Signature of patient 
Date _ _ ___ ___ _ 
Name of Researcher 









ÜAPAKAAn Y n o r P A ^ T E ME TA APXIKA LAE KA0E ENA AUO 
TA TETPATilNAKIA 
1 
ETußeßauovw o n Z%(Ù S iaßaae i Kai 7tXf|pax; Kaxavorjaei TO 
evr^eptoTiKÓ (puAXaÔio Ttou acpopâ TT|V 7tapa7tavœ épeuva Kai óxi 
u.ou 6ó6r|Ke r\ 5uvaTÓTT|Ta va u7toßaMxu öieuKpivioTucec 
epcoxfiaeiç. Emßeßaiovco óxi éxco evnuepcoÖEi yia TOV tpójto ux 
TOV cwioio ( i n o p ó va ép0a> oe e^ acpfj rnv Epeuvfrcpia. 
2 
'E/co 7iXf|pcoç KaTavofjcei óxi r\ auuuxxoxri \iov cm\v épeuva eivai 
s9eXovriKT| Kai ÓTI eijxai eXeû6epoç/r| va aîtooûpto TT)V 
m>(i(i£TOxr| |iou ae 07ioio5f|7tOTe xpóvo X^P^Ç va Ôcoato e^r)yfio"eiç 
yia xo Xóyo rcou TO KCIVCO Kai x w P k v a emipeaaTei T| rcapoxn TTIÇ 
uupiicriç \LOV (ppovtiÔaç f| ÓWJX oiKauóuaxa noi) éxco. 
3 
Kaxavocü òri rj epeuvf|Tpia 0a xp£i&<ruei va yvcopiÇei laxpiKéç 
7I>.TlpO(pOpÌ£C 7IOU U£ aCpODOUV. AlVO) TT|V àÔEia OTT1V £p£DVf|Tpia 
va éxei 7ipoaßaffn oro tatpiKÓ flou apxeio. 
4 
'Exto Kaia^aßei òri óhx xa ôeôouéva u.ou 0a napaueivouv 
eunioreuTiKà Kai 6a xpTloiu.o7toir|6oûv (lóvo yia epeuvriTiKoûç 
<TK07tOÛÇ. 
5 
0 a eniOufioÛCTa va evr| | iepu)8ó yia xa a7iOTeXécu.aTa TT|Ç 
épeuvaç. 
6 










DEMOGRAPHIC DATA QUESTIONNAIRE 
This questionnaire asks you to provide some gênerai information 
related to your démographie or other characteristics. 
Please reply to the questions below putting a mark (X) to the relevant 
box. 
Code Number: (it is complétée by the researcher). 







• Primary School 
• Secondary School 





• Clerk officer 
• Skilled workman 
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• Farmer 
• Work on their own job 
• Other 
• Not work due to the disease. 
Income (per month) 
• Less than Euro 440 
• Euro 440-880 Euro 
• Euro 880-1467 Euro 
• Euro 1467-2347 Euro 
• Over Euro 2347 
Date of Birth: 
APPENDIX 8 
modern greek t r a n s l a t i o n o f the 
demographical data questionnaire 
e p î î t h m a t o a o r i o ahmotpaoiksin 
xapakthpi_:tik_in 
To rcapaKdtTco EpcoTrmaToXoyio aaç ÇijTà va aTravr^ aeTE «JE Y E V I K E Ç 
£ptoTT]<TEiç nov cr/ETiÇovTai U E ôr|uoypa<piKà r\ akXa xapaKTnpumicâ 
aaç. 
TTapaKa>wtb arcavrrjoTE ariç TtapaKàTto EpomjaEiç aimEicovovraç fis éva 
X T O avriaror/o Kourâia. 
ATJÇGÛV apiGuoç: 



















• EXsu0epoç enayyek\iaTiaq 
• A U o 
• Anéikem epyaaiaç Xoy(û ao0év6iaç 
QiKoyevsiaKÓ avviato siGÓ5r|ua 
• 'ECÙÇ 440 Eupœ (150-OOOôpx) 
• ATEO 440-880 Eupcò (151.000-3000.000 Spx) 
• Airó 880-1467 Eupá) (301.000-500,000 ôpx) 
• A T O 1467-2347 Eupá (501.000-800.000 Spz) 




FUNCTIONAL ASSESSMENT OF CANCER THERAPY-
COLORECTAL (FACT-C) QUALITY OF LIFE 
INSTRUMENT 
Below is a list of statement that other people with your illness have said are 
important. By circling one number per line, please indicate how true 
each statement has been for you durine the last 7 davs. 
Not at ali A little bit Somewhat Quite a bit Very much 
0 1 2 3 4 
1.1 have a lack of energy 1 2 3 4 
Items (usîng the same format as above): 
PHYSICAL WELL-BEING 
1.1 have a lack of energy 
2.1 have nausea 
3. Because of my physical condition, I have trouble meeting the needs of my 
family 
4.1 have pain 
5.1 am bothered by side effects of treatment 
6.1 feel sick 
7.1 am forced to spend time in bed 
SOCIAL/FAMILY WELL-BEING 
8.1 feel distant from my friends 
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9.1 get emotional support from my family 
10.1 get support from my friends and neighbors 
11. My family has accepted my illness 
12 Family communication about my illness is poor 
13.1 feel close to my partner (or the person who is my main support) 
14. Have you been sexually activity during the past year? 
No— Yes If yes: I am satisfied with my sex life 
EMOTIONAL WELL-BEING 
15.1 feel sad 
16.1 am proud of how F m coping with my illness 
17.1 am losing hope in the fight against my illness 
18.1 feel nervous 
19.1 worry about dying 
20.1 worry that my condition will get worse 
FUNCTIONAL WELL-BEING 
21.1 am able to work (including work in home) 
22. My work (including work in home) is fulfilling 
23.1 am able to enjoy life 
24.1 have accepted my illness 
25.1 am sleeping well 
26.1 am enjoying the things I usually do for fun 
27.1 am content with the quality of my life right now 
ADDITIONAL CANCERNS 
28.1 have swelling or cramps in my stomach area 
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29.1 am losing weight 
30.1 have control of my bowels 
31.1 can digest my food well 
32.1 have diarrhea 
33.1 have a good appetite 
34.1 like the appearance of my body 
Do you have an ostomy appliance? 
No— Yes— if yes; answer #35 & 36. 
35.1 am embarrassed by my ostomy appliance 
36. Caring for my ostomy appliance is difficult 
APPENDIX 10 
MODERN GREEK TRANSLATION OF THE FUNCTIONAL 
ASSESSMENT OF CANCER THERAPY-COLORECTAL 
(FACT-C) QUALITY OF LIFE INSTRUMENT 
napaKÓTCù eivai \ua Xiaxa ano òVitauoeic nov éicavav aXXoi áv0pcu7ioi nox> naaxouv 
a7üó TT|V aoBéveiá aaç Kai eírcav ÓTI eivai OT|uavriKoí. Litusuavovraç ue KVK) .O 
évav (1) apiOuó avá ypauuTJ, KaOopíorc TO Kara nóoo avraTtoKpivórav arny 
ApayuaTiKÓTíiTa KÓOS uta arcó T IÇ OUXCÓCTEU; avréq yia aaç, Kara T IC TeXgüTaíec 
7 niiépgg. 
OYS.IKH EYESIA K a e ó Aíyo Apicerá napa 
o^t> Káncoc noki) 
0 1 2 3 4 
AiaOávouai KÓTCcoan 
'E t^o vauria f| xáori yia E^IETÓ 0 1 2 3 4 
EÇaixiaç TT|Ç aa)u.aTiKf[ç uou KaTáorao-nc ¿xco jrpoß>.Tiu.a 
oro va avxajroKpiOü) oriç aváyKec TTJÇ oiKoyéveiác |iou 
0 1 2 3 4 
'Exa> TÜÓVODC 0 1 2 3 4 
EvoxXoúuxu arcó TIÇ Tuapevépyeieç xnç GepanEÎaç \iox> 0 1 2 3 4 
NOIÍÜGCO appcooroç 0 1 2 3 4 
AvayicáCou-ai va p¿vco oro KpsßaTi 0 1 2 3 4 
KOINÍ1NIKH / OIKOrENEIAKH Ka6ó Aíyo Ká*o> A P k £ t napa 
EYESIA ^ ç á * o W 
NOUÓUCO KOVlá OTOUÇ (píXODC flOt) 0 1 2 3 4 
H oiKoyévEiá fiou TtpoacpépEí <ruvaia0nuxiTiKT| 
ouujtapáoraori 0 1 2 3 4 
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Y7tooTT|pí^o|iai ano touç (piXouç \ixm 0 1 2 3 4 
H oiKoyéveiá u.ou é/ei anobeyxeí rnv aaoévetá u.ou 0 1 2 3 4 
Eiu,ai iKavojiomu-evoc / n \\z rnv eniKoivcovía 7tou é%(û ne 
TT]V oiKoyéveiá u.ou ÓCTOV a(popá rnv aaôéveia uou 
0 1 2 3 4 
AiCT0ávonai Kovxá aro (arr|) cnjvxpotpó u.ou (f| oro áxou.o 
jtou Kupicoç ftou <rü(ajtapa<rcéKexai) 0 1 2 3 4 
AveÇapxrjra JÀE TO EKÎTZEÔO xnç mjfiepivîjç aaç aeÇovaÀiKrjç 
ôpaoxnpioxnxaç, KopaxaloúpE va (uiavajore axnv axókovOn Epá>xr\ar\. 
Eáv npoxipáxE va pnv rnv anavx^aEXE, an^eicbare peXxo KOVXÓKI auxói 
Kai OVVSXÍOTE (TTTJV ETCÓfiEVT} EVÓXnXO. | | 
1 2 3 4 
Eíu.ai iKavortoirmévoí; (r|) ux xn aeCouaXiKií pov Çœf| Q 
221 
Ztipsuàvovra^ ux KUKXO évav (1) apiOjió ava ypaujiTJ, KaOopiaTE TO Hard 
novo avranoKpivÓTav <rrr|V TrpayuaTiKÓTnra KàOs uaa ano T I ^ Òt)>xb(r8i^  
aurés yia cai;, KOTÓ T IC TxXfUTatec 7 nuepec. 
LYNAIX0HMAT1KH EYESIA 
Aia0dvopai 0Xu|/r| 
Eijiai ucavo7coir|U£Voq / r| UE TOV TpÓTio ux xov OJCOÌO 




Xdvco xii; eha&eq pou arri u.a/r) ux Tnv ao"0év£tà u.ou 0 
Aia0àvou.ai avr|croxia 0 
Aio0àvonai avncroxto 0 1 1 0 a 7re0àvco 0 














A E I T O Y P r i K H EYESIA Ka0ó Aiyo Kdnco ApK£ Ilàpa 
Ei)jai CE 0ÉOT| va epya<JTG> (au(i7tepiXàp£TE TT|V epyaoia 
oro onixi) 0 
H Epyaaia uou (aunjiEptXdpETE xny epyaoia aro antri) 
(j.e ucavorcoiEi 0 
Mnopco Kai xcupopai TT| tpyf\ iiov 0 
A7Eo8éxpnai Tny aa0év£id (iou 0 
Koi^duai KaXd 0 
ATtoXxtfipàvo) aura nox> auvfjOco^  icàvco yia SiamcéSacrn, 
/ avaMfx>xf\ 0 
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Eí|xai iKavo7toiTm£voç (r\) (iE xnv jioió-ctira Çtofjç ^ou 
aurfi TTj öTiynri 0 1 2 3 4 
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EilUEicóvovrac UÈ KVKXO évav (1) apiWuó avá ypapuri, teaOopíoTe TO Kara novo 
avranoKpivÓTav cnrny jrpay^xiKÓTnxa KÓOE pia ana T IC ÔI^. IÛÎTEIÇ auréç yia 
aaç, Kara T IC Tskevraiec 7 tmépEg. 
n P O £ 0 E T E £ ANHEYXIEE KaUó Aiyo K ô t i i o ç ApKerá napa 
'E/co (poDoxo^ iaxa f| KpapjtEç omv 7CEpioyf| TOU 
OTOpá/ou 0 
Xávíu ßapoc 0 
EA¿yx<o xo 7TÓTE Evepyoúpai 0 
XGWEUCÖ KaXá TO (paynxó ¿IOU 0 
'Exco Siáppoia 0 
H ópE^T] p.ou EÍvaí KOXT\ 0 
0 
Mou apéoei r\ Epxpaviari xoi> acopaxóc (ioi> 
'E^STE CTUOKEVTJ KOta>OTOpíOC (ST|p£lOöTE OXO OVTÍOXOIXO 
7tXaíaio) 
Av vai, JtapcocaXEÍore va a7tavxf[<TT£ ara oúo 
napaicáxto Epcoxfipaxa: 
ME ítElpá^El 7101) ¿XO) GDCTKEUTÍ KoXoCXO(iíaC 0 
To ßpiöKW OÚOKOXO va va (ppovxíCco yia XTJ 






SHORT FORM 36 HEALTH SURVEY 
(MENTAL HEALTH) 
INSTRUCTIONS: This set of questions asks for your views about your 
health. This information will help keep track of how you feel and how well 
you are able to do your usual activities. 
Answer every question by making the answer as indicated. If you are unsure 
about answer a question please give the best answer you can. 
1. Du ring the past 4 weeks, have you had any of the folio wing problems 
with your work or other regular daily activities as a resuit of any emotional 
problems (such as feeling depressed or anxious)? 
(Please circle one number on each line.) 
YES NO 
a. Cut down on the 
amount of time you 
spent on work or other 
activities 
1 2 
b. Accomplished less 
than you would like 
1 2 
c. Didn't do work or 
other activities as 
carefully as usual 
1 2 
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2. Düring the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your normal social activities with 
family, friends, neighbours, or groups? 
(Please circle one number) 
Not at all 1 
Slightly 2 
Moderately 3 
Quite a bit 4 
Extremely 5 
3. Thèse questions are about how you feel and how things have been with 
you during the past 4 weeks. Please give the one answer that is closest to 
the way you have been feeling for each items. 
(Please circle one number on each line.) 
AH of Most of AGood Some of A little None of 
the the Bit of the ofthe the 
Time Time the 
Time 
Time Time Time 
Did you feel full of 1 2 3 4 5 6 
fe? 
have you been a 1 2 3 4 5 6 
sry nervous person? 
Have you feit so 1 2 3 4 5 6 
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own in the dumps 
iat nothing could 
heer you up? 
. Have you feit calm 
nd peaceful? 
1 2 3 4 5 6 
. Did you have a lot 
f energy? 
1 2 3 4 5 6 
have you feit 
ownhearted and blue? 
1 2 3 4 5 6 
. Did you feel worn 
ut? 
1 2 3 4 5 6 
. Have you been a 
appy person? 
1 2 3 4 5 6 
Did you feel tired? 1 2 3 4 5 6 
4. Düring the past 4 weeks, how much of the time has your physical health 
or emotional problems interfered with your social activities (like visiting 
with friends, relatives etc). 
(Please circle one number) 
A l i of the time 1 
Most of the time 2 
Some of the time 3 
A little of the time 4 
None of the time 5 
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APPENDIX 12 
MODERN GREEK TRANSLATION OF SHORT FORM 36 
HEALTH SURVEY 
(MENTAL HEALTH) 
SF -36 EPEYNA YTEIAL 
OAHTIEL: To epwxrjuaxoXóyio aoxó £r|xà tiq òiKÉq aaq anóysiq yia XT|V 
vyeia aaq. Ol 7rXn,po(popi£<; oaq 9a \iaq ßor|0f|aoi>v va e^aKpißwaoupe n<bq 
aio0dveoxe arcò nksvpàq uyeiac; Kai TCÓCTO KaXà UTtopeixe va aa/oXriOeixs U£ 
TU ; auvn0iau£vs<; OpaaxripióxTixéq aaq. 
Arcavxf|axe cxiq epoJxriaei<;, ßa9p.oA,oycovxac; K à O e aJtdvxT|oT| ue xov xpÓTio 
Tcou aa<; Òeiyyo\)\xe. Av Ssv siaxe anóXma ßeßaio<^r| yia TTIV a7idvxr|OT| aaq, 
7EapaKaA.oi3u£ va 5(òaexe TTIV arcdvTT|OTi TTOU voui^exe ÓT I xaipid^ei KaXuxepa 
OTTjV 7T8pÌ7CXQ)OT| Oaq. 
1. Tu; tekevraieq 4 sßöoudÖec, oaq 7iapoi)aiàoxr|K£ -eixe axr|v SouXsid aaq 
eixe ae Kàrcoia àXkr\ ai)vr|0iapévr| Ka0T|p,epivr| 5paaxTjpióxT|xa - KÓTEOIO ano 
xa 7iapaKdxco 7cpoßA,f)paxa s^arria«; 07toiot)8t|7roTe avvaiaBrmoTiKov 
7Tpoß}vT|paTOi; (k.% eneiÒr) voióaaxe peXayxoXia f| ày%oq); 
(KDKÀtóaTe évav apiOpó ae KÓ9e aeipà) 
NAT lOXI 
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a. MeióaaTE TO gpóvo nov crovf|0(ûç ÇoÔeuaxe axriv 
ÔooXeia aaç f| ae àXXeq ôpaaxiipioxTixeç 1 2 
ß. EmxeXiaaxe Xiyóxepa ano óaa Ga Gelare 1 2 
Kávaxe TT| ôouXsia f| Kai áXXeq ÔpaaxT]pioxr|xeç 
¿.lyóxepo npoae/TiKa an7 óxi auvriGcoç 
1 2 
2. Tiç TetavTaieç 4 eßöouaöec, ae rcoio ßaGuo 87rr|péaae r| Kaiaaraari TT|Ç 
acouaxiicríc aaç uyeiaç TÍ Kárcoia owaiaGrjuaxucá 7tpoßXrmaxa xiç 
auvii0ia|j.éveç KOIVCÛVIKÉÇ aaç 8paaxT]pioxr|xeç ue XT|V oiKoyéveia, xouç 
(piXouç, f\ xouç yeixovéç aaç r) pe áXXzq KoivcoviKéç ouâôeç; 





napa noXx) 5 
3. Oi TtapaKaxcû epcoxriaeiç avacpépovxai axo na>q aioGáveaxe Kai axo róc 
x)xav yevuca r\ oiáGearí aaç T I Ç TetevTafeç 4 eßÖojiaOec. Tía KáGe EpáTnori, 
rcapaKa^eiaxe va ôcoaexe eKeivr] xr|v a7r.ávxT)ari rcou rcXîiaiaÇei Ttspiaaóxepo 
ae óxi aiaGavGf|Kaxe. 
Tiq TskEmaisq 4 EßÖouaÖEc, yia rcóao xpoviKÓ ÔiaaxT|ua 
(KUK^XÖOTE évav apiOuó oe KáOe OEipá) 










1 2 3 4 5 6 
. Eí/axe 7coA,i3 
icveopiauó 





ou TÍ7COT6 Ôev 
T i o p o ú o e va 
aç cpxiaÇei TO 
écpi 




1 2 3 4 5 6 
Eíxaxe nókó 
yer^xiKÓTnxa 








^ á v T ^ r ) O T | 
1 2 3 4 5 6 
|. 'Haaate 
UTuxiau.évoç/r| 
1 2 3 4 5 6 
UaGavóaaare 
:oTjpaor| 
1 2 3 4 5 6 
4. Tiç TC^XDTaisç 4 eßSouadec, T | Karáo-raar) TT|Ç atouariittiç caç uysiaç 
KÓTTOia <n) vaiato) piariKá TTpoß^uaTa yia rcóao xpovucó 5iáoTr|ua 
87mpéaaav nç KOIVCOVIKÍC oaç ÔpaaTTipiOTnreç (rc.x ETUOKéyeiç as (píA,ouc, 
croyyeveíc); 
(ßa>T8 évav KÚKXO) 
Euvexwç 1 
To ueyaXúiepo 5iáorrma 2 
MáM-ov niKpó 5iáGTTi|ia 3 




Center for Epidemiologic Studies Depression 
Scale (CES-D) 
Below is a list of some of the ways you may have felt or behaved. 
Please indicate how often you have felt this way during the last 
week by checking the appropriate box for each question. 
Rarely or 
none of the 
time 
(less than 1 
day) 
Some or a 








All the time 
(5-7 days) 
I was bother by 
things that usually 
do not bother me 
I did not feel like 
eating; my appetite 
was poor 
I felt that I could not 
shake off the blues 
even with help from 
my family 
I felt that I was just 
as good as other 
people 
I had trouble 
keeping my mind on 
what I was doing 
I felt depressed 
I felt that everything 
I did was an effort 
I felt hopeful about 
the future 
I thought my life 
had been a failure 
I felt fearful 
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ly sleep was restless 
was happy 






had crying spells 
felt sad 
felt that people 
isliked me 




MODERN GREEK TRANSLATION OF CES-D 
CENTER FOR EPIDEMIOLOGICAL STUDIES 
DEPRESSION SCALE (CES-D) 
IlapaKaXd) OTpnAripcocrre sva X aro Terpayoovo 7tou Gaopevre an avrajtoKpivetai aro mx; 
aioGavoaacrrav rata IT | 5idpK£ia tr\q 7tepaanevr|<; eP5opd8a<; (rail o^i novo nrnq aiaGaveaxe 












riuepe^ (5-7 ^ 
1. Me evoxAoiJoav Tipcr/waxa nov cwntfcoc; OEV u.e 
evoxXow. 
2. Aev er/a 5id0eor| va 96x0. H ope^n uoo frcav 
KaKq. 
3. Aiottovououv on oev tfa UJtopouoa va e^cpuyco 
OTTO TU ; uaupa; uov, aicoua ouxe Kai ue xn poriGeia 
Tng oiKcr/eveidf; uau r) xcov (piAxov uou. 
4. Aiatfavouow on eiuai TO i&io onmc, 01 aXkoi 
dv0po)7ioi. 
i . hixa 7ip6(iA,r)ua axo va KpaTf|aco TO puaAo UOU 
croyKevxpcouevo a' amo nox> eKava. 
6. AioGavouow Kaxa0A,n|ni. 
/. Aiotiavouow on on&fiJtoxe EKava arcaixovjae 
u£ydlr| 7tpooita0eia. 
8. AioOavououv yeudxoc/ r| eXjrioa yia TO UEXAOV. 
9. llicxeua on r\ tpi) uou oA6KA,r|pri rjxav jiia 
aTcoxuxia. 
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10. AioGcrvójiOUV yeuriioç/ rj cpoßo. 
11.0 vkvoç pou f|iav avrïouxoç. 
12. 'Huouv xapouu£voç/ T|. 
13. MiÀoóoa Àayórepo curó TO (TUVT)9IO)1£VO. 
14. AioOavóuouv uova^iá. 
15. Oí ávopamoi Ô8V fjxav (píXiKoí uaCí uoo. 
16. AKoXaußava TTJ ÇCDTJ. 
17. HecjTioúoa OE t&áua. 
18. Aic^avóuouv Xvm\[iévoc/ r\. 
19. 'EvicoOa ón oí áXXoi pe ctvTurxiGoúoTjtv. 





Enriching & Nurturing Relationship Issues, Communication & 
Happîness 
COMMUNICATION SCALE WITH PARTNER 
The questions below related with your relationship with your familiär social 
environment. Please replay to the next question putting a mark X to the 
relevant box. 
Do you live with a partner? 
YES • 
NO • 
If your answer is YES please circle one number on each line of the questions 












1. It is very easy 
for me to express 
all my true 
feelings to my 
partner. 
1 2 3 4 5 
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2. When we have 
a problem my 
partner often 
gives me the 
silent treatment 
1 2 3 4 5 
3. My partner 
sometimes 
makes comments 
which put me 
down 
1 2 3 4 5 
4.1 am 
sometimes afraid 
to ask my partner 
for what I want 
1 2 3 4 5 
5.1 whish my 
partner was more 
willing to share 
his/her feelings 
with me 





partner tells me 
1 2 3 4 5 
7. Often do not 
teli my partner 
1 2 3 4 5 
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8.1 am very 
satisfied with 
how my partner 
and I talk with 
each other 
1 2 3 4 5 
9.1 do not 
always share 
negative feelings 
I have about my 
partner because I 
am afraid he/ she 
will get angry 
1 2 3 4 5 
10. My partner is 
always a good 
listner 
1 2 3 4 5 
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COMMUNICATION SCALE WITH AN IMPORTANT 
PERSON 
Is there someone in your life (friend, family membership) with whom you 
can share your feelings? Please put a mark X to the relevant box. 
YES • 
NO • 
If your answer is YES, please circle one number on each line of the 
questions below. 












1. It is very easy 
for me to express 
ail my true 
feelings to this 
person. 
1 2 3 4 5 
2. When we have 
a problem this 
person often 
gives me the 
silent treatment. 
1 2 3 4 5 
3. This person 
sometimes 1 2 3 4 5 
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makes comments 




to ask this 
person for what I 
want. 
1 2 3 4 5 
5.1 whish this 
person was more 
willing to share 
his/her feelings 
with me. 
1 2 3 4 5 




person tells me. 
1 2 
V 
3 4 5 
7.1 often do not 
tell to this person 




1 2 3 4 5 
8.1 am very 
satisfied with 1 2 3 4 5 
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how this person 
and I talk with 
each other. 
9.1 do not 
always share 
negative feelings 
I have about this 
person because I 
am afraid he/ she 
will get angry. 
1 2 3 4 5 
10. This person 
is always a good 
listner 
1 2 3 4 5 
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APPENDIX 16 
MODERN GREEK TRANSLATION OF THE ENRICHING 
& NURTURING RELATIONSHIP ISSUES, 
COMMUNICATION & HAPPINESS (ENRICH) 
COMMUNICATION SCALE WITH PARTNER 
EPftTHMATOAOriO EIIIKOINONIAE ME TO/TH 
LYNTPOOO 
Oi 7EapaK<XTCû epcûifiaeiç acpopouv TT|V O"XÉOT| aaç LIS TO OTSVÔ aaç KOIVCOVIKÔ 
7rspipdXXov. IlapaKaXa) aTtavrfioxe Tnv S7iôu.evr| epayrnori ormsiœvovxaç UE 
X TO avdXoyo KOUTCIKI . 
ZsiTS U.S K0171OIO aiJVTpocpo; 
NAI • 
OXID 
Eàv NAI 7iapaKaX,a> a7iavTf|aTS onç îrapaKctTco spœTr|aeiç pdÇovraç as 














1. EKcppdÇco us 
\ieyâXr\ evKokia Ta 
aXnGivd uou 
auvaia0f||iaTa 







cwcpocpoc uou cru^vá 
aOiaípopeí. 
1 2 3 4 5 
3. Ta axóÀaa TOU/TÏ IÇ 
auvipócpou uou 
uspiKéç (popéç pe 
Kávouv va VOICO0OÛ 
(aeicoveKxiKá. 
1 2 3 4 5 
4. Mepixéç cpopéç 
(poßauai va CX)TT\O<Ù 
ano TOV/TTIV 
owrpocpó pou K a l l 
1 2 3 4 5 
5. 0a eu/óuouv o/r\ 





TOU/TTIÇ uaÇi pou. 
1 2 3 4 5 
o.Mepucéç (popéç 
ôuaKoA,euouai va 1 2 3 4 5 
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moTéy(ù 7ipáyuaxa 
Ttou O/T| oúvxpotpóc 
pou Xé&i. 
7.Suxá Ösv Xé(ü 
OTO/aTT| CTÜVTpOípÓ 
pOl) TO 7CCÛÇ 
aioGávouai £7i8iôf| 
OeCOpCO ÓTl 6a 87lpS7lS 
fjOri va yvcopíCsi xa 
cnjvaia9t)paxá uoi>. 
1 2 3 4 5 
8. Eíuai noXò 
iKavo7ioirjuévoc/r| us 
XOV XpÓ7CO US xov 
0710ÍO auCnxáus 
uexaCú uaç. 
1 2 3 4 5 
9. Aev uoipáCouai 
7IOXÉ xa apvnxncá 
rjuvaio0r|uaxa rcou 
xpscpco yia xov/xnv 
CTÜVXpOípÓ UOD 87C8lÔrj 
cpopápai óxi 0a 
Ouuœasi. 
1 2 3 4 5 
10.O/H rjóvxpocpóc 
UOD sívaí 7iávxa 
Ôia0écuuoç va us 
aKOÚO£l. 
1 2 3 4 5 
244 
EPÍXTHMATOAOriO EIHKOINÍINIAL ME LHMANTIKO 
r i p o s a n o 
Oí 7capaK(iTû) epœxfïaeiç acpopoúv XT|V OSSOTI aaç ue TO axevó aaç KOIVCUVIKÓ 
TiepißaXXov. üapaKaXa) aT tavxf i axe TT|V e7TÓuevr| epG)TT|ar| a r i usuavovxaç ue 
X TO aváXoyo K O U T O X I . 
Yjcápxei K a r c o i o ç atri Çcor| aaç (cpiXoç, (p\Xr\ fj uéX,oç a7ió xo o i K o v e v e i a t c ó aaç 




Eáv NAI 7iapaKaXcb a7iavxf|axe axiç 7capaKáxco epcoxfiaeic paÇovxaç ae 
KÚKXO évav apiGuó as Ká0s asipá. Eáv OXI, cqueuóaxe pe èva X xo 












1. ExxppaCü) pe 




1 2 3 4 5 
2. Oxav 
avxiuexamíCouue éva 
1 2 3 4 5 
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7ipoßXr)ua TO áxouo 
auxó ou^vá 
aôiacpopei. 
3. Ta o%óAia TOD 
axóuou auxoú pou 
pSplKÉÇ CpOpSÇ US 
Kávouv va VOIÓ0CD 
ueioveKxucá. 
1 2 3 4 5 
4. Mepucéç (popéç 
(poßauai va CT|xf|c(u 
ano TO áxouo auto 
K Ó T I rcou 0éXa>. 
1 2 3 4 5 
5. 0a euxóuouv xo 
ÓTOUO auTÓ va f|xav 
Tispiaaóiepo 
7ipó0uuoc/r| va 
uoipaaxeí T a 
ouvaiaGfiuaTá 
TOU/XT|Ç uaÇi uou. 




Tiou xo áxouo auxó 
XÍ81. 
1 2 3 4 5 
7.Lu/á Ôsv Aito oro 




Gecopcó on 0a tnpens 
fior] va yvtopiÇei ta 
auvaia0f|uaxá uou. 
1 2 3 4 5 
8. Eíuai itókò 
iKavo7toiîiuévoç/r| us 
TOV TpÓ7lO US TOV 
07coio cruÇnxaue 
usxa^ú uaç 
1 2 3 4 5 
9. Aev uoipáCouai 
7tOTS xa apVT|TlKá 
cn)vaia0f|uaxa nero 
Tpé(pco yia TO áxouo 
auxó eTieiôf) cpoßauai 
óxi 0a Oouœoei. 
1 2 3 . 4 5 
10. To áxouo aoxó 
eivai návxa 
ÔiaGéaiuoç va ue 
aKovaei. 
1 2 3 4 5 
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APPENDIX 17 
Granted permission for undertaking the study research from 
the relevant authority of "Oi Agioi Anargyroi" hospital. 
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the relevant authority of "Henri Dunant" hospital. 
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